Mathematical modeling of species-specific diacylglycerol dynamics in the raw 264.7 macrophage following P2Y6 receptor activation by uridine 5\ue2-diphosphate by Callender, Hannah Lea
MATHEMATICAL MODELING OF SPECIES-SPECIFIC DIACYLGLYCEROL
DYNAMICS IN THE RAW 264.7 MACROPHAGE FOLLOWING P2Y6
RECEPTOR ACTIVATION BY URIDINE 5’-DIPHOSPHATE.
By
Hannah L. Callender
Dissertation
Submitted to the Faculty of the
Graduate School of Vanderbilt University
in partial fulfillment of the requirements
for the degree of
DOCTOR OF PHILOSOPHY
in
Mathematics
August, 2007
Nashville, Tennessee
Approved: Date:
Mary Ann Horn May 23, 2007
H. Alex Brown May 23, 2007
Glenn F. Webb May 23, 2007
Philip S. Crooke May 23, 2007
Emmanuele DiBenedetto May 23, 2007
Copyright c© 2007 by Hannah L. Callender
All Rights Reserved
acknowledgements
I would first like to thank my advisor, Professor Mary Ann Horn, for all of her help and
guidance. In addition to all of her mathematical advice, she has provided exceptional
career advice and moral support for which I will be infinitely grateful.
I would next like to thank my biology advisor, Professor H. Alex Brown, for giving
me the opportunity to develop my skills as a true biomathematician while working in
his laboratory, as well as for providing me with continual support and encouragement.
I would also like to thank Professor Glenn Webb for serving as my on site mathe-
matics advisor and for providing key ideas for analysis techniques and encouragement,
Professor Emmanuele DiBenedetto for serving as my inspiration to enter into the field
of mathematical biology, and Professor Philip Crooke for his valuable feedback on my
research.
This work was supported in part by the Alliance for Cellular Signaling National
Institutes of Health grant, LIPID MAPS, the Ingram Endowment (to HAB) and
by a Vanderbilt University Summer Research Award (HLC). I am thankful for that
support.
Finally, I would like to thank my friends and family for their unconditional love
and encouragement, and my Lord and Savior Jesus Christ for remaining by my side
throughout this journey.
iii
table of contents
Page
ACKNOWLEDGEMENTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . iii
LIST OF TABLES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . vi
LIST OF FIGURES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . vii
LIST OF ABBREVIATIONS . . . . . . . . . . . . . . . . . . . . . . . . . . . ix
Chapter
I INTRODUCTION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
II MODEL CONSTRUCTION . . . . . . . . . . . . . . . . . . . . . . . . . 7
II.1 Module 1: Receptor Dynamics . . . . . . . . . . . . . . . . . . . . 7
II.2 Module 2: G-protein Cascade . . . . . . . . . . . . . . . . . . . . . 10
II.3 Module 3: Diacylglercol production and degradation . . . . . . . . 13
II.4 Module 4: Cytosolic Calcium dynamics . . . . . . . . . . . . . . . 16
II.5 Dimensionless Scaling . . . . . . . . . . . . . . . . . . . . . . . . . 18
II.6 Initial Conditions of the Model . . . . . . . . . . . . . . . . . . . . 20
III THEORETICAL MODEL ANALYSIS . . . . . . . . . . . . . . . . . . . 22
III.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
III.2 Existence and Uniqueness of Solutions . . . . . . . . . . . . . . . . 24
III.3 Steady-State Solution . . . . . . . . . . . . . . . . . . . . . . . . . 38
III.3.1 Local Stability of Steady States . . . . . . . . . . . . . . . 40
III.3.2 Global Stability of Steady States . . . . . . . . . . . . . . 45
IV NUMERICAL MODEL ANALYSIS . . . . . . . . . . . . . . . . . . . . . 60
IV.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 60
IV.2 Estimation of Unknown Rate Parameters from Experimental Data 61
IV.2.1 Numerical Methods . . . . . . . . . . . . . . . . . . . . . . 61
IV.2.2 Experimental Methods . . . . . . . . . . . . . . . . . . . . 63
IV.2.3 Parameter Estimation . . . . . . . . . . . . . . . . . . . . 64
IV.3 Sensitivity Analysis . . . . . . . . . . . . . . . . . . . . . . . . . . 71
IV.3.1 Sampling Method and Sensitivity Technique . . . . . . . . 71
IV.3.2 Implementation of the Sensitivity Methods . . . . . . . . . 74
V DIACYLGLYCEROL PATHWAY ANALYSIS . . . . . . . . . . . . . . . 79
V.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 79
V.2 Two-Dose UDP Experiments . . . . . . . . . . . . . . . . . . . . . 80
V.3 DAG Kinase Inhibitor II (R59949) Experiments . . . . . . . . . . . 80
iv
V.4 Multiple DAG Inhibitors Experiments . . . . . . . . . . . . . . . . 88
V.5 Propranolol Experiments . . . . . . . . . . . . . . . . . . . . . . . 91
VI QUANTIFICATION OF MOLECULAR SPECIES OF DIACYLGLYC-
EROL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 96
VI.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 96
VI.2 Experimental Materials and Methods . . . . . . . . . . . . . . . . 98
VI.2.1 Materials . . . . . . . . . . . . . . . . . . . . . . . . . . . . 98
VI.2.2 Extraction of glycerophospholipids from stimulated cells . 99
VI.2.3 Diacylglycerol isolation and recovery . . . . . . . . . . . . 99
VI.2.4 Mass spectrometric analysis of DAG extracts . . . . . . . . 100
VI.3 Results and Discussion . . . . . . . . . . . . . . . . . . . . . . . . 100
VI.3.1 Isotopic correction . . . . . . . . . . . . . . . . . . . . . . 100
VI.3.2 Chromatographic separation and DAG detection . . . . . . 104
VI.3.3 Mathematical analysis of data and development of standard
curves . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 105
VI.3.4 Quantification of DAG species in RAW 264.7 cells after PAF
stimulation . . . . . . . . . . . . . . . . . . . . . . . . . . 113
VII CONCLUSIONS AND FUTURE DIRECTIONS . . . . . . . . . . . . . 117
VII.1 Modeling Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . 117
VII.2 Pathway Analysis Results . . . . . . . . . . . . . . . . . . . . . . . 119
VII.3 DAG Quantification Results . . . . . . . . . . . . . . . . . . . . . 121
Appendix 122
A ADDITIONAL SIMULINK FIGURES . . . . . . . . . . . . . . . . . . . 123
B MATLAB CODE FOR NUMERICAL ANALYSIS . . . . . . . . . . . . 123
BIBLIOGRAPHY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 153
v
list of tables
Table Page
1 Time-dependent nondimensionalized model variables . . . . . . . . . . . . 18
2 Modified rate parameters for nondimensionalized system . . . . . . . . . . 19
3 Eigenvalues for the Jacobian Matrix . . . . . . . . . . . . . . . . . . . . . 44
4 Time-independent model variables . . . . . . . . . . . . . . . . . . . . . . 65
5 Materials used for DAG quantification . . . . . . . . . . . . . . . . . . . . 98
6 % Total abundance of masses of naturally occurring 38:4 DAG . . . . . . 103
7 Slopes for eight DAG standards . . . . . . . . . . . . . . . . . . . . . . . 109
8 Coefficients of the multiple parameter linear model for estimating slopes . 111
9 Predicted slopes for the 28 species of DAG . . . . . . . . . . . . . . . . . 112
10 Limits of detection for the eight DAG internal standards . . . . . . . . . 113
vi
list of figures
Figure Page
1 Schematic of UDP canonical pathway . . . . . . . . . . . . . . . . . . . . 11
2 Two pool DAG model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
3 Jacobian matrix of our system at the steady state solution ξ. . . . . . . . 43
4 Full SIMULINK model . . . . . . . . . . . . . . . . . . . . . . . . . . . . 62
5 UDP Timecourse for 38:4 and 34:1 DAG, IP3, and Ca
2+ . . . . . . . . . . 66
6 UDP Timecourse for P2Y6, Gα·GTP, and PIP2 . . . . . . . . . . . . . . . 70
7 SRCs and R2y values for IP3 . . . . . . . . . . . . . . . . . . . . . . . . . . 75
8 SRCs and R2y values for DAG . . . . . . . . . . . . . . . . . . . . . . . . . 76
9 34:1 DAG changes for variations in kdp2 . . . . . . . . . . . . . . . . . . . 77
10 34:1 DAG changes for variations in kap2 . . . . . . . . . . . . . . . . . . . 78
11 34:1 DAG changes for variations in kdp1 . . . . . . . . . . . . . . . . . . . 78
12 Two-Dose UDP DAG Graphs . . . . . . . . . . . . . . . . . . . . . . . . . 81
13 Fold changes and p-values for DAG response to 250 nM UDP . . . . . . . 82
14 Fold changes and p-values for DAG response to 250 µM UDP . . . . . . . 82
15 DAG Kinase Inhibitor Graphs . . . . . . . . . . . . . . . . . . . . . . . . 84
16 Differences and p-values for R59949 data . . . . . . . . . . . . . . . . . . 85
17 Comparison between responses of UDP and UDP + R59949 . . . . . . . . 86
18 Propranolol effects on DAG response to UDP at 15 minutes . . . . . . . . 88
19 Thimerosal effects on DAG response to UDP at 15 minutes . . . . . . . . 89
20 U73122 effects on DAG response to UDP at 15 minutes . . . . . . . . . . 89
21 U73433 effects on DAG response to UDP at 15 minutes . . . . . . . . . . 90
22 R59949 effects on DAG response to UDP at 15 minutes . . . . . . . . . . 90
23 Propranolol Graphs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 92
24 Lipid Array for PA response to UDP +/− Propranolol . . . . . . . . . . . 94
25 Identification of DAG sodium adducts . . . . . . . . . . . . . . . . . . . . 101
vii
26 Baseline mass spectrum from RAW 264.7 cell extract . . . . . . . . . . . 102
27 Example of isotopic correction . . . . . . . . . . . . . . . . . . . . . . . . 103
28 Positive ESI mass spectrum with 9 diacylglycerol standards . . . . . . . . 106
29 Effects on normalized signal strength of additions of 34:1 DAG to lipid
extracts from RAW 264.7 cells. . . . . . . . . . . . . . . . . . . . . . . . . 108
30 Differences in standard curves among different cellular extracts. . . . . . . 114
31 PAF timecourse for four DAG species . . . . . . . . . . . . . . . . . . . . 116
32 SIMULINK Activated Receptor subsystem . . . . . . . . . . . . . . . . . 123
33 SIMULINK Inactivated Receptor subsystem . . . . . . . . . . . . . . . . 123
34 SIMULINK Activated G-protein subsystem . . . . . . . . . . . . . . . . . 124
35 SIMULINK PIP2 subsystem . . . . . . . . . . . . . . . . . . . . . . . . . 124
36 SIMULINK IP3 subsystem . . . . . . . . . . . . . . . . . . . . . . . . . . 125
37 SIMULINK DAGp1 subsystem . . . . . . . . . . . . . . . . . . . . . . . . 126
38 SIMULINK DAGp2 subsystem . . . . . . . . . . . . . . . . . . . . . . . . 126
39 SIMULINK Cytosolic Ca2+ subsystem . . . . . . . . . . . . . . . . . . . . 127
40 SIMULINK h subsystem . . . . . . . . . . . . . . . . . . . . . . . . . . . 128
41 SIMULINK c0 subsystem . . . . . . . . . . . . . . . . . . . . . . . . . . . 128
42 SIMULINK Block Definitions . . . . . . . . . . . . . . . . . . . . . . . . . 129
viii
list of abbreviations
Abbreviation
GPCR G-protein-coupled receptor
Ca2+ calcium
ER endoplasmic reticulum
PLC phospholypase C
PIP2 phosphatidylinositol 4,5-bisphosphate
DAG diacylglycerol
IP3 inositol 1,4,5-trisphosphate
ATP adenosine triphosphate
RNA ribonucleic acids
DNA deoxyribonucleic acid
UTP uridine triphosphate
ADP andenosine diphosphate
UDP uridine diphosphate
ODEs ordinary differential equations
NX number of molecules of species X
[X] concentration (in µM) of species X
IP3-R IP3 receptor
GDP guanine diphosphate
GTP guanine triphosphate
PA phosphatidic acid
PUFA poly-unsaturated fatty acid
PLD phospholipase D
PI phosphatidylinositol
CDP-DG cytidine diphosphate DAG
SRC standardized regression coefficient
ix
LHS latin hypercube sampling
R2y model coefficient of determination
DAGk DAG kinase
LPP lipid phosphate phosphatase
MAG monoacylglycerol
MAGT monoaclyglycerol acyltransferase
MALDI matrix-assisted laser desorption/ionization
ESI-MS electrospray ionization mass spectrometry
PAF platelet-activating factor
PC phosphatidylcholine
PE phosphatidylethanolamine
RSE residual standard error
LOD limit of detection
x
chapter i
introduction
Strong selection advantages are provided to any organism with the ability to send,
receive and interpret information from the surrounding environment. In order to
achieve proper development and function, multi-cellular organisms require an elabo-
rate communication network between individual cells. These networks typically rely
on the release and subsequent binding of signaling molecules. The effects of the sig-
nals on the target cells are very broad; responses can include survival, chemotaxis,
proliferation, and even programmed cell death (apoptosis). The process of a signaling
molecule, also called a ligand, binding to a receptor protein and subsequently causing
a response is known as cell signaling.
Cell signaling can be divided into three stages: reception, transduction, and re-
sponse. Reception occurs when a chemical agent from outside the cell binds to a
cellular protein, often at the cell’s surface. This binding of the signal molecule alters
the receptor protein in some way, which initiates the process of transduction. Trans-
duction then converts the signal to a different form in order to elicit a specific cellular
response. Transduction may occur in one step; however it often requires a signal-
transduction pathway involving a complex series of relay molecules. In the third
stage of signaling, the transduced signal triggers the specific cellular response, which
can include catalysis by an enzyme, rearrangement of the cytoskeleton, or activation
of specific genes in the nucleus. The cell-signaling process is a critical component of
cell behavior, playing an important role in normal cell development.
In order to recognize many different signals, cells express a large variety of receptor
proteins that can recognize specific signal molecules. The binding of a signal molecule
occurs due to its complementary shape with a specific site on the receptor, similar
to a key in a lock. Many receptors are found on the cell membrane, also known as
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the plasma membrane. Although the plasma membrane regulates the entry and exit
of both protein constituents and small molecules, these molecules can also influence
cellular activity through the binding to specific sites on receptor proteins embedded
in the cell’s plasma membrane. Such receptors can then transmit the information
to the inside of the cell through allostery (changing shape) or aggregation caused by
the binding of the ligand. Three major classes of receptors are G-protein-coupled
receptors (GPCRs), tyrosine-kinase receptors, and ion-channel receptors.
Not all components of signal-transduction pathways are proteins. Second mes-
sengers, which are small, non-protein molecules or ions generated in response to an
extracellular signaling molecule binding to a cell-surface receptor, play a vital role
in signal transduction by activating other pathway components. Due to their small
size, second messengers can readily spread throughout the cell by diffusion, where
they participate in pathways initiated by both GPCRs and tyrosine-kinase receptors.
Two of the most widely used and studied second messengers are cyclic adenosine
monophosphate and calcium ions (Ca2+). A large variety of relay proteins are sen-
sitive to the cytosolic concentration of one or the other of these second messengers
which can produce hysteretic responses in the target cells, allowing an initial response
to be translated into longer term effects.
Many signaling molecules in animals, including neurotransmitters, growth factors,
and some hormones, use signal transduction pathways which increase the cytosolic
concentration of Ca2+. This increase in Ca2+ is used to produce a wide variety of
tissue dependent responses, which include muscle cell contraction, secretion of various
hormones or enzymes, and cell division. Calcium also functions as a second messen-
ger in plant cell signaling pathways that allow for coping with environmental stresses,
such as drought or cold. Cells use Ca2+ as a second messenger in both G-protein path-
ways and tyrosine-kinase pathways. Although cells contain Ca2+, this ion is able to
function as a second messenger because of the concentration gradient created between
the various compartments within the cell. Calcium ions are actively transported out
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of the cytosol by a variety of protein pumps, which either remove the Ca2+ ions from
the cell or sequester it within various cellular organelles including the endoplasmic
reticulum (ER), mitochondria, or chloroplasts (in plant cells). As a result, the cytoso-
lic concentration is usually much lower than that of the ER and extracellular fluid.
Upon receiving a signal, the cytosolic Ca2+ level may rise, usually by a mechanism
that releases Ca2+ from the cell’s ER. Once a signal molecule binds to a receptor,
the enzyme phospholypase C (PLC) is activated. This enzyme cleaves the plasma-
membrane phospholipid phosphatidylinositol 4,5-bisphosphate (PIP2) into two other
second messengers, diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3). IP3,
a small molecule, quickly diffuses through the cytosol and binds to a ligand-gated
calcium channel in the ER membrane, causing it to open. Calcium ions flow out of
the ER (down their gradient, from areas of higher to lower concentration), raising
the Ca2+ level in the cytosol. The Ca2+ ions activate the next protein in one or more
signaling pathways, often by means of calmodulin, a Ca2+-binding protein present at
high levels in eukaryotic cells. The proteins most often regulated by calmodulin are
protein kinases (enzymes that transfer phosphate groups from adenosine triphosphate
(ATP) to a protein) and phosphatases (enzymes that remove phosphate groups from
proteins)-the most common relay proteins in signaling pathways.
Due to the importance of these cellular signaling pathways in cellular function,
much research has been conducted in order to identify the underlying mechanisms.
However, signaling pathways often involve large numbers of molecules and varying
levels of complexity, limiting the amount of information attainable from traditional
experimental methods and thus suggesting the construction and analysis of quantita-
tive models. Such mathematical models enable one to simultaneously study individual
pathway elements and make predictions about the dynamical and interconnected be-
havior of the signaling pathway, such as the effect of pathway perturbations or the
discovery of novel pathway components, and are thus powerful tools for directing
further experimental research.
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Although nucleotides serve as some of the most basic building blocks of ribonu-
cleic acids (RNA) and deoxyribonucleic acid (DNA), they can also act as important
signaling molecules, activating the family of P2 nucleotide receptors [35]. Nucleotides
such as adenosine triphosphate (ATP) and uridine triphosphate (UTP) are known
to regulate an array of diverse biological effects upon their release from cells that
have undergone inflammation due to trauma or have been mechanically stimulated
[7, 23, 36, 87]. Once released into the extracellular fluid, ATP and UTP are de-
graded by enzymes called ecto-nucleotidases into adenosine diphosphate (ADP) and
uridine diphosphate (UDP), respectively [13, 26, 88]. UDP then serves as the primary
agonist, or ligand, for the G protein-coupled receptor known as P2Y6 [51].
This work focuses on modeling the signaling events downstream UDP activation
of the P2Y6 receptor in a macrophage-like cell line. Originating from monocytes
(white blood cells), macrophages move through tissue fibers and engulf and then
digest cellular debris and pathogens. This process of ingesting an invading organism
by certain types of white cells is known as phagocytosis, and tissue macrophages are
the largest phagocytic cells. Because of the difficulty of working with cells taken
directly from an organism, our data are collected from a specific cell line. These cells
are grown and live in a tissue-culture dish, surrounded by appropriate media for cell
survival. They are similar to the primary cell (taken from the organism) but are
essentially “immortal”, in that they will continue to grow and survive for as long as
they are provided with nutrients. The macrophage-like cell line from which all of our
data are derived is called RAW 264.7.
There have been a number of mathematical models developed to study GPCR
signaling pathways in a variety of cell types [21, 39, 45, 73, 80]. Although several
models have helped to uncover complex interactions in the areas of the G-protein
cascade [43, 74, 85] and the intricate details surrounding the above mentioned Ca2+
flux [16, 19, 33, 40, 76], there is no information on modeling DAG changes following
GPCR stimulation. DAGs also serve as second messengers through the activation
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of protein kinase C, an enzyme linked to the regulation of many cellular processes
including cell differentiation, proliferation, carcinogenesis, development, and memory
in multiple mammalian cell types [4, 15, 46, 50, 52]. Increase in intracellular DAG
levels is also believed to contribute to the transduction of mitogenic signals [24, 42,
54, 59, 69] as well as secondary secretion and aggregation [78]. More than 50 different
species of DAG have been identified, depending on acyl chain length (number of
carbons in the two fatty acyl chains of the DAG molecule) and degree of unsaturation
(number of double bonds in the fatty acyl chains). With evidence for differential
roles of these species in cellular processes [14, 55], determining the species-specific
regulation of DAG in the signaling process is crucial to obtaining a comprehensive
understanding of how the cell responds to its stimulus. The work presented here
therefore places a major emphasis on the study of species-specific DAG dynamics.
Though the mechanisms of DAG production and degradation downstream agonist
stimulation of P2Y receptors is still relatively unclear, our modeling efforts are leading
to new insights and novel pathway propositions.
In this dissertation, we describe a system of ten nonlinear ordinary differential
equations (ODEs) which we have constructed to model the UDP signaling pathway in
RAW 264.7 cells. In Chapter II, we describe in detail the interactions and correspond-
ing ODEs involved in this signaling pathway, including the introduction of a novel
branch of the signaling pathway involving DAG kinetics as suggested by the model. In
Chapter III, we rigorously analyze the existence and uniqueness of solutions of the full
model as well as the positivity, boundedness, and stability behavior of steady states
for an altered model whereby the Ca2+ interactions have been simplified. In Chapter
IV, we provide methods and descriptions of the numerical analysis performed, includ-
ing parameter estimation techniques used to obtain best fits to experimental data and
sensitivity analysis to determine which rate parameters are responsible for the most
model output uncertainty. Then in Chapter V, we discuss results from data analysis
of experiments performed to test the newly proposed signaling pathway introduced
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in Chapter II. Chapter VI is devoted to the development of a novel method of simul-
taneous quantification of multiple species of DAG, a method which has enhanced the
modeling efforts by enabling the modeling of species-specific DAG dynamics. This
method has been previously published in Analytical Chemistry (Callender, et al.). In
Chapter VII, we draw the final conclusions of our mathematical modeling efforts and
propose future areas of research, both biological and mathematical. Finally, Chapters
VII.3 and VII.3 are devoted to Appendices A and B, respectively, where we include
further explanation of the numerical methods of analysis used, including code written
to generate numerical simulations to the system of ODEs.
6
chapter ii
model construction
Our model utilizes the the law of mass action which is based on diffusion of species
(in the membrane or cytosol), collisional interaction, and binding (or unbinding),
such that the effective rates (of production or degradation) are proportional to the
number of molecules (or concentration) of each species that contributes to a given re-
action. The model consists of a system of ten nonlinear ordinary differential equations
and is separated into four modules: Receptor Dynamics, G-protein Cascade, DAG
Production and Degradation, and Cytosolic Calcium Dynamics. Where appropriate,
number of molecules of species X will be denoted by NX , while [X] will denote the
concentration of X in µM.
II.1 Module 1: Receptor Dynamics
Our representation of P2Y6 receptor dynamics is based on previous work by Lemon et
al. [39], which provides a detailed account of receptor regulation for the P2Y2 receptor
in response to its primary agonist UTP [51]. In the case of the P2Y6 receptor, the
mechanisms are assumed to be similar to those of P2Y2, only Brinson and Harden
[6] observed a much slower rate of desensitization for the P2Y6 receptor in response
to its primary agonist UDP. To account for this slower rate of desensitization, the
receptor phosphorylation rate, kp, is modified to fit the P2Y6 observations of Brinson
and Harden.
The activity of a GPCR is regulated by several processes. GPCRs may undergo
phosphorylation and subsequent uncoupling from G-proteins or internalization. The
phosphorylated receptors can then be dephosphorylated, returning to the surface of
the plasma membrane. In our model, we assume that the ligand is not depleted
by binding to the receptors and therefore has a fixed concentration. The reactions
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involved for receptor dynamics are therefore given by the following:
L + R
k+1−−⇀↽−
k−1
LR
kp−→ LRp
k−2−−⇀↽−
k+2
L + Rp (1)
LRp
ke−→ RI kr−→ R. (2)
As seen in equations (1) and (2), cell surface receptors are allowed to bind extracellu-
lar ligand reversibly, with forward rate constant k+1 and backward rate constant k
−
1 .
Ligand-bound receptors, LR, can be phosphorylated and therefore inactivated irre-
versibly at a rate kp, forming LRp, while phosphorylated receptors, Rp are still able
to interact with ligand but with possibly different rates of binding and unbinding,
given by k±2 [60]. Since phosphorylation of LR causes desensitization of these recep-
tors, G-protein is only activated by unphosphorylated receptors, R and LR. Although
Lemon’s model is similar to the cubic ternary complex model [77] in that G-proteins
are allowed to bind to both R and LR, upon further analysis Lemon showed that un-
der certain assumptions receptor/ligand and G-protein systems largely decouple and
the only receptors that need to be included in the G-protein cascade are the activated
surface receptors, LR. Upon phosphorylation, receptors are internalized at a rate that
depends on agonist occupancy. This is incorporated into the model by having the
phosphorylated receptors, LRp, internalized at the rate ke. Internalized receptors, RI ,
are then recycled back to the surface at a rate kr. The ordinary differential equations
corresponding to the reactions from equations (1) and (2) are
dNR(t)
dt
= −k+1 [L]NR + k−1 NLR + krNRI , (3)
dNLR(t)
dt
= k+1 [L]NR − (k−1 + kp)NLR, (4)
dNLRp(t)
dt
= k+2 [L]NRp − (k−2 + ke)NLRp + kpNLR, (5)
dNRp(t)
dt
= −k+2 [L]NRp + k−2 NLRp , (6)
dNRI (t)
dt
= −krNRI + keNLRp , (7)
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where [L] denotes the ligand concentration, NR andNLR represent number of unbound
and bound receptors, NRp and NLRp represent number of phosphorylated unbound
and phosphorylated bound receptors, and NRI is the number of internalized receptors.
Since this is a closed system (the sum of equations (3)-(7) is zero), we have that the
total number of receptors in the cell, NRT , is given by
NR +NLR +NLRp +NRp +NRI = NRT . (8)
The kinetics of ligand binding are considered to be fast relative to the other processes
in the model, so that we may combine equations (3)-(7) to leave only the slow kinetics
given by
dNRS(t)
dt
= −krNRI − kpNLR, (9)
dNRSp (t)
dt
= −keNLRp + kpNLR, (10)
where NRS = NR+NLR represents the total number of unphosphorylated, and there-
fore “active”, surface receptors, and NRSp = NRp +NLRp represents the total number
of phosphorylated, and therefore “inactive”, surface receptors. Ligand binding occurs
through the following reactions:
L + R
k+1−−⇀↽−
k−1
LR and L + Rp
k+2−−⇀↽−
k−2
LRp,
where k±1 and k
±
2 are the forward and backward rate constants for ligand binding
to unphosphorylated and phosphorylated receptor, respectively. Therefore, the rapid
ligand binding kinetics assumption [76], which is equivalent to assuming instantaneous
equilibrium in the two above reactions, along with mass action kinetics gives
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dNR(t)
dt
=−k+1 [L]NR + k−1 NLR = 0, (11)
dNLR(t)
dt
= k+1 [L]NR − k−1 NLR = 0, (12)
dNLRp(t)
dt
= k+2 [L]NRp − k−2 NLRp = 0, (13)
dNRp(t)
dt
=−k+2 [L]NRp + k−2 NLRp = 0. (14)
Simplifying equations (11) through (14) and using NRS = NR + NLR and NRSp =
NRp +NLRp from above, we have the following relations:
NR =
K1NRS
K1 + [L]
, (15)
NLR =
[L]NRS
K1 + [L]
, (16)
NLRp =
[L]NRSp
K2 + [L]
, (17)
NRp =
K2NRSp
K2 + [L]
, (18)
where K1 = k
−
1 /k
+
1 is the unphosphorylated receptor dissociation constant and
K2 = k
−
2 /k
+
2 is the phosphorylated receptor dissociation constant. Substituting equa-
tions (15)-(18) into equations (9) and (10) and using the conservation equation (8),
receptor regulation is modeled using the following reduced two-variable system:
dNRS(t)
dt
= krNRT −
(
kr +
kp[L]
K1 + [L]
)
NRS − krNRSp (19)
dNRSp (t)
dt
= [L]
(
kpNRS
K1 + [L]
− keNRSp
K2 + [L]
)
. (20)
II.2 Module 2: G-protein Cascade
A simplified schematic of the canonical signaling pathway downstream receptor acti-
vation by UDP is shown in Figure 1. Once a P2Y6 receptor becomes activated through
ligand binding, it undergoes a conformational change (a change in shape), allowing
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Figure 1: Simplified schematic of the UDP signaling pathway. UDP binds to the P2Y6
receptor, causing exchange of GDP for GTP on the bound G-protein and release of
Gα·GTP from Gβγ. Activated Gα·GTP and Ca2+ bind to and activate membrane-
bound PLC, which then hydrolyses PIP2 into DAG and IP3. IP3 diffuses through the
cytosol and releases Ca2+ from the ER by binding to the IP3 receptor (IP3-R).
a G-protein to bind to the activated receptor. G-proteins are receptor activated pro-
teins that are bound to the inside surface of the cell membrane. They consist of three
subunits: Gα, and the tightly associated Gβ and Gγ. Once bound to an activated
GPCR, the G-protein releases its bound nucleotide guanine diphosphate (GDP) from
the Gα subunit, binding a new molecule of guanine triphosphate (GTP). This nu-
cleotide exchange causes the dissociation of the GTP-bound Gα subunit, the Gβγ
dimer, and the GPCR. Although both Gα·GTP and Gβγ can then activate different
signaling pathways and effector proteins, we are concerned only with the reactions
downstream Gα·GTP activation. Eventually the Gα subunit will hydrolyze the GTP
to GDP through its inherent enzymatic activity. This allows Gα to reassociate with
Gβγ, starting a new cycle. A simplified model of the time-dependent production and
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degradation of Gα·GTP, denoted by G∗, is
dNG∗(t)
dt
= ka NRS (NGT −NG∗)− kd NG∗ , (21)
where, according to mass action kinetics, we have assumed that G∗ are produced at a
rate proportional to the number of activated surface receptors, NRS , and the number
of inactive G-proteins, NGT −NG∗ , where NGT is the total number of G-proteins, both
activated and inactivated. The second term in equation (21) represents deactivation
rate of G-proteins from hydrolysis of GTP into GDP and is proportional to the
current number of active G-proteins. As laterally diffusing Gα·GTP subunits bind
the (presumably freely diffusing) inactive cytosolic PLC enzymes on the inner leaflet
of the plasma membrane, Gα·GTP·PLC complexes are formed.
The bound state complex Gα·GTP·PLC is considered fully activated when bound
to Ca2+ where it then hydrolyzes plasma membrane-bound PIP2 molecules into IP3
and DAG. For simplicity, we assume that the number of Gα·GTP·PLC complexes is
directly proportional to the number of G∗, with proportionality constant λ, and PIP2
replenishment occurs through a phenomenological term linear in the difference from
the initial amount, NPIP2(0). Therefore we can write the time dependence of PIP2 as
dNPIP2(t)
dt
= −khyd
(
[Ca2+]
Kc + [Ca2+]
)
λNG∗ NPIP2
+ krep (NPIP2(0)−NPIP2), (22)
where the effective hydrolysis rate is proportional to the number of PIP2 and G
∗
molecules, with rate constant khyd, and we assume rapid binding kinetics of cytoso-
lic Ca2+ (in µM) to the activated Gα·GTP·PLC complex. Here KC represents the
dissociation constant for the Ca2+ binding site on the PLC molecule.
The generation of IP3 is determined by the hydrolysis rate of PIP2. As IP3
molecules are known to diffuse through the cytosol, we refer to IP3 production and
degradation in terms of concentration (in µM) instead of number of molecules. We
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assume that IP3 is degraded at a rate proportional to the current concentration of
IP3, with rate constant kd3. The equation for IP3 is therefore
d[IP3](t)
dt
= khyd
(
[Ca2+]
Kc + [Ca2+]
)
λNG∗
(
106
Nav · v
)
NPIP2 − kd3 [IP3], (23)
where v is the volume of the cell (in L) and Nav is Avogadro’s constant.
II.3 Module 3: Diacylglercol production and degradation
The main focus of this work is on modeling the production and degradation of different
species of DAG. As stated above, it is well-known that early DAG production is a
result of PIP2 hydrolysis at the plasma membrane [30, 81, 82], where it is produced
stoichiometrically with IP3. DAG can then be converted into other molecules via
several pathways. In particular, a diacylglycerol kinase can phosphorylate DAG into
phosphatidic acid (PA). The effects of these pathways are combined into one effective
rate constant, kdp1, so that the rate at which DAG is lost is proportional to its current
concentration. Using this canonical pathway to describe total DAG production and
degradation in the cell results in an equation very similar to that of IP3:
d[DAG](t)
dt
= khyd
(
[Ca2+]
Kc + [Ca2+]
)
λNG∗
(
106
Nav · v
)
NPIP2 − kdp1 [DAG]. (24)
Using a new method of DAG quantification developed by Callender et al. [10], which
allows for the simultaneous quantification of up to 28 different species of DAG, we
found that the responses of many DAG species cannot be modeled via this signaling
pathway alone (see Fig. 5a and 5b). In fact, many mono- and di-unsaturated DAGs
(DAGs with one or two double bonds) such as 34:1 DAG (containing 34 carbons and 1
double bond), shown in Figure 5b, exhibit a biphasic response to a 25µM stimulation
with UDP.
These data suggest the existence of two separate pools of DAG for each DAG
species: DAGp1, originating from PIP2 hydrolysis post agonist stimulation and de-
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graded as described above, and an intracellular pool, DAGp2, present in high con-
centrations in resting cells, that is rapidly converted to PA upon UDP stimulation
via a DAG kinase, therefore creating an initial decrease in DAGp2 levels. Each DAG
species has varying levels of representation in each of these two pools. For instance,
the second pool contains more of the mono- and di-unsaturated DAG species, while
those species produced from early PIP2 hydrolysis are more poly-unsaturated fatty
acid-containing (PUFA-containing) species.
All DAG species measured exhibit a later rise phase, peaking on average around 15
minutes. Although this second rise phase has in some cases been attributed to phos-
pholipase D (PLD) activity [30, 81, 82], RAW 264.7 cells have been shown to exhibit
no PLD activation upon stimulation by UDP (data not shown). Thus a hypothetical
mechanism for the observed response is, in addition to early production from PIP2
hydrolysis, the activation of a known DAG metabolic pathway: agonist stimulated
conversion of an intracellular pool of DAG to PA followed by cytidine diphosphate-
DAG (CDP-DG) production and subsequent converstion to phosphatidylinositol (PI),
resulting in a transformed pool of PIP2 from the original primarily polyunsaturated
form. A schematic of this two-pool DAG model is shown in Figure 2. In this scenario
DAGp2 is replenished by a phosphatidylcholine-specific enzyme while it is simulta-
neously used for PI production and replenishment of the PIP2 pool. The revised
equation for DAG produced from PIP2 hydrolysis based on this two-pool model is
similar to equation (24) but includes an additional term to account for a contribution
from the second pool of DAG. We make note here that our model includes a separate
DAG module for each individual species of DAG. While the form of the modules
(consisting of the two equations (25) and (26) below) for each species is identical,
certain rates of production and degradation are assumed to vary, thus causing differ-
ential responses among species. This change in parameters, which is dependent upon
the DAG species under consideration, is noted in the equations below by parameters
containing the superscript i.
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Figure 2: Proposed two-pool model for DAG kinetics post agonist stimulation with
UDP. Initial production of DAG from the hydrolysis of PIP2 in pool 1 (plasma mem-
brane) is offset by phosphorylation of DAG by a DAG kinase in pool 2 (either in the
ER or the nucleus) to aid in the PI replacement pathway. The second wave of DAG
is a result of resynthesis of PIP2 which is then hydrolyzed to form DAG and IP3.
The equation for DAGp1 of the i
th DAG species, denoted DAGip1, is therefore given
by
d[DAGip1](t)
dt
= khyd
(
[Ca2+]
Kc + [Ca2+]
)
λNG∗
(
106
Nav · v
)
NPIP2
−kidp1 [DAGip1] + ηikidp2 [DAGip2], (25)
where ηi denotes the fraction of DAGip2 contributing to DAG
i
p1, and k
i
dp2 is the degra-
dation rate of DAGip2 implicitly dependent on ligand concentration such that k
i
dp2 = 0
when [L] = 0. To account for the dynamics of the second pool of DAG in the ith
DAG species, denoted DAGip2, we also include the equation
d[DAGip2](t)
dt
= −kidp2[DAGip2] + kiap2 ([DAGip2](0)− [DAGip2]), (26)
where DAGs from pool 2 are phosphorylated at a rate proportional to the current con-
centration of DAGp2 for the i
th DAG species and are replenished at a rate proportional
to the amount of DAGip2 that has been phosphorylated by DAG kinase.
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II.4 Module 4: Cytosolic Calcium dynamics
Upon receptor activation, PIP2-derived IP3 diffuses through the cytosol and binds to
IP3-gated Ca
2+ channels (IP3-Rs) on the ER, releasing Ca
2+ into the cytosol. In the
development of a model for agonist-induced cytosolic Ca2+ oscillations in a “closed
cell” (i.e., no Ca2+ exchange with the extracellular medium through the plasma mem-
brane), De Young and Keizer [16] assumed that the balance of Ca2+ levels is deter-
mined only by Ca2+ release out of the ER (mediated by the IP3-R) and Ca
2+ flow
back into the ER (via a Ca2+-ATPase in the ER membrane). This model utilized
the biophysical theory that the ion current through a channel is proportional to the
channel’s open probability times the ion’s concentration gradient across the ER mem-
brane when the ER membrane potential is zero [32] to develop ordinary differential
equations for the IP3-R channel gating process. Here they assumed that on each of
the four subunits of the IP3-R there exists one IP3 binding site and two Ca
2+ binding
sites, one site for channel activation and a separate channel inactivation site. This
model contained a total of nine differential equations: one Ca2+ balance equation,
and eight equations for the channel gating kinetics (three binding sites corresponds
to eight different possibilities of IP3-R states).
By considering the different time scales of this nine-equation system along with the
assumption that each of the three binding processes are independent of one another,
Li and Rinzel [40] developed a simplified model of cytosolic Ca2+ dynamics which
includes an additional term that allows for Ca2+ exchange between the cell and the
extracellular medium, thus relaxing the “closed cell” constraints of the De Young and
Keizer model. Due to the simpler form of the Li and Rinzel model as well as its ability
to explain various experimental data, we have chosen to utilize this model of Ca2+
dynamics in our system. Thus cytosolic Ca2+ dynamics are modeled by the following
system:
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d[Ca2+](t)
dt
=
[
ν1 m
3
∞ (h)
3 + ν2
]
× [[c0]− (1 + c1) [Ca2+]]
− ν3 [Ca
2+]2
k2er + [Ca
2+]2
+ 
[
jin − ν4 [Ca
2+]2
k2pl + [Ca
2+]2
]
(27)
m∞ =
(
[IP3]
[IP3] + dIP3
)(
[Ca2+]
dact + [Ca2+]
)
dh(t)
dt
= a ([Ca2+] + dinh)
[(
dinh
[Ca2+] + dinh
)
− h
]
(28)
d[c0]
dt
= 
[
jin − ν4 [Ca
2+]2
k2pl + [Ca
2+]2
]
. (29)
Here h(t) represents the fraction of IP3 receptors not yet inactivated by Ca
2+
binding to the inactivation site of the IP3-R, while m∞ represents the probability of
the IP3-R being in the activated (open) state, with IP3 bound as well as Ca
2+ bound
to the activation site. Although the IP3-R contains four subunits, De Young and
Keizer found that a power close to 3 for each of these terms provided the best fit to
experimental data [16]. The c0 term represents total free Ca
2+ per cytosolic volume,
and the paramter c1 is the volume ratio between the ER and the cytosol.
The rate parameters ν1, ν2, ν3, and ν4 are effective permeability constants for the
IP3 channels, ER membrane leakage, Ca
2+ pumps on the ER, and Ca2+ flux through
the plasma membrane via voltage-sensitive Ca2+ channels, respectively. The receptor
dissociation constant for the IP3 receptor is denoted by dIP3 , while dissociation con-
stants for the Ca2+ activation and deactivation sites on the IP3-R are dact and dinh,
respectively, and a is the IP3-R binding constant for Ca
2+-dependent inhibition. The
parameter ker is the Michaelis constant for Ca
2+ uptake from cytosol into the ER,
and kpl is the Michaelis constant for Ca
2+ flux out of cell across plasma membrane.
The term jin, which represents the flux of Ca
2+ through the plasma membrane and
into the cell, is considered to be constant. The parameter  is the ratio of the total
area of the plasma membrane to the total area of the ER.
Although the modeling of Ca2+ was not a major emphasis of this work, its impor-
tance to the overall signaling pathway necessitates its inclusion in the model. For a
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more detailed account and analysis of the role of Ca2+ in this pathway in RAW 264.7
cells, see Flaherty et al. [19].
II.5 Dimensionless Scaling
Dimensionless forms for the above signaling equations may be written which relate
ratios of species, indicating which parameters are essential for the kinetics. We define
the quantities xi(t) as given in Table 1.
Table 1: Time-dependent nondimensionalized model variables
Original Nondimensionalized Formula
Variable Variable
NRS(t) x1(t) NRS(t)÷NRT
NRSp (t) x2(t) NRSp (t)÷NRT
NG∗(t) x3(t) NG∗(t)÷NGT
NPIP2(t) x4(t) NPIP2(t)÷NPIP2(t = 0)
[IP3](t) x5(t) [IP3](t)÷
[(
106
Nav · v
)
NPIP2(t = 0)
]
[DAGp1](t) x6(t) [DAGp1](t)÷
[(
106
Nav · v
)
NPIP2(t = 0)
]
[DAGp2](t) x7(t) [DAGp2](t)÷ [DAGp2](t = 0)
[Ca2+] xˆ8(t) [Ca
2+]÷ [CaT ]
h xˆ9(t) h
c0 xˆ10(t) c0 ÷ [CaT ]
Note that since IP3 and DAGp1 originate from PIP2 hydrolysis, they are therefore
scaled by the maximum number of PIP2 molecules, given by NPIP2(t = 0). Also,
the Ca2+ module equations are assigned a special notation, xˆi, i = {8, 9, 10}, as we
will perform mathematical analysis with a simplified version of these equations. The
modified parameters resulting from nondimensionalization are given in Table 2.
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Table 2: Modified rate parameters for nondimensionalized system
Modified Formula Modified Formula
Parameter Parameter
k˜a ka NRT =
(
k∗a
m2µMa
)
NRT k˜er
ker
[CaT ]
k˜hyd khyd NGT λ =
(
k∗hyd
m2µMa
)
NGTλ j˜in
jin
[CaT ]
ζ
[DAGp2](t = 0)η
(m2µMa)NPIP2(t = 0)
ν˜4
ν4
[CaT ]
K˜c
Kc
[CaT ]
k˜pl
kpl
[CaT ]
d˜IP3
dIP3
(m2µMa)NPIP2(t = 0)
a˜ a [CaT ]
d˜act
dact
[CaT ]
d˜inh
dinh
[CaT ]
ν˜3
ν3
[CaT ]
am2µM = 106/(Nav · v) is a conversion factor which converts number of molecules to
concentration (in µM); ∗ denotes a rate constant in terms of concentration instead
of number of molecules. (Here Nav is Avogadro’s constant = 6.02252 × 1023, and
v = 5× 10−13 is the volume of one cell in µM.)
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The nondimensionalized model equations in terms of the variables listed in Table
1 and parameters in Table 2 are given in equations (30) - (39):
dx1(t)
dt
= kr −
(
kr +
kp [L]
K1 + [L]
)
x1 − kr x2 (30)
dx2(t)
dt
= [L]
(
kp x1
K1 + [L]
− ke x2
K2 + [L]
)
(31)
dx3(t)
dt
= k˜a x1 (1− x3)− kd x3 (32)
dx4(t)
dt
=−k˜hyd
(
xˆ8
K˜c + xˆ8
)
x3 x4 + krep (1− x4) (33)
dx5(t)
dt
= k˜hyd
(
xˆ8
K˜c + xˆ8
)
x3 x4 − kd3 x5 (34)
dx6(t)
dt
= k˜hyd
(
xˆ8
K˜c + xˆ8
)
x3 x4 − kdp1 x6 + kdp2 ζ x7 (35)
dx7(t)
dt
=−kdp2 x7 + kap2 (1− x7) (36)
dxˆ8(t)
dt
=
ν1
(
x5
x5 + d˜IP3
)3 (
xˆ8
xˆ8 + d˜act
)3
(xˆ9)
3 + ν2

× (xˆ10 − (1 + c1) xˆ8)− ν˜3 xˆ
2
8
k˜2er + xˆ
2
8
+ 
j˜in − ν˜4 xˆ28
k˜2pl + xˆ
2
8
 (37)
dxˆ9(t)
dt
= a˜ (xˆ8 + d˜inh)
[(
d˜inh
xˆ8 + d˜inh
)
− xˆ9
]
(38)
dxˆ10(t)
dt
= 
j˜in − ν˜4 xˆ28
k˜2pl + xˆ
2
8
 . (39)
II.6 Initial Conditions of the Model
With the exception of the calcium module variables, initial conditions for each model
variable are chosen to reflect the levels of each variable over baseline levels prior to
pathway activation. Since we assume rapid ligand binding, we set RS(0) = RT . Also,
since PIP2 and DAGp2 are initially at their maximum value, we have NPIP2(0) =
NPIP2T and NDAGp2(0) = NDAGp2T . Phosphorylated surface receptors, R
S
p , activated
G-proteins, IP3, and DAGp1 are all given an initial value of zero since we assume
there is no production of these molecules prior to receptor activation. While the
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initial concentration of calcium, 0.0009 µM, is taken from experimental data, the
initial values of the remaining two calcium module variables, h and c0, are chosen to
reflect values given by Li and Rinzel [40]. Therefore, the initial conditions for the
nondimensionalized system are as follows:
x1(t = 0) = 1
x2(t = 0) = 0
x3(t = 0) = 0
x4(t = 0) = 1
x5(t = 0) = 0
x6(t = 0) = 0
x7(t = 0) = 1
xˆ8(t = 0) = 1.34× 10−4
xˆ9(t = 0) = 0.8
xˆ10(t = 0) = 0.02985.
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chapter iii
theoretical model analysis
III.1 Introduction
As the complexity of our model precludes an analytic solution, we make use of several
known mathematical results to investigate the analytical behavior of our system of
equations. First we want to ensure that our model is well-posed. Using the nondimen-
sionalized form of the mathematical model described in the previous chapter, we thus
perform a rigorous study of the existence and uniqueness of solutions to our model.
Next, we turn our focus toward the asymptotic behavior of the model’s solutions.
The majority of this analysis will be conducted on a simplified version of the
nondimensionalized model, where the contribution of Ca2+ is simplified using the
following fit to the experimental Ca2+ data shown in Section IV.2:
dx8(t)
dt
= α(−βx9 + γx10), (40)
dx9(t)
dt
=−βx9, (41)
dx10(t)
dt
=−γx10,
where α, β, and γ are positive constants, and x8 denotes the simplified Ca
2+ equation.
From this system of equations, we can determine an analytic solution for x8(t), x9(t),
and x10(t):
x8(t) = α(x9 − x10) + α(x10(0)− x9(0)) + x8(0)
= α(e−βt − e−γt) + ν,
x9(t) = x9(0)e
−βt, (42)
x10(t) = x10(0)e
−γt,
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where
ν = α(x10(0)− x9(0)) + x8(0).
Solving for x10(t) in the analytic solution (42) gives
x10(t) =
−x8(t) + ν
α
+ x9(t).
Substituting this equation in for x10 in (40) gives
dx8(t)
dt
= α
(
−βx9 + γ
(−x8 + ν
α
+ x9
))
=−γx8 + α(γ − β)x9 + γν. (43)
This also allows us to eliminate the x10(0) term from the analytic solution for x8(t),
so that we have
x8(t) = ν + αx9(0)(e
−βt − e−γt) + x8(0)e−γt, (44)
where now we set
ν := lim
t→∞x8(t), (45)
and we require that γ > β to ensure positivity of x8(t) for all t > 0. We also note
that the solution x8(t) remains bounded, with maximum value
M8 :=
ln[γ(αx9(0)− x8(0))]− ln[αβx9(0)]
γ − β . (46)
We now use equations (41) and (43) for our mathematical analysis of the system,
for a system total of nine ordinary differential equations. Although this Ca2+ module
is a significant simplification to the original Ca2+ equations, it results in little effect
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to the model behavior and will allow for a more thorough and detailed mathematical
analysis of the system.
III.2 Existence and Uniqueness of Solutions
Using the simplified version of the nondimensionalized model, we prove local existence
of solutions using the well-known results (taken from Brauer’s Theorem 3.3 [8] and
shown below) for systems of ordinary differential equations of the type
x˙ = f(t,x) (47)
such that f ∈ C1 is bounded and is Lipschitz continuous on some domain.
Theorem III.2.1. ([8], Theorem 3.3) Let f and ∂f/∂xj (j = 1, . . . , n) be continuous
on the box B = {(t,x)
∣∣∣|t− t0| ≤ a, |x−η| ≤ b}, where a and b are positive numbers,
and satisfying the bounds,
|f(t,x)| ≤ N,
∣∣∣∣∣∂f(t,x)∂xj
∣∣∣∣∣ ≤ K (j = 1, . . . , n)
for (t,x) in B. Let α be the smaller of the numbers a and b/N and define the succes-
sive approximations

φ0(t) = η
φn(t) = η +
∫ t
t0
f(s,φn−1(s))ds
Then the sequence {φj} of successive approximations converges (uniformly) on the
interval |t − t0| ≤ α to a solution φ(t) of (47), that satisfies the initial condition
φ(t0) = η.
We now show that our system meets all the requirements of Theorem III.2.1 for
η ≥ 0. Although we have shown that we can compute the analytic solutions of x8(t)
and x9(t), we include these in our analysis for the sake of completeness. It is clear
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that all fj (j = 1, . . . , 9) are continuous for xi ≥ 0 (i = 1, . . . , 9). Computing the first
partial derivatives, we have the following:
f1 =
dx1(t)
dt
= kr −
(
kr +
kp [L]
K1 + [L]
)
x1 − kr x2 (48)
⇒ ∂f1
∂x1
= kr +
(
kp [L]
K1 + [L]
)
∂f1
∂x2
= −kr,
f2 =
dx2(t)
dt
= [L]
(
kp x1
K1 + [L]
− ke x2
K2 + [L]
)
(49)
⇒ ∂f2
∂x1
= [L]
(
kp
K1 + [L]
)
∂f2
∂x2
= [L]
(
− ke
K2 + [L]
)
,
f3 =
dx3(t)
dt
= k˜a x1 (1− x3)− kd x3 (50)
⇒ ∂f3
∂x1
= k˜a (1− x3)
∂f3
∂x3
= −k˜a x1 − kd,
f4 =
dx4(t)
dt
= −k˜hyd
(
x8
K˜c + x8
)
x3 x4 + krep (1− x4) (51)
⇒ ∂f4
∂x3
= −k˜hyd
(
x8
K˜c + x8
)
x4
∂f4
∂x4
= −k˜hyd
(
x8
K˜c + x8
)
x3 − krep
∂f4
∂x8
= −k˜hyd
(
K˜c
(K˜c + x8)2
)
x3 x4,
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f5 =
dx5(t)
dt
= k˜hyd
(
x8
K˜c + x8
)
x3 x4 − kd3 x5 (52)
⇒ ∂f5
∂x3
= k˜hyd
(
x8
K˜c + x8
)
x4
∂f5
∂x4
= k˜hyd
(
x8
K˜c + x8
)
x3
∂f5
∂x5
= −kd3
∂f5
∂x8
= k˜hyd
(
K˜c
(K˜c + x8)2
)
x3 x4,
f6 =
dx6(t)
dt
= k˜hyd
(
x8
K˜c + x8
)
x3 x4 − kdp1 x6 + kdp2 ζ x7 (53)
⇒ ∂f6
∂x3
= k˜hyd
(
x8
K˜c + x8
)
x4
∂f6
∂x4
= k˜hyd
(
x8
K˜c + x8
)
x3
∂f6
∂x6
= −kdp1
∂f6
∂x7
= kdp2 ζ
∂f6
∂x8
= k˜hyd
(
K˜c
(K˜c + x8)2
)
x3 x4,
f7 =
dx7(t)
dt
= −kdp2 x7 + kap2 (1− x7) (54)
⇒ ∂f7
∂x7
= −kdp2 − kap2,
f8 =
dx8(t)
dt
= −γx8 + α(γ − β)x9 + γν (55)
⇒ ∂f8
∂x8
= −γ
∂f8
∂x9
= α(γ − β),
f9 =
dx9(t)
dt
= −βx9 (56)
⇒ ∂f9
∂x9
= −β.
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Although our initial analysis will only use information from f8 and f9, the original
equations for Ca2+ also satisfy the hypotheses of Theorem III.2.1, as shown below:
fˆ8 =
dxˆ8(t)
dt
=
ν1
(
x5
x5 + d˜IP3
)3 (
xˆ8
xˆ8 + d˜act
)
(xˆ9)
3 + ν2
 (57)
× (xˆ10 − (1 + c1) xˆ8)− ν˜3 xˆ
2
8
k˜2er + xˆ
2
8
+ 
j˜in − ν˜4 xˆ28
k˜2pl + xˆ
2
8

⇒ ∂fˆ8
∂x5
= 3ν1
(
x5
x5 + d˜IP3
)2 ( ˜dIP3
(x5 + d˜IP3)
2
)(
xˆ8
xˆ8 + d˜act
)
(xˆ9)
3
× (xˆ10 − (1 + c1) xˆ8)
∂fˆ8
∂xˆ8
= ν1
(
x5
x5 + d˜IP3
)3 (
d˜act
(xˆ8 + d˜act)2
)
(xˆ9)
3 (xˆ10 − (1 + c1) xˆ8)
−
ν1
(
x5
x5 + d˜IP3
)3 (
xˆ8
xˆ8 + d˜act
)
(xˆ9)
3 + ν2
 (1 + c1)
− 2ν˜3 k˜
2
er xˆ8
(k˜2er + xˆ
2
8)
2
+
2 ν˜4 k˜
2
pl xˆ8
(k˜2pl + xˆ
2
8)
2
∂fˆ8
∂xˆ9
= 3ν1
(
x5
x5 + d˜IP3
)3 (
xˆ8
xˆ8 + d˜act
)
(xˆ9)
2
× (xˆ10 − (1 + c1) xˆ8)
∂fˆ8
∂xˆ9
= ν1
(
x5
x5 + d˜IP3
)3 (
xˆ8
xˆ8 + d˜act
)
(xˆ9)
3 + ν2,
fˆ9 =
dxˆ9(t)
dt
= a˜ (xˆ8 + d˜inh)
[(
d˜inh
xˆ8 + d˜inh
)
− xˆ9
]
(58)
⇒ ∂fˆ9
∂xˆ8
= a˜
[(
d˜inh
xˆ8 + d˜inh
)
− xˆ9
]
+ a˜ (xˆ8 + d˜inh)
( −d˜inh
(xˆ8 + d˜inh)2
)
∂fˆ9
∂xˆ9
= −a˜ (xˆ8 + d˜inh),
fˆ10 =
dxˆ10(t)
dt
= 
j˜in − ν˜4 xˆ28
k˜2pl + xˆ
2
8
 (59)
⇒ ∂fˆ10
∂xˆ8
=
2 ν˜4 k˜
2
pl xˆ8
(k˜2pl + xˆ
2
8)
2
.
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All other partial derivatives equal zero. From equations (48) - (56), we see that all
partial derivatives are continuous in all of R9+, where R9+ = {x ∈ R9
∣∣∣xi ≥ 0 ∀ i =
1, . . . , 9}, since all rate constants are positive. In particular, each fi and all of its
partial derivatives are continuous on [0,M] such that 1 ≤Mi <∞ for i ∈ {1, . . . , 9},
where, as we will show in Propositions III.2.1 and III.2.2, each xi (i = 1, . . . , 9) is
bounded. Therefore, this guarantees the existence of a solution φ(t) of our system
(47) which is defined on the interval |t − t0| ≤ α and satisfies the initial condition
φ(t0) = η. Here α is the smaller of a and b/N as defined in the statement of Theorem
III.2.1.
According to Brauer’s Theorem 3.4 [8] stated below, this solution φ is the unique
solution satisfying the initial condition
φ(t0) = η. (60)
Theorem III.2.2. ([8], Theorem 3.4) Suppose f and ∂f/∂yj (j = 1, . . . , n) are con-
tinuous on the “box”
B = {(t,y)
∣∣∣|t− t0| ≤ a, |y − η| ≤ b}.
Then there exists at most one solution of (47) satisfying the initial condition (60).
Now let D = {(t,x) ∈ R10
∣∣∣ t ≥ 0, 0 ≤ xi ≤ 1 for i ∈ {1, 2, 3, 4, 7}, with x1+x2 ≤ 1,
and 0 ≤ xj ≤ Mj for j ∈ {5, 6, 8, 9} and 0 < Mj <∞}. We note that from (42) and
(44), we have M9 = x9(0) > 0, and M8 is given by equation (46). Since our system
satisfies the hypotheses of Theorems III.2.1 and III.2.2 on D, we know a local solution
exists for any initial condition vector η in D on some interval [0, t(η)], where, as we
have indicated notationally, this interval is dependent on the initial condition vector
η. We let [0, tmax(η)], where 0 < tmax(η) ≤ ∞, be the maximal interval of existence,
and we will show that in fact tmax(η) =∞ in Proposition III.2.3.
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In order to find solutions to our system of nondimensionalized equations in the
region of biological interest, we must have that all solutions xi(t), i = (0, . . . , 9), are
positive and remain bounded for all t ∈ (0, tmax(η)). In other words, we want to show
that D is positively invariant, so that all solutions with initial conditions in D remain
in D for all t ∈ [0, tmax(η)]. As we have already shown that x8(t) and x9(t) meet
these criteria, we now verify that the remaining equations in our system satisfy these
requirements. From the receptor conservation equation (8), we are only interested in
solutions for the receptor module on the closed set
Dˆ = {x1, x2 ∈ R
∣∣∣ x1, x2 ≥ 0 and x1 + x2 ≤ 1}. (61)
We make use of the following results of Amann [1]:
Theorem III.2.3. ([1], Theorem 16.5) Let Dˆ ⊆ R2 be closed. Then Dˆ is positively
invariant if and only if for every x ∈ Dˆ, the subtangent condition
lim inf
h→0+
1
h
dist(x+ hF (x); Dˆ) = 0 (62)
is satisfied.
Therefore, we need to show that the subtangent condition (62) holds for points on
the boundary of Dˆ defined in (61) since it is straightforward to show this condition
is met on interior points of Dˆ. We verify this condition in Proposition III.2.1.
Proposition III.2.1. Let η1, η2 ∈ Dˆ. If t ∈ (0, tmax(η)), then x1(t), x2(t) ∈ Dˆ.
Proof. We consider three cases: A: x1 + x2 = 1 and 0 < x2 < 1, B: 0 ≤ x1 ≤ 1 and
x2 = 0, and C: 0 ≤ x2 ≤ 1 and x1 = 0, with
F

x1
x2

 =
kr(1− x1 − x2)− c1 x1
c1 x1 − c2 x2
 ,
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where F is defined as in equations (48) and (49), and we have simplified the right
hand sides of these equations by setting
c1 =
kp[L]
K1 + [L]
and c2 =
ke[L]
K2 + [L]
. (63)
Case A: For x1 + x2 = 1 and 0 < x2 < 1, we have
dist
(I+ hF)
x1
x2
 , Dˆ
= dist

x1
x2
+ h
 −c1 x1
c1 x1 − c2 x2
 , Dˆ

= dist

 (1− hc1) x1
hc1 x1 + (1− hc2) x2
 , Dˆ

= dist

 (1− hc1) x1
(1− h(c1 + c2)) x2 + hc1
 , Dˆ
 .
Now for h sufficiently small, note that
0 < ((I+ hF)x)1 = (1− hc1) x1 < 1,
0 < ((I+ hF)x)2 = (1− h(c1 + c2)) x2 + hc1 < 1,
and also
((I+ hF)x)1 + ((I+ hF)x)2 = (1− hc1) x1 + hc1 x1 + (1− hc2) x2
= x1 + x2 − hc2 x2 = 1− hc2 x2 < 1.
Therefore, for h sufficiently small, we have (I + hF)x ∈ Dˆ, giving the required sub-
tangent condition and thus ensuring that solutions x1(t) and x2(t) remain in Dˆ.
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Case B: For 0 ≤ x1 ≤ 1 and x2 = 0, we have
dist
(I+ hF)
x1
x2
 , Dˆ
= dist

x1
x2
+ h
kr(1− x1)− c1 x1
c1 x1
 , Dˆ

= dist

(1− h(kr + c1)) x1 + hkr
hc1 x1
 , Dˆ
 .
For h sufficiently small, we have
0 < ((I+ hF)x)1 = (1− h(kr + c1)) x1 + hkr < 1,
0 ≤ ((I+ hF)x)2 = hc1 x1 < 1,
and also
((I+ hF)x)1 + ((I+ hF)x)2 = (1− h(kr + c1)) x1 + hkr + hc1 x1 < 1
= (1− hkr)x1 + hkr ≤ 1.
For h sufficiently small this gives (I+ hF)x ∈ Dˆ, so that (62) is satisfied.
Case C: For 0 ≤ x2 ≤ 1 and x1 = 0, we have
dist
(I+ hF)
x1
x2
 , Dˆ
= dist

x1
x2
+ h
kr(1− x2)−c2 x2
 , Dˆ

= dist

 hkr(1− x2)
(1− hc2) x2
 , Dˆ
 .
Once again, for h sufficiently small, we have
0 < ((I+ hF)x)1 = hkr(1− x2) < 1,
0 ≤ ((I+ hF)x)2 = (1− hc2) x2 < 1,
31
and also
((I+ hF)x)1 + ((I+ hF)x)2 = hkr(1− x2) + (1− hc2) x2 < 1.
For such small h we have (I+hF)x ∈ Dˆ, so that again (62) holds. Therefore, we have
that the subtangent condition from Theorem III.2.3 is satisfied for all three cases A,
B, and C, ensuring that x1(t) and x2(t) remain in Dˆ for all t ∈ (0, tmax(η)). 
In Proposition III.2.2, we prove positivity and boundedness for the remaining
equations xi(t) for i ∈ {3, . . . , 7}, and we also extend the result of Proposition III.2.1
to show that 0 < x1(t), x2(t) < 1 and therefore x1(t), x2(t) ∈ int(Dˆ) for all t ∈
(0, tmax(η)), a result needed for proving global existence of a unique solution.
Proposition III.2.2. Let η ∈ int(D). If t ∈ (0, tmax(η)), then 0 < xi(t) < Mi for
i = {1, . . . , 7}, with M = (1, 1, 1, 1,M5,M6, 1).
Proof. For the sake of contradiction, assume there exists some t∗i ∈ (0, tmax(η)) such
that one of two possibilities occurs for each i ∈ {1, . . . , 7}: xi(t∗i ) ≥Mi or xi(t∗i ) ≤ 0.
Suppose xi(t
∗
i ) ≥Mi for some t∗i ∈ (0, tmax(η)). Define tˆi := inf {t ∈ [0, tmax(η))
∣∣∣
xi(t) ≥Mi}, and therefore
lim
t→tˆi
xi(t) =Mi.
We wish to verify that for each xi, this gives
lim
t→tˆi
dxi(t)
dt
< 0.
If this inequality holds, using the fact that dxi(t)/dt is continuous on (0, tˆi) and
dxi(tˆi)/dt < 0, we can find a δ > 0 so that
dxi(t)
dt
< 0, for t ∈ (tˆi − δ, tˆi). (64)
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By the Fundamental Theorem of Calculus and equation (64),
xi(tˆi)− xi(τi) =
∫ tˆi
τi
x′i(t) dt < 0.
Therefore, xi(tˆi) < xi(τi) < Mi for τi ∈ (tˆi − δ, tˆi), which contradicts the definition of
tˆi, therefore proving that we must have xi(t) < Mi for t ∈ (0, tmax(η)).
Now to show xi(t) > 0 for t ∈ (0, tmax(η)), we again proceed by method of
contradiction. Suppose xi(t
∗
i ) ≤ 0 for some t∗i ∈ (0, tmax(η)). Define t˜i := inf {t ∈
[0, tmax(η))
∣∣∣ xi(t) ≤ 0}, and therefore
lim
t→t˜i
xi(t) = 0.
If we can show
lim
t→t˜i
dxi(t)
dt
> 0,
we again reach a contradiction by using continuity of the derivative along with the
Fundamental Theorem of Calculus, thereby proving that in fact we must have xi(t) >
0 for t ∈ (0, tmax(η)).
Therefore, by considering each xi as a separate case, we need only show that for
each xi
lim
t→tˆi
dxi(t)
dt
< 0 and lim
t→t˜i
dxi(t)
dt
> 0,
where tˆi and t˜i are defined above.
Case A: By continuity, there exists a t0 such that 0 < x1(t), x2(t) < 1 for 0 ≤ t ≤
t0 for η1, η2 ∈ Int(D). Stipulations for η1 and η2 on the boundary of D are discussed
at the end of Case A.
33
From equation (31), we have
lim
t→tˆ2
dx2(t)
dt
= lim
t→tˆ2
[
[L]
(
kp x1
K1 + [L]
− ke
K2 + [L]
)]
< 0
since, from Proposition III.2.1, x1(t)+x2(t) ≤ 1 for all t ∈ [0, tmax(η)], which implies
here that
lim
t→tˆ2
x1(t) ≤ 0,
proving, by the comments above, that we must have x2(t) < 1 for t ∈ (0, tmax(η)).
From equation (30), we also have
lim
t→t˜1
dx1(t)
dt
= kr − kr
[
lim
t→t˜1
x2(t)
]
> 0
since, from above, x2(t) < 1 for all t ∈ (0, tmax(η)). This shows that x1(t) > 0 for
t ∈ (0, tmax(η)).
Next, from equation (31), we have
lim
t→t˜2
dx2(t)
dt
= lim
t→t˜2
[
[L]
(
kp x1(t)
K1 + [L]
)]
> 0
since, from above, x1(t) > 0 for all t ∈ (0, tmax(η)). This proves that x2(t) > 0 for
t ∈ (0, tmax(η)).
Finally, from equation (30), we have
lim
t→tˆ1
dx1(t)
dt
= kr −
(
kr +
kp [L]
K1 + [L]
)
− kr
[
lim
t→tˆ1
x2(t)
]
< 0
since, from above, x2(t) > 0 for all t ∈ (0, tmax(η)). Therefore, we have that x1(t) < 1
for t ∈ (0, tmax(η)).
Note that for η1 = 1 we have that dx1(t)/dt|t=0 < 0 as long as η2 ≥ 0 and for η2 = 0
we have that dx2(t)/dt|t=0 > 0 as long as η1 > 0. Furthermore, for η1 = 0 we have
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that dx1(t)/dt|t=0 > 0 as long as η2 < 1, and for η2 = 1 we have that dx2(t)/dt|t=0 < 0
when η1 = 0. Therefore, by continuity of dx1(t)/dt and dx2(t)/dt, each one of these
initial conditions ensures the existence of a t0 such that 0 < x1(t), x2(t) < 1 for
0 ≤ t ≤ t0. The same arguments as mentioned above can then be used to show that
x1(t) and x2(t) will remain in Int(D) for any of these initial conditions. We do not
consider initial conditions which violate the conservation equation (8).
Case B: There exists a t0 such that 0 < x3(t) < 1 for 0 ≤ t ≤ t0 for the following
initial conditions: η3 ∈ Int(D) by continuity; η3 = 0 with η1 > 0, since this gives
dx3(t)/dt|t=0 > 0; and η3 = 1 since this gives dx3(t)/dt|t=0 < 0 and dx3(t)/dt is
continuous in D. Also, by (32),
lim
t→tˆ3
dx3(t)
dt
= −kd < 0 and lim
t→t˜3
dx3(t)
dt
= lim
t→t˜3
[
k˜ax1(t)
]
> 0
since from Case A, x1(t) > 0 for t ∈ (0, tmax(η)). Therefore, we have that 0 < x3(t) <
1 for t ∈ (0, tmax(η)).
Case C: There exists a t0 such that 0 < x4(t) < 1 for 0 ≤ t ≤ t0 for the
following initial conditions: η4 ∈ Int(D) by continuity; η4 = 1 with η3, η8 > 0,
since this gives dx4(t)/dt|t=0 < 0 (in fact, we can also have η4 = 1 and η3 = 0 since
dx3(t)/dt|t=0 > 0 for η3 = 0, which implies the existence of a t0 such that 0 < x3(t) < 1
for 0 ≤ t ≤ t0, and therefore dx4(t)/dt > 0 on this interval); and η4 = 0 since this
gives dx4(t)/dt|t=0 > 0 and dx4(t)/dt is continuous in D. Also, by (33),
lim
t→tˆ4
dx4(t)
dt
= lim
t→tˆ4
[
−k˜hyd
(
x8(t)
K˜c + x8(t)
)
x3(t)
]
< 0
since 0 < x8(t) < 1 always, and 0 < x3(t) < 1 from Case B. Furthermore,
lim
t→t˜4
dx4(t)
dt
= krep > 0,
so that we have 0 < x4(t) < 1 for t ∈ (0, tmax(η)).
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Case D: There exists a t0 such that 0 < x7(t) < 1 for 0 ≤ t ≤ t0 for the
following initial conditions: η7 ∈ Int(D) by continuity; η7 = 0, since this gives
dx7(t)/dt|t=0 > 0; and η7 = 1 since this gives dx7(t)/dt|t=0 < 0 and dx7(t)/dt is
continuous in D. Also, by (36),
lim
t→tˆ1
dx7(t)
dt
= −kdp2 < 0 and lim
t→tˆ0
dx7(t)
dt
= k˜ap2 > 0.
Therefore, we have that 0 < x7(t) < 1 for t ∈ (0, tmax(η)).
Case E: There exists a t0 such that 0 < x5(t) < M5 for 0 ≤ t ≤ t0 for the following
initial conditions: η5 ∈ Int(D) by continuity; η5 = 0 with η3, η4, η8 > 0, since this
gives dx5(t)/dt|t=0 > 0 (for the same reason as in Case C, we can also have η5 = 0
with η3 = 0 as well as η4 = 0, where we keep the condition η8 > 0). Now from (34),
lim
t→t˜5
dx5(t)
dt
= lim
t→t˜5
[
k˜hyd
(
x8(t)
K˜c + x8(t)
)
x3(t) x4(t)
]
> 0
since, by definition, 0 < x8(t) < 1 always, and 0 < x3(t), x4(t) < 1 from Cases B and
C, ensuring that x5(t) > 0 for t ∈ (0, tmax(η)). Taking M5 > k˜hyd/kd3, we also have
lim
t→tˆ5
dx5(t)
dt
= lim
t→tˆ5
[
k˜hyd
(
x8(t)
K˜c + x8(t)
)
x3(t) x4(t)
]
− kd3M5 ≤ k˜hyd − kd3M5 < 0,
which gives a contradiction. Therefore, we now have 0 < x5(t) < M5 for t ∈
(0, tmax(η)).
Case F: This case is very similar to Case E, as x5(t) and x6(t) are produced
stoichiometrically from x4(t). Indeed, there exists a t0 such that 0 < x6(t) < M6 for
0 ≤ t ≤ t0 for the following initial conditions: η6 ∈ Int(D) by continuity; and, for
the same reasons as in Case E, η6 = 0 with η3, η4, η7 ≥ 0 and η8 > 0, since this gives
dx6(t)/dt > 0 on an interval 0 ≤ t ≤ t0. Now from (35),
lim
t→t˜6
dx6(t)
dt
= lim
t→t˜6
[
k˜hyd
(
x8(t)
K˜c + x8(t)
)
x3(t) x4(t) + kdp2ζ x7(t)
]
> 0
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from the remarks given in Case E, and since 0 < x7(t) < 1 from Case D. Thus, we
have x6(t) > 0 for t ∈ (0, tmax(η)). Now taking M6 > (k˜hyd + kdp2ζ)/kdp1, we have
lim
t→tˆ6
dx6(t)
dt
= lim
t→tˆ6
[
k˜hyd
(
x8(t)
K˜c + x8(t)
)
x3(t) x4(t) + kdp2ζ x7(t)
]
− kdp1M6
≤ k˜hyd + kdp2ζ − kdp1M6 < 0,
which gives a contradiction. Therefore, we now have 0 < x6(t) < M6 for t ∈
(0, tmax(η)). 
We now use Brauer’s Theorem 3.6 stated below to obtain the unique continuation
of our solution.
Theorem III.2.4. ([8], Theorem 3.6) Suppose that f and ∂f/∂xj (j = 1, . . . , n) are
continuous in a given region D and suppose f is bounded on D. Let (t0,η) be a given
point of D. Then the unique solution φ of the system x˙ = f(t,x) passing through the
point (t0,η) can be extended until its graph meets the boundary of D.
Proposition III.2.3. For η ∈ Int(D) and for the special cases of ηi, i ∈ {1, . . . , 7}
discussed in Propositions III.2.1 and III.2.2, tmax(η) =∞.
Proof. We have established continuity of our system f and ∂f/∂xj (j = 1, . . . , 9) on
D = {(t,x) ∈ R10
∣∣∣ t ≥ 0, 0 ≤ xi ≤ 1 for i ∈ {1, 2, 3, 4, 7}, with x1 + x2 ≤ 1, and
0 ≤ xj ≤ Mj for j ∈ {5, 6, 8, 9} and 0 < Mj < ∞}. Since D is closed, f is also
bounded on D. Therefore, for η satisfying the conditions in Propositions III.2.1 and
III.2.2, by Theorem III.2.4, the unique solution φ of our system x˙ = f(t,x) passing
through the point (t0,η) can be extended until its graph meets the boundary of D.
Since we have established that for these such η, φ remains in Int(D), we must have
tmax(η) =∞. 
We have thus established the global existence of a unique solution to our system
given by equations (30) - (36), (41), and equation (43).
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III.3 Steady-State Solution
The steady state solutions for our simplified system can be found by setting the right
hand side of the system equal to zero. Therefore, for the receptor module (equations
(30) and (31)), we have
dx1
dt
=
dx2
dt
= 0
implies
kr −
(
kr +
kp [L]
K1 + [L]
)
x1 − kr x2 = 0
and
(
kp x1
K1 + [L]
− ke x2
K2 + [L]
)
= 0. (65)
Solving for x2 in equation (65) we have
kp x1
K1 + [L]
=
ke x2
K2 + [L]
⇒ x2 = kp
ke
(
K2 + [L]
K1 + [L]
)
x1.
Substituting this value of x2 in for x1 in equation (65) and simplifying gives
kr −
(
kr +
kp [L]
K1 + [L]
)
x1 − krkp
ke
(
K2 + [L]
K1 + [L]
)
x1 = 0
⇒ krke =
(
krke +
kp [ke [L] + kr(K2 + [L])]
K1 + [L]
)
x1
⇒ x1 = krke(K1 + [L])
krke(K1 + [L]) + kp [ke [L] + kr(K2 + [L])]
. (66)
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Next we substitute this value of x1 into equation (65) and simplify to obtain
x2 =
[
krkp(K2 + [L])
krke(K1 + [L]) + kp [ke [L] + kr(K2 + [L])]
]
. (67)
These two values can be interpreted as the percentage of phosphorylated (in equation
(67)) and unphosphorylated (in equation (66)) surface receptors remaining after the
ligand concentration has been held fixed for a long period of time. For future refer-
ence, we set ξ1 and ξ2 to be the steady-state values of x1 and x2, respectively. The
steady-state number of molecules for the two groups of surface receptors is found by
multiplying ξ1 and ξ2 by NRT . We can now determine the equilibrium number of
surface receptors NRSE by setting
NRSE = limt→∞(NRS +NRSp ) = (ξ1 + ξ2)NRT
=
krke(K1 + [L]) + krkp(K2 + [L])
krke(K1 + [L]) + kp [ke [L] + kr(K2 + [L])]
=
kr
[
1 +
kp
ke
(
K2 + [L]
K1 + [L]
)]
[
kr +
kp[L]
K1 + [L]
+
kpkr
ke
(
K2 + [L]
K1 + [L]
)] .
Steady states for the remaining equations are also found by setting the right hand
side of the equation equal to zero and solving for ξi, where ξi denotes the steady state
for equation xi(t). The remaining steady states in terms of ξ1 are
ξ3 =
ξ1k˜a
ξ1k˜a + kd
(68)
ξ4 =
krep(K˜c + ν)(kd + k˜aξ1)
kdkrep(K˜c + ν) + k˜a(K˜ckrep + (krep + k˜hyd)ν)ξ1
(69)
ξ5 =
k˜ak˜hydkrepνξ1
kdkd3krep(K˜c + ν) + k˜akd3(K˜ckrep + (krep + k˜hyd)ν)ξ1
(70)
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ξ6 =
krep +
kap2kdp2ζ
kap2 + kdp2
− k
2
rep(K˜c + ν)(kd + k˜aξ)
kdkrep(K˜c + ν) + k˜a(K˜ckrep + (krep + k˜hyd)ν)ξ1)
kdp1
(71)
ξ7 =
kap2
kap2 + kdp2
(72)
ξ8 = ν (73)
ξ9 = 0, (74)
with ν given in equation (45).
III.3.1 Local Stability of Steady States
Due to the fact that our model is a simplification of the actual signaling pathway and
therefore our system of ordinary differential equations as well as the initial condi-
tions are approximations to the actual dynamical response to a stimulus, it becomes
necessary to investigate the qualitative behavior of the model, such as how sensi-
tive our model is to small perturbations or changes of initial conditions and various
model parameters. One important qualitative phenomenon is that of the stability of
a certain state or solution of our system of equations. In particular, we now look
into the stability of the steady states of our simplified model. First we define the
concepts of stability and asymptotic stability of a steady state ξ0 of an autonomous
(not explicitly depending on time) system of the form
x˙ = f(x), (75)
and then of an arbitrary solution to the nonautonomous (explicitly depending on
time) system of the form
x˙ = f(t,x). (76)
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Definitions 1 and 2 are for the autonomous system, and definitions 3 and 4 are for
the nonautonomous system.
Definition 1. ([8], Definition 1) Denote ξ0 to be the equilibrium solution of (75).
This solution is said to be stable if for each number ε > 0 we can find a number δ > 0
(depending on ε) such that if φ(t) is any solution of (75) having ‖φ(t0) − ξ0‖ < δ,
then the solution φ(t) exists for all t ≥ t0 and ‖φ(t)− ξ0‖ < ε for t ≥ t0 (where, for
convenience, ‖ · ‖ may be thought of as the Euclidean norm.)
Definition 2. ([8], Definition 2) The equilibrium solution ξ0 is said to be asymptot-
ically stable if it is stable and if there exists a number δ0 > 0 such that if φ(t) is any
solution of (75) having ‖φ(t0)− ξ0‖ < δ0, then limt→+∞φ(t) = ξ0.
The equilibrium solution ξ0 is said to be unstable if it is not stable.
In equation (76) above, the real vector f with n components is defined and con-
tinuous in some region D = {(t,x)
∣∣∣ 0 ≤ t ≤ ∞, |x| < a} of real (n+1)-dimensional
Euclidean space, and with a ∈ R such that a ≥ 0. For the purposes of Definitions 3
and 4, we let φ(t) be some solution of (76) existing on [0,∞), and ψ(t, t0,x0), t0 ≥ 0,
be a solution of (76) such that ψ(t0, t0,x0) = x0.
Definition 3. ([8], Definition 3) The solution φ(t) of (76) is said to be stable if for
every ε > 0 and every t0 ≥ 0 there exists a δ > 0 (δ now depending on both ε and
possibly t0) such that whenever
∣∣∣φ(t0) − x0∣∣∣ < δ, the solution ψ(t, t0,x0) exists for
all t > t0 and satisfies
∣∣∣φ(t)−ψ(t, t0,x0)∣∣∣ < ε for t ≥ t0.
Definition 4. ([8], Definition 4) The solution φ(t) of (76) is said to be asymptotically
stable if it is stable and if there exists a δ0 > 0 such that whenever
∣∣∣φ(t0)− x0∣∣∣ < δ0,
the solution ψ(t, t0,x0) approaches the solution φ(t) as t → ∞ (in other words,
limt→∞
∣∣∣ψ(t, t0,x0)− φ(t)∣∣∣ = 0).
We first consider the local stability properties of our steady state solution ξ of the
system x˙ = F(x) with Fi = fi for i ∈ {1, . . . , 9} defined in equations (48) through
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(56). To examine the local stability properties of ξ, we first need the following result
due to Poincare and Perron [8]:
Theorem III.3.1. ([8], Theorem 4.3) Consider the system
x˙ = Ax+ f(t,x), (77)
where all eigenvalues ofA have negative real parts, f(t,x) and (∂f/∂xj)(t,x) for (j =
1, . . . , n) are continuous in (t,x) for 0 ≤ t < ∞, |x| < k where k > 0 is a constant,
and f is small in the sense that
lim
|x|→0
|f(t,x)|
|x| = 0 (78)
uniformly with respect to t on 0 ≤ t < ∞. Then the solution x ≡ 0 of (77) is
asymptotically stable.
Using Theorem III.3.1, we show in Proposition III.3.1 that the equilibrium solution
ξ(t) of our system is indeed locally asymptotically stable.
Proposition III.3.1. The equilibrium solution ξ(t) of the system of equations (48)
through (56) is locally asymptotically stable.
Proof. First we consider the linearization of our system F at ξ by defining y = x−ξ(t)
so that
y˙=F(t,x)− F(t, ξ(t)) = F(t,y + ξ(t))− F(t, ξ(t))
=
∂F
∂x
(t, ξ(t))y +G(t,y), (79)
where G, by construction, satisfies condition (78) of Theorem III.3.1. Furthermore,
by setting A = ∂F
∂x
(t, ξ(t)), which is the Jacobian matrix of our system at the steady
state solution ξ, we simply need to determine the sign of the eigenvalues of this
Jacobian matrix given in Figure 3. Eigenvalues for this Jacobian matrix are found
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using Mathematica and are listed in Table 3. Except in the case of λ5 and λ6 it is
immediately clear that all eigenvalues are real and negative, as all rate parameters
are strictly positive. If the term under the square root in λ5 and λ6 is positive, both
of these eigenvalues have negative real parts, and if the term under the square root
is negative, then λ6 is real and negative. In this second case, λ5 is also real and
negative by the following argument: λ5 can be written as
−b+√b2−4ac
2a
, so that we have
b2 − 4ac > 0 ⇒ the real part of λ5 is negative ⇐⇒ b >
√
b2 − 4ac ⇐⇒ b2 >
b2 − 4ac ⇐⇒ −4ac < 0, but this is always true since all of the rate constants
contained in the terms a and c are positive. Therefore, we have that all eigenvalues
of the Jacobian matrix ∂F
∂x
(t, ξ(t)) have negative real parts, so that the hypotheses of
Theorem III.3.1 are satisfied for the linearization equation (79).
We can thus conclude that the solution y ≡ 0 of equation (79) is asymptoti-
cally stable, which is equivalent to concluding the (local) asympototic stability of the
solution x = ξ(t). 
III.3.2 Global Stability of Steady States
Here we extend the local stability analysis from the previous section to a global
stability result. We make note that from the analytical equations for x8(t) and x9(t),
we know that the steady states ξ8 = ν and ξ9 = 0 are globally asymptotically stable.
First we simultaneously prove global stability of ξ1 and ξ2, the steady states of x1
and x2, respectively.
Proposition III.3.2. The steady states ξ1 and ξ2 are globally asymptotically stable
within the region of global existence of x1(t) and x2(t) as defined in Proposition III.2.2.
Proof. First we rewrite the differential equations for x1 and x2 as follows:
x′1 = kr(1− x1 − x2)− c1x1
x′2 = c1x1 − c2x2,
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where c1 and c2 are defined in equation (63). Writing this system of equations in
matrix form, we have
x1
x2

′
=
−(kr + c1)−kr
c1 −c2

x1
x2
+
kr
0
 .
Then by the variation of parameters formula, we have that
x(t) = e[tA]x0 +
∫ t
0
e[(t−s)A]
kr
0
 ds
is the solution of this system, where
A =
−(kr + c1)−kr
c1 −c2
 (80)
with eigenvalues
λ1 =
−c1 − c2 − kr +
√
c21 + (c2 − kr)2 − 2c1(c2 + kr)
2
(81)
λ2 =
−c1 − c2 − kr −
√
c21 + (c2 − kr)2 − 2c1(c2 + kr)
2
. (82)
In general, for an n-by-n matrix A with n distinct eigenvalues, we know that there ex-
ist n linearly independent eigenvectors v1, . . . ,vn, corresponding to these eigenvalues.
We can then define the matrix
T = [v1,v2, . . . ,vn] (83)
having these n linearly independent eigenvectors as columns. As a result of Theorem
III.3.2 stated below (taken from Brauer and Nohel’s Theorem 2.8 on page 76 [8]), we
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can therefore write
T−1AT = D,
where D is the diagonal matrix
D =

λ1 0
λ2
. . .
0 λn

. (84)
Theorem III.3.2. (Diagonal Canonical Form. [8], Theorem 2.9) If the n-by-n con-
stant matrix A has n linearly independent eigenvectors v1, . . . ,vn, corresponding to
the eigenvalues λ1, λ2, . . . , λn, then A is similar to the diagonal matrix D given by
(84), and the matrix T that accomplishes the similarity is given by (83).
So by Theorem III.3.2, since our eigenvalues λ1 and λ2 from equations (81) and
(82) are distinct, we can write
T−1AT = J ⇒ A = TJT−1, (85)
where
T = [v1,v2] and J =
λ1 0
0 λ2
 .
Then by equation (85) and by property of the exponential of a matrix, we have
e[tA] = Te[tJ]T−1. (86)
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Since we have that λ1, λ2 from (81) and (82) have negative real part, equation (86)
gives
lim
t→∞ e
[tA] = lim
t→∞
(
Te[tJ]T−1
)
=
0
0
 .
Therefore as t→∞, our solution x(t) = (x1(t), x2(t)) in equation (80) becomes
lim
t→∞x(t) = limt→∞
(
e[tA]x0
)
+ lim
t→∞
∫ t
0
e[(t−s)A]
kr
0
 ds

= lim
t→∞
(
Te[tJ]T−1x0
)
+ lim
t→∞
∫ t
0
Te[(t−s)J]T−1
kr
0
 ds

= 0+ lim
t→∞
T(∫ t
0
e[(t−s)J]ds
)
T−1
kr
0


= lim
t→∞
T
∫ t
0
e(t−s)λ1 0
0 e(t−s)λ2
 ds
T−1
kr
0


=T
− 1λ1 0
0 − 1
λ2
T−1
kr
0
 =
ξ1
ξ2
 . (87)
Thus no matter what choice of initial vector x0, we will always attain the steady state
given by (87) and equivalent to the matrix [ξ1, ξ2]
T , where ξ1 and ξ2 are the steady
states found earlier for x1(t) and x2(t), respectively. We have therefore proved the
global stability of this steady state solution. 
As seen in the next proposition, we now turn our focus to determining the global
stability of the model’s remaining steady states given in equations (68) through (74).
Proposition III.3.3. The steady states ξi, i = 3 . . . 7, are globally asymptotically
stable within the region of global existence as defined in Proposition III.2.2.
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Proof. We split the proof into a separate case for each steady state.
Case A: Global stability of ξ3. Since
x′3(t) = k˜ax1(t)− (k˜ax1(t) + kd)x3(t),
by variation of parameters, we have
x3(t) = e
−
∫ t
0
(k˜ax1(s)+kd)dsx3(0) +
∫ t
0
e−
∫ t
s
(k˜ax1(r)+kd)drk˜ax1(s) ds. (88)
Note that k˜ax1(s) + kd ≥ kd since x1(s) ≥ 0 for all s ≥ 0 and k˜a, kd > 0 always.
Therefore, we have
lim
t→∞
∫ t
0
kd ds =∞⇒ lim
t→∞
∫ t
0
(k˜ax1(t) + kd) ds =∞
⇒ lim
t→∞ e
−
∫ t
0
(k˜ax1(s)+kd)dsx3(0) = 0,
so that the asymptotic behavior of x3(t) does not depend on the choice of initial
conditions. We now show that the solution x3(t) converges to its steady state ξ3. By
(88), we have
lim
t→∞x3(t) = limt→∞
(
e−
∫ t
0
(k˜ax1(s)+kd)dsx3(0) +
∫ t
0
e−
∫ t
s
(k˜ax1(r)+kd)drk˜ax1(s) ds
)
if this limit exists.
Now take ε > 0 such that ε < k˜aξ1 + kd, and choose a t1 such that
|k˜ax1(t)− k˜aξ1| < ε for t > t1 > 0. (89)
Such a t1 exists since from (87) we know that limt→∞ x1(t) = ξ1. Note also for t
sufficiently larger than t1, the following conditions hold:
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(i) e−
∫ t
0
(k˜ax1(s)+kd)dsx3(0) <
ε
2
(ii)
k˜a
kd
e−kdt
[
ekdt1 − 1
]
<
ε
2
(iii) e−(k˜aξ1+kd+ε)(t−t1) < ε.
Now from (88), we can write
x3(t) = e
−
∫ t
0
(k˜ax1(s)+kd)dsx3(0) +
∫ t1
0
e−
∫ t
s
(k˜ax1(r)+kd)drk˜ax1(s) ds
+
∫ t
t1
e−
∫ t
s
(k˜ax1(r)+kd)drk˜ax1(s) ds.
Notice for the above choice of t1 in (89) and for t >> t1 such that conditions (i)−(iii)
hold, we have
e−
∫ t
0
(k˜ax1(s)+kd)dsx3(0) +
∫ t1
0
e−
∫ t
s
(k˜ax1(r)+kd)drk˜ax1(s) ds
≤ ε
2
+ k˜a
∫ t1
0
e−
∫ t
s
(k˜ax1(r)+kd)dr ds
≤ ε
2
+ k˜a
∫ t1
0
e−
∫ t
s
(kd)dr ds
=
ε
2
+ k˜ae
−kdt
∫ t1
0
ekds ds
=
ε
2
+
k˜a
kd
e−kdt
[
ekdt1 − 1
]
<
ε
2
+
ε
2
= ε. (90)
Then for the same choice of t1 and t >> t1, we also have
∫ t
t1
e−
∫ t
s
(k˜ax1(r)+kd)drk˜ax1(s) ds
=
∫ t
t1
e−
∫ t
s
[(k˜ax1(r)−k˜aξ1)+(k˜aξ1+kd)]dr
[
(k˜ax1(s)− k˜aξ1) + k˜aξ1
]
ds
≤
∫ t
t1
e−
∫ t
s
[(k˜aξ1+kd)−ε]dr(ε+ k˜aξ1) ds
= (ε+ k˜aξ1)
∫ t
t1
e−(k˜aξ1+kd−ε)te(k˜aξ1+kd−ε)s ds
=
(
ε+ k˜aξ1
k˜aξ1 + kd − ε
)
e−(k˜aξ1+kd−ε)t
[
e(k˜aξ1+kd−ε)t − e(k˜aξ1+kd−ε)t1
]
=
(
ε+ k˜aξ1
k˜aξ1 + kd − ε
) [
1− e−(k˜aξ1+kd−ε)(t−t1)
]
≤
(
ε+ k˜aξ1
k˜aξ1 + kd − ε
)
. (91)
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Thus (90) and (91) together give
x3(t) ≤ ε+
(
ε+ k˜aξ1
k˜aξ1 + kd − ε
)
∀ t >> t1. (92)
Now we need to find a lower bound for x3(t). For the above choice of t1 and t >> t1,
we have
x3(t) = e
−
∫ t
0
(k˜ax1(s)+kd)dsx3(0) +
∫ t
0
e−
∫ t
s
(k˜ax1(r)+kd)drk˜ax1(s) ds
≥
∫ t1
0
e−
∫ t
s
(k˜ax1(r)+kd)drk˜ax1(s) ds+
∫ t
t1
e−
∫ t
s
(k˜ax1(r)+kd)drk˜ax1(s) ds
≥
∫ t
t1
e−
∫ t
s
(k˜ax1(r)+kd)drk˜ax1(s) ds
=
∫ t
t1
e−
∫ t
s
[(k˜ax1(r)−k˜aξ1)+(k˜aξ1+kd)]dr
[
(k˜ax1(s)− k˜aξ1) + k˜aξ1
]
ds
≥
∫ t
t1
e−
∫ t
s
[(k˜aξ1+kd)+ε]dr(k˜aξ1 − ε) ds
=
(
k˜aξ1 − ε
k˜aξ1 + kd + ε
)
e−(k˜aξ1+kd+ε)t
[
e(k˜aξ1+kd+ε)t − e(k˜aξ1+kd+ε)t1
]
=
(
k˜aξ1 − ε
k˜aξ1 + kd + ε
) [
1− e−(k˜aξ1+kd−ε)(t−t1)
]
≥
(
k˜aξ1 − ε
k˜aξ1 + kd + ε
)
[1− ε] .
Together with (92), this gives
(
k˜aξ1 − ε
k˜aξ1 + kd + ε
)
[1− ε] ≤ x3(t) ≤ ε+
(
ε+ k˜aξ1
k˜aξ1 + kd − ε
)
∀ t >> t1.
Taking ε→ 0 forces t→∞, giving the desired result:
lim
t→∞x3(t) =
k˜aξ1
k˜aξ1 + kd
= ξ3.
We proceed in a similar fashion for the remaining model equations.
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Case B: Global stability of ξ4. Since
x′4(t) =
[
−k˜hyd x8(t)
K˜c + x8(t)
x3(t)− krep
]
x4(t) + krep,
by variation of parameters, we have
x4(t) = e
−
∫ t
0
(
k˜hyd
x8(s)
K˜c+x8(s)
x3(s)+krep
)
ds
x4(0)
+
∫ t
0
e
−
∫ t
s
(
k˜hyd
x8(s)
K˜c+x8(s)
x3(s)+krep
)
ds
krep ds. (93)
Recalling that ξ8 = ν, now we take ε > 0 such that ε < k˜hyd
ν
K˜c+ν
ξ3 + krep. We
can choose a t1 > 0 such that
∣∣∣∣∣
(
k˜hyd
x8(s)
K˜c + x8(s)
x3(s)
)
−
(
k˜hyd
ν
K˜c + ν
ξ3
)∣∣∣∣∣ < ε for t > t1 > 0. (94)
Such a t1 exists since from (45) and (93). Note also for t sufficiently larger than t1,
the following conditions hold:
(i) e
−
∫ t
0
(
k˜hyd
x8(s)
K˜c+x8(s)
x3(s)+krep
)
ds
x4(0) <
ε
2
(ii) e−krept
[
ekrept1 − 1
]
<
ε
2
(iii) e
−(k˜hyd νK˜c+ν ξ3+krep+ε)(t−t1) < ε.
Now from (93), we can write
x4(t) = e
−
∫ t
0
(
k˜hyd
x8(s)
K˜c+x8(s)
x3(s)+krep
)
ds
x4(0)
+
∫ t1
0
e
−
∫ t
s
(
k˜hyd
x8(s)
K˜c+x8(s)
x3(s)+krep
)
ds
krep ds
+
∫ t
t1
e
−
∫ t
s
(
k˜hyd
x8(s)
K˜c+x8(s)
x3(s)+krep
)
ds
krep ds.
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Notice for the above choice of t1 in (94) and for t >> t1 such that conditions (i)−(iii)
hold, we have
e
−
∫ t
0
(
k˜hyd
x8(s)
K˜c+x8(s)
x3(s)+krep
)
ds
x4(0) +
∫ t1
0
e
−
∫ t
s
(
k˜hyd
x8(s)
K˜c+x8(s)
x3(s)+krep
)
ds
krep ds
≤ ε
2
+ e−krept
[
ekrept1 − 1
]
<
ε
2
+
ε
2
= ε. (95)
Then for the same choice of t1 and t >> t1,
∫ t
t1
e
−
∫ t
s
(
k˜hyd
x8(s)
K˜c+x8(s)
x3(s)+krep
)
ds
krep ds
=
∫ t
t1
e
−
∫ t
s
([
k˜hyd
x8(s)
K˜c+x8(s)
x3(s)−k˜hyd νK˜c+ν ξ3
]
+k˜hyd
ν
K˜c+ν
ξ3+krep
)
ds
krep ds
≤
∫ t
t1
e
−
∫ t
s
[k˜hyd
ν
K˜c+ν
ξ3+krep−ε]drkrep ds
=
krep
k˜hyd
ν
K˜c+ν
ξ3 + krep − ε
[
1− e−(k˜hyd νK˜c+ν ξ3+krep−ε)(t−t1)
]
≤ krep
k˜hyd
ν
K˜c+ν
ξ3 + krep − ε
. (96)
Combining (95) and (96), we have
x4(t) ≤ ε+ krep
k˜hyd
ν
K˜c+ν
ξ3 + krep − ε
∀ t >> t1. (97)
For the above choice of t1 and t >> t1,
x4(t) = e
−
∫ t
0
(
k˜hyd
x8(s)
K˜c+x8(s)
x3(s)+krep
)
ds
x4(0) +
∫ t
0
e
−
∫ t
s
(
k˜hyd
x8(s)
K˜c+x8(s)
x3(s)+krep
)
ds
krep ds
≥
∫ t1
0
e
−
∫ t
s
(
k˜hyd
x8(s)
K˜c+x8(s)
x3(s)+krep
)
ds
krep ds
+
∫ t
t1
e
−
∫ t
s
(
k˜hyd
x8(s)
K˜c+x8(s)
x3(s)+krep
)
ds
krep ds
≥
∫ t
t1
e
−
∫ t
s
(
k˜hyd
x8(s)
K˜c+x8(s)
x3(s)+krep
)
ds
krep ds
≥ krep
k˜hyd
ν
K˜c+ν
ξ3 + krep + ε
[
1− e−(k˜hyd νK˜c+ν ξ3+krep+ε)(t−t1)
]
≥ krep
k˜hyd
ν
K˜c+ν
ξ3 + krep + ε
[1− ε] .
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Together with (97), this gives
krep
k˜hyd
ν
K˜c+ν
ξ3 + krep + ε
[1− ε] ≤ x4(t) ≤ ε+ krep
k˜hyd
ν
K˜c+ν
ξ3 + krep − ε
∀ t >> t1.
Taking ε→ 0 forces t→∞, giving the desired result:
lim
t→∞x4(t) =
krep
k˜hyd
ν
K˜c+ν
ξ3 + krep
= ξ4.
(98)
Case C: Global stability of ξ5. The derivative for x5(t) is given by
x′5(t) = k˜hyd
x8(t)
K˜c + x8(t)
x3(t)x4(t)− kd3x5(t), (99)
so by the variation of parameters formula we can write
x5(t) = e
−
∫ t
0
kd3dsx5(0) +
∫ t
0
e−
∫ t
s
kd3dsk˜hyd
x8(t)
K˜c + x8(t)
x3(t)x4(t) ds. (100)
Here we take any ε > 0 and choose a t1 > 0 such that
∣∣∣∣∣
(
k˜hyd
x8(t)
K˜c + x8(t)
x3(t)x4(t)
)
−
(
k˜hyd
ν
K˜c + ν
ξ3ξ4
)∣∣∣∣∣ < ε for t > t1 > 0. (101)
Such a t1 exists by (45), (93), and (98).
Note also for t sufficiently larger than t1, the following conditions hold:
(i) e−
∫ t
0
kd3dsx5(0) <
ε
2
(ii)
k˜hyd
kd3
e−kd3t
[
ekd3t1 − 1
]
<
ε
2
(iii) e−kd3(t−t1) < ε.
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From (100), we can write
x5(t) = e
−
∫ t
0
kd3dsx5(0) +
∫ t1
0
e−
∫ t
s
kd3dsk˜hyd
x8(t)
K˜c + x8(t)
x3(t)x4(t) ds
+
∫ t
t1
e−
∫ t
s
kd3dsk˜hyd
x8(t)
K˜c + x8(t)
x3(t)x4(t) ds.
Notice for the above choice of t1 in (101) and for t >> t1 such that conditions
(i)− (iii) hold, we have
e−
∫ t
0
kd3dsx5(0) +
∫ t1
0
e−
∫ t
s
kd3dsk˜hyd
x8(t)
K˜c + x8(t)
x3(t)x4(t) ds
≤ ε
2
+
k˜hyd
kd3
e−kd3t
[
ekd3t1 − 1
]
(102)
<
ε
2
+
ε
2
= ε.
Then for the same choice of t1 and t >> t1,
∫ t
t1
e−
∫ t
s
kd3dsk˜hyd
x8(t)
K˜c + x8(t)
x3(t)x4(t) ds
=
∫ t
t1
e−
∫ t
s
kd3ds
[(
k˜hyd
x8(t)
K˜c + x8(t)
x3(t)x4(t)− k˜hyd ν
K˜c + ν
ξ3ξ4
)
+ k˜hyd
ν
K˜c + ν
ξ3ξ4
]
ds
≤
∫ t
t1
e−
∫ t
s
kd3ds
(
ε+ k˜hyd
ν
K˜c + ν
ξ3ξ4
)
ds
=
ε+ k˜hyd
ν
K˜c+ν
ξ3ξ4
kd3
[
1− e−kd3(t−t1)
]
≤ ε+ k˜hyd
ν
K˜c+ν
ξ3ξ4
kd3
. (103)
Therefore (102) and (103) give
x5(t) ≤ ε+
ε+ k˜hyd
ν
K˜c+ν
ξ3ξ4
kd3
∀ t >> t1. (104)
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For the above choice of t1 and t >> t1,
x5(t) = e
−
∫ t
0
kd3dsx5(0) +
∫ t1
0
e−
∫ t
s
kd3dsk˜hyd
x8(t)
K˜c + x8(t)
x3(t)x4(t) ds
+
∫ t
t1
e−
∫ t
s
kd3dsk˜hyd
x8(t)
K˜c + x8(t)
x3(t)x4(t) ds
≥
∫ t
t1
e−
∫ t
s
kd3dsk˜hyd
x8(t)
K˜c + x8(t)
x3(t)x4(t) ds
≥ k˜hyd
ν
K˜c+ν
ξ3ξ4 − ε
kd3
[
1− e−kd3(t−t1)
]
≥ k˜hyd
ν
K˜c+ν
ξ3ξ4 − ε
kd3
[1− ε] .
In combination with (104), this gives
k˜hyd
ν
K˜c+ν
ξ3ξ4 − ε
kd3
[1− ε] ≤ x5(t) ≤ ε+
ε+ k˜hyd
ν
K˜c+ν
ξ3ξ4
kd3
∀ t >> t1.
Sending ε→ 0 forces t→∞, giving the desired result:
lim
t→∞x5(t) =
k˜hyd
ν
K˜c+ν
ξ3ξ4
kd3
= ξ5.
In order to study the global stability of ξ6, we first need to investigate the stability
properties of ξ7.
Case D: Global stability of ξ7. From
x′7(t) = −kdp2x7(t) + kap2(1− x7(t)),
variation of parameters gives
x7(t) = e
−
∫ t
0
(kap1+kap2)dsx7(0) +
∫ t
0
e−
∫ t
s
(kap1+kap2)dskap2 ds.
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Thus
lim
t→∞x7(t) = limt→∞
(
e−
∫ t
0
(kap1+kap2)dsx7(0) +
∫ t
0
e−
∫ t
s
(kap1+kap2)dskap2 ds
)
= lim
t→∞
∫ t
0
e−
∫ t
s
(kap1+kap2)dskap2 ds
= lim
t→∞
(
kap2
kap1 + kap2
)
e−(kap1+kap2)t
[
e(kap1+kap2)t − 1
]
= lim
t→∞
(
kap2
kap1 + kap2
) [
1− e−(kap1+kap2)t
]
=
kap2
kap1 + kap2
= ξ7.
Therefore ξ7 is globally asympototically stable. Now we can investigate the stability
of ξ6.
Case E: Global stability of ξ6. Since
x′6(t) = k˜hyd
x8(t)
K˜c + x8(t)
x3(t)x4(t) + kdp2ζx7(t)− kdp1x6(t), (105)
variation of parameters gives
x6(t) = e
−
∫ t
0
kdp1dsx6(0)
+
∫ t
0
e−
∫ t
s
kdp1ds
(
k˜hyd
x8(t)
K˜c + x8(t)
x3(t)x4(t) + kdp2ζx7(t)
)
ds. (106)
Given ε > 0, we choose a t1 > 0 such that for all t > t1 > 0,
∣∣∣∣∣
(
k˜hyd
x8(t)
K˜c + x8(t)
x3(t)x4(t) + kdp2ζx7(t)
)
−
(
k˜hyd
ν
K˜c + ν
ξ3ξ4 + kdp2ζξ7
)∣∣∣∣∣ < ε. (107)
Such a t1 exists by (45), (93), (98), and (105). Note also for t sufficiently larger
than t1, the following conditions hold:
(i) e−
∫ t
0
kdp1dsx6(0) <
ε
2
(ii)
k˜hyd + kdp2
kdp1
e−kdp1t
[
ekdp1t1 − 1
]
<
ε
2
(iii) e−kdp1(t−t1) < ε.
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From (106), we can write
x6(t) = e
−
∫ t
0
kdp1dsx6(0) +
∫ t1
0
e−
∫ t
s
kdp1ds
(
k˜hyd
x8(t)
K˜c + x8(t)
x3(t)x4(t) + kdp2ζx7(t)
)
ds
+
∫ t
t1
e−
∫ t
s
kdp1ds
(
k˜hyd
x8(t)
K˜c + x8(t)
x3(t)x4(t) + kdp2ζx7(t)
)
ds.
Notice for the above choice of t1 in (107) and for t >> t1 such that conditions
(i)− (iii) hold, we have
e−
∫ t
0
kdp1dsx6(0) +
∫ t1
0
e−
∫ t
s
kdp1ds
(
k˜hyd
x8(t)
K˜c + x8(t)
x3(t)x4(t) + kdp2ζx7(t)
)
ds
≤ ε
2
+
k˜hyd + kdp2
kdp1
e−kdp1t
[
ekdp1t1 − 1
]
<
ε
2
+
ε
2
= ε. (108)
Then for the same choice of t1 and t >> t1,
∫ t
t1
e−
∫ t
s
kdp1ds
(
k˜hyd
x8(t)
K˜c + x8(t)
x3(t)x4(t) + kdp2ζx7(t)
)
ds
=
∫ t
t1
e−
∫ t
s
kdp1ds
(k˜hyd x8(t)
K˜c + x8(t)
x3(t)x4(t) + kdp2ζx7(t)
−k˜hyd ν
K˜c + ν
ξ3ξ4 − kdp2ζξ7
)
+ k˜hyd
ν
K˜c + ν
ξ3ξ4 + kdp2ζξ7
 ds
≤
∫ t
t1
e−
∫ t
s
kdp1ds
(
ε+ k˜hyd
ν
K˜c + ν
ξ3ξ4 + kdp2ζξ7
)
ds
=
ε+ k˜hyd
ν
K˜c+ν
ξ3ξ4 + kdp2ζξ7
kdp1
[
1− e−kdp1(t−t1)
]
≤ ε+ k˜hyd
ν
K˜c+ν
ξ3ξ4 + kdp2ζξ7
kdp1
. (109)
Hence (108) and (109) together give
x6(t) ≤ ε+
ε+ k˜hyd
ν
K˜c+ν
ξ3ξ4 + kdp2ζξ7
kdp1
∀ t >> t1. (110)
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For the above choice of t1 and t >> t1,
x6(t) = e
−
∫ t
0
kdp1dsx6(0) +
∫ t1
0
e−
∫ t
s
kdp1ds
(
k˜hyd
x8(t)
K˜c + x8(t)
x3(t)x4(t) + kdp2ζx7(t)
)
ds
+
∫ t
t1
e−
∫ t
s
kdp1ds
(
k˜hyd
x8(t)
K˜c + x8(t)
x3(t)x4(t) + kdp2ζx7(t)
)
ds
≥
∫ t
t1
e−
∫ t
s
kdp1ds
(
k˜hyd
x8(t)
K˜c + x8(t)
x3(t)x4(t) + kdp2ζx7(t)
)
ds
≥ k˜hyd
ν
K˜c+ν
ξ3ξ4 + kdp2ζξ7 − ε
kdp1
[
1− e−kdp1(t−t1)
]
≥ k˜hyd
ν
K˜c+ν
ξ3ξ4 + kdp2ζξ7 − ε
kdp1
[1− ε] .
Together with (110), this gives
k˜hyd
ν
K˜c+ν
ξ3ξ4 + kdp2ζξ7 − ε
kdp1
[1− ε]≤ x6(t)
≤ ε+ ε+ k˜hyd
ν
K˜c+ν
ξ3ξ4 + kdp2ζξ7
kdp1
∀ t >> t1.
Once again, taking ε→ 0 forces t→∞, giving the desired result:
lim
t→∞x6(t) =
k˜hyd
ν
K˜c+ν
ξ3ξ4 + kdp2ζξ7
kdp1
= ξ6.

We have therefore concluded global asymptotic stability of the unique steady state
solution ξ within the region defined in Propositions III.2.1 and III.2.2.
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chapter iv
numerical model analysis
IV.1 Introduction
We now turn our focus to the numerical analysis of our model. The first half of
this chapter is devoted to the techniques of nonlinear parameter estimation used
to estimate unknown rate parameters from experimental data. We then provide
a comparison of model simulations with empirical data followed by a discussion of
which parameters were used to fit which aspects of the experimental data.
In the second half of this chapter we focus on the sensitivity of our model output
to the rate parameters, which here we will refer to as input variables. Sensitivity
analysis techniques are valuable tools designed to answer questions regarding which
of the uncertain input variables is more important in determining the uncertainty
in the model output. Likewise, sensitivity analysis can provide insight into which
parameters should be studied in more detail in order to reduce the most variance
in the model output [65]. The ability to answer these types of questions could lead
to important insight into the design of new experiments and in determining which
experiments would give us the most valuable information.
The most frequently used sensitivity analysis techniques consist of local measures
of the effect of a given input variable on a particular output of the model [66]. This
type of analysis is usually obtained by either directly or indirectly computing system
derivatives Sj = ∂Y/∂Mj, where Y is the output of interest and Mj, j = 1, . . . , k,
is an input variable [38, 75]. This technique provides the effect of varying one input
variable while all other variables remain fixed, thus falling under the class of the one-
factor-at-a-time (OAT) methods. These methods are only effective if the model is
linear in all of its input variables and therefore have limited use and can often provide
misleading information for nonlinear models. Therefore, we have instead chosen to use
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the Standardized Regression Coefficients (SRCs) obtained by performing regression
analysis as a means of sensitivity analysis, since the use of SRCs is considered to be
more of a global technique, offering a measure of sensitivity that is multi-dimensionally
averaged over the entire space of parameter values. Indeed, SRCs are preferable over
the normal derivatives, Sj, as they give insight into the degree of nonlinearity in the
model and also provide a measure of the effect of a particular input variable, Mj,
averaged over a range of possible values for Mj, instead of being computed at a single
fixed value of Mj, as is the case for the Sj.
This technique of calculating SRCs first requires the generation of a sample matrix
of dimension n × k, where n is the user-defined number of samples to be taken
from the sample space (the space consisting of the probability distributions of each
parameter value), and k is the total number of input variables considered in the
sensitivity analysis. We first discuss our choice of sample generation, followed by
the methodology behind regression analysis as a means of calculating sensitivity. We
conclude with an explanation of our particular implementation of these methods and
a discussion of the results from our analysis.
IV.2 Estimation of Unknown Rate Parameters from Experimental Data
IV.2.1 Numerical Methods
Our system of ordinary differential equations was integrated using the MATLAB solver
ode15s, which is a variable order solver based on the numerical differentiation for-
mulas (NDFs) [71]. Once an exhaustive search through the literature for known rate
parameters was performed, unknown rates were estimated using SIMULINK, which esti-
mates the parameters by minimizing a user-specified cost function via a user-specified
optimization method [44]. We chose the nonlinear least squares optimization method
of Levenberg-Marquardt to minimize a sum of squared errors cost function of the
empirical observations and model predictions for IP3, Ca
2+, and multiple species of
DAG.
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In order to perform the nonlinear parameter estimation in SIMULINK, we first cre-
ated the SIMULINK model shown in Figure 4 to recreate our original (dimensionalized)
system of nonlinear ordinary differential equations.
Figure 4: SIMULINK model used in the estimation of unknown rate parameters to
simultaneously fit IP3, Ca
2+, and DAG data.
Each “subsystem” in the SIMULINK model represents an ODE for each variable
in the original model. Interactions within each subsytsem are shown in Appendix A,
Figures 32 through 41. Each block joined by connectors performs a specific function
on the value fed into the block an outputs the result from the specific operation. A
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list of blocks used in our SIMULINK model along with the function of each is shown
in Figure 42 of Appendix A.
IV.2.2 Experimental Methods
In this section we provide a detailed explanation of the experimental methods used
to obtain the time-based data for DAG, IP3, and Ca
2+.
For the diacylglycerol assay, RAW 264.7 cells used by the Alliance for Cellular
Signaling (AfCS) were obtained from the American Type Culture Collection (ATCC
catalog number TIB-71, lot number 2263775). For ligand stimulation, 4× 106 RAW
264.7 cells were plated in 4 ml RAW Growth Medium 1 (DMEM supplemented with
10% FBS, 2 mM L-glutamine, and 20 mM NaHEPES, pH 7.4) per 60 mm TC-treated
dish (Falcon). Cells were grown overnight in 5% C02 and the medium replaced with
3.6 ml serum-free assay medium (DMEM containing 2 mM L-glutamine, 20 mM
NaHEPES, pH 7.4, and 0.1 mg/ml bovine serum albumin) for 1 hr. After 1 hr
serum-starvation, cells were stimulated with 0.4 ml serum-free medium (control) or
10x ligand (25 µM UDP) in a 37◦C glove box for the indicated times. The medium
was aspirated on ice, cells were washed with 2 ml ice-cold PBS, aspirated again and
resuspended in 0.8 ml ice-cold PBS by scraping. The cell suspension was transferred
to a cold 1.5 ml PCR tube (Laboratory Products) and centrifuged for 5 min at 1000
x g, 4◦C. The PBS was aspirated and the pellets were frozen and stored in dry ice.
Phospholipids were extracted using a modified Bligh/Dyer procedure [5]. Ice-cold 1:1
0.1N HCl:CH3OH (800 µL) was added to each cell pellet, and the suspensions were
transferred to individual cold 12 × 75 mm borosilicate glass test tubes. 24:0 DAG
(10 µL, 10 µg/mL, Avanti Polar Lipids) was added to all samples as an internal stan-
dard. After addition of 400 µL ice-cold CHCl3 and thorough mixing, phospholipids
were collected from the lower (organic) phase after layer separation by centrifugation.
Diacylglycerol isolation from phospholipid extracts and species-specific diacylglycerol
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quantification using electrospray ionization mass spectrometry was achieved accord-
ing to the procedures described in Callender et al. [10].
Next, for the IP3 binding assay, lysates from RAW 264.7 cells were assayed using
the [3H] Biotrak assay kit from GE Healthcare, based on a competitive radioreceptor
assay [53]. RAW 264.7 cells were grown in 60 mm dishes and stimulated as described
in Callender et al. [10]. Cells were washed with 2 ml ice-cold PBS, aspirated and
lysed by scraping in 250 µl 5.4% perchloric acid on ice. Cell lysates were transferred
to 1.5 ml microfuge tubes and assayed according to the manufacturer’s instructions.
[IP3] is calculated as pmols/100 µl lysate.
Finally, for the intracellular free calcium assay, data were obtained by mea-
suring the fluorescent emission at 538 nM of RAW 264.7 cells loaded with fluo-3
acetoxymethyl (Molecular Probes). Fluorescence measurements were performed us-
ing a Fluoroskan Ascent microplate fluorometer with the Ascent software (Thermo-
Labsystems), according to AfCS Procedure Protocol PP00000176, described in detail
on the AfCS website: http://www.signaling-gateway.org. Intracellular free calcium
data for RAW 264.7 cells stimulated with 25 µM UDP were obtained from the AfCS
single ligand screen [49], and are also available on the AfCS website.
All IP3 and Ca
2+ data were collected by the AfCS cell laboratory at the University
of Texas Southwestern.
IV.2.3 Parameter Estimation
Experimental observations of P2Y6 receptor dynamics from Brinson and Harden in
1321N1 astrocytoma cells [6] and IP3, Ca
2+, and species-specific DAG measurements
of the response to 25 µM UDP in RAW 264.7 cells are all used to compare with the
simulations obtained from the system of ten nonlinear ordinary differential equations
described in Chapter II (using equations (25) and (26) for the DAG module) and to
aid in the estimation of unknown rate parameters. Table 4 includes a list of all model
parameters, their values, and a reference for those taken from the literature.
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Table 4: Time-independent model variables
Parameter Value Reference
[L] 25 µM
NRT 20000 [21, 43]
K1 5 µM [39, 41]
K2 100 µM [39]
kr 1.75× 10−4s−1 [39]
kp 1.75× 10−3s−1 see text
ke 6× 10−3s−1 [39]
NGT 3× 105 [19]
ka 0.137 µM
−1s−1 [19]
kd 0.02 s
−1 [43]
NPIP2T 9× 106 see text
v 5× 10−13L [68]
Kc 0.4 µM [19, 39]
kˆhyd 1× 10−5 #mol−1s−1 see text
krep 0.014 s
−1 see text
kd3 6× 10−3 s−1 see text
NDAGp2T 480 (500) µM see text
kdp1 7.37× 10−3s−1 see text
(1.2× 10−3s−1)a
kdp2 5.4× 10−3s−1 see text
(1.71× 10−3s−1)a
kap2 1.08× 10−2s−1 see text
(1.96× 10−3s−1)a
η 0.66 (0.45)a see text
 0.01 [16, 40]
dIP3 0.2 µM [40]
dact 0.4 µM [40]
dinh 0.02 µM [39]
a 3.1 s−1 see text
ν1 40 s
−1 [40]
ν2 5.08× 10−3s−1 see text
ν3 0.24 µM s
−1 [40]
ν4 1.4 µM s
−1 see text
ker 0.4 µM [39]
kpl 1.56× 10−2 µM see text
jin 0.447 µM s
−1 see text
c1 0.185 [16]
aParameter values not in parentheses correspond to 38:4 DAG,
while those in parentheses are for 34:1 DAG.
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Of these 34 parameters, 18 are taken from the literature, 2 are directly measured,
and 14 are estimated from experimental data.
The primary focus of this work is on the differential mechanisms of species-specific
DAG production and degradation. Time-series data for the 38:4 DAG and 34:1 DAG
responses to 25 µM UDP are shown in Figures 5a and 5b, respectively. Solid grey
Figure 5: Timecourse of stimulation with 25 µM UDP in RAW 264.7 cells. Solid
black lines represent model simulations for the system of equations using the two-pool
model (with equations (25) and (26)), while gray lines represent simulations using the
canonical pathway for DAG (equation (24)). (a) 38:4 DAG response (representative
of the response of most poly unsaturated fatty acid-containing DAG species). (b)
34:1 DAG response (representative of the response of most mono- and di-unsaturated
fatty acid-containing DAG species). Data points in (a) and (b) contain nine replicates
performed on three different experimental days, with error bars = 1 SEM. Units are
total change in ng over baseline levels in ∼ 8×106 cells. (c) IP3 response in pmols
per ∼ 3.5×105 cells. Points represent the average of four experiments, and error bars
are 1 SEM. (d) Ca2+ response in µM. Red curve is a representative Ca2+ trace taken
from the UDP experiments within the AfCS single ligand screen as described in the
“Intracellular free calcium assay” portion of Section IV.2.2.
66
lines are derived from numerical simulations of our initial DAG model (using equation
(24)), while solid black lines are derived from numerical simulations of the combined
effect of DAG from pools 1 and 2, as described in Section II.3. As the method used for
quantification of DAG species measures change in total cellular DAG over baseline
levels, DAG response is simulated by adding the outputs from equations (25) and
(26). Data points and error bars correspond to experimental values obtained using
the DAG assay as described in Section IV.2.2. Although the second and larger rise
phase is observed in most of the DAG species, the early kinetic behavior, within the
first three minutes of stimulation, varies quite drastically between PUFA-containing
DAGs and mono- and di-unsaturated DAGs. PUFA-containing DAGs, such as 38:4
DAG, are consistently seen as increasing immediately upon stimulation, while mono-
and di-unsaturated species, such as 34:1 DAG, display an immediate and small peak
(∼43 ng for 34:1 DAG) two minutes after stimulation and then exhibit a brief yet
almost full recovery by 3 minutes which is followed by a larger production (∼104
ng for 34:1 DAG) at 15 minutes. All DAG species have begun to recover by the 30
minute time point.
We make note here that in approximately 30% of the experimental cases, total
DAG levels in many of the mono- and di-unsaturated species are seen to actually
decrease significantly below baselines levels within the first 3 minutes of stimulation
(data not shown). Although the reason for this variation in response could not be
determined, according to the two-pool model structure, this would suggest a more
rapid phosphorylation of DAGp2 such that initial production of DAGp1 is more than
offset by early conversion of DAGp2 resulting in a net loss of total DAG until enough
DAGp2 has been converted to aid in PIP2 replenishment. By increasing the value of
kdp2, our model can accurately reproduce this kinetic behavior.
As seen in Figure 5, different species of DAG have been shown to respond dif-
ferently to P2Y6 stimulation, suggesting different rates of conversion or degradation
from both pools as well as different initial values and rates of production of DAG
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from the second pool. The rate of degradation of DAGip2, k
i
dp2 (where, as mentioned
earlier in Section II.3, the superscript i refers to a particular species of DAG), was
estimated to fit the early behavior of different DAG species. In particular, for species
showing an early rise phase followed by a recovery to baseline by ∼ 3 minutes, such as
34:1 DAG (Fig. 5b), kidp2 sets the level and time of recovery. The degradation rate of
DAGip1, k
i
dp1, and production rate of DAG
i
p2, k
i
ap2, were then used to set the size and
time of the peak observed at later time points. As ηi represents the fraction of DAGip2
contributing to the resynthesis of DAGip1 through the two-pool model (Fig. 2), this
parameter was chosen to fit the overall magnitude of DAG response throughout the
timecourse. The initial concentration of resting DAGip2 levels in the RAW 264.7 cell,
NDAGip2 , was estimated from the methods developed in Callender et al. [10].
Figure 5c displays the total synthesis of IP3 over baseline levels in response to
25µM UDP over a timecourse of 30 minutes. The solid line represents the solution to
equation (23) with initial condition NIP3(t) = 0, as we assume no change in number
of IP3 molecules for times t ≤ 0 (i.e., before ligand addition). Data points with
error bars are experimental values obtained from the IP3 assay described in Section
IV.2.2. Results show that IP3 peaks within the first 3-4 minutes (∼9 pmoles) and
remains above baseline levels throughout the tested timecourse, suggesting prolonged
stimulation of receptors and hydrolysis of PIP2 molecules.
Total PIP2 per cell, NPIP2T , was determined by direct infusion mass spec using a
16:0 PIP2 standard. The rate of IP3 degradation, kd3, was used to fit the IP3 peak
time and height observed from the experimental data, while the rates of receptor
phosphorylation, kp, effective PIP2 hydrolysis, kˆhyd (= khydλ), and PIP2 replenish-
ment, krep, were all used to simultaneously fit the experimental observations of IP3
and multiple species of DAG. The parameter kp was chosen to match the height of
recovery at later time points in both IP3 and DAG. The overall magnitude of DAG
throughout the timecourse and the shape of the IP3 response were fit with kˆhyd, while
krep was taken to match the size of the DAG response after the initial peak and the
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peak height of IP3.
Parameters for the Ca2+ module were either taken from Li and Rinzel [40] or
Lemon [39], or they were estimated to obtain a best fit to the experimental data in
Figure 5d. Three of the five estimated Ca2+ parameters were chosen to lie within
ranges of parameters chosen by Li and Rinzel [40]. These include the following: the
receptor binding constant for Ca2+-dependent inhibition, a, which sets the size of
Ca2+ peak; the maximum Ca2+ flux out of the cell across the plasma membrane, ν4,
which helps to determine peak height and width; and Ca2+ flux through the plasma
membrane, jin, which controls overall magnitude of the Ca
2+ response. The remaining
two parameters are the maximum Ca2+ leak flux through the ER, ν2, used to help
fit the peak height and shape, and the Michaelis constant for Ca2+ flux out of the
cell across the plasma membrane, kpl, which affects the peak height as well as the
sustained level of Ca2+.
Predictions for the remaining model variables, including activated and inactivated
P2Y6, activated G-proteins, and available PIP2, are obtained by solving equations
(19) through (22). Figure 6 shows model simulations for these four remaining vari-
ables, all in response to 25 µM UDP.
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Figure 6: Model simulations for timecourse of stimulation with 25 µM UDP in a
single RAW 264.7 cell for remaining model variables. (a) Activated (solid line) and
inactivated (dashed line) P2Y6 surface receptors. (b) Total number of activated
Gα·GTP. (c) Total number of PIP2 available for hydrolysis.
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IV.3 Sensitivity Analysis
IV.3.1 Sampling Method and Sensitivity Technique
As mentioned in the previous section, several of the rate parameters could not be
obtained from the literature and therefore had to be estimated. Thus, we now examine
which parameters in the model are most responsible for model output uncertainty.
This can then guide us in determining the parameters for which we may need to
obtain better measurements in order to reduce output uncertainty.
In order to perform such a sensitivity analysis, we first generate a random sample
of our space of input variables over a ten percent variation from each parameter’s
nominal value using the Latin Hypercube Sampling (LHS) method. LHS may be
considered to be a particular case of stratified sampling, whose main goal is to achieve
a better coverage of the sample space of the input variables [28, 47]. In LHS the range
of each input variable, denoted Mj, j = 1, 2, . . . , k, is divided into n subintervals
of equal marginal probability, 1/n, and one observation of each input variable is
taken from each interval using random sampling within that interval. This technique
results in n non-overlapping realizations for each of the k input variables. To obtain
the first sample, denoted m1, one of the realizations on M1 is randomly selected
(each observation is equally likely to be selected), paired with a randomly selected
realization of M2, and so on all the way out to Mk. For the next sample, m2, one
of the remaining realizations of M1 is paired at random with one of the remaining
observations of M2, and so on. Continuing this procedure, we obtain the remaining
samples m3, . . . ,mn, which exhausts the observations and results in a latin hypercube
sample m = (mij), where i = 1, . . . , n and j = 1, . . . , k.
One of the advantages of this sampling method is that it ensures each input
variable has all portions of its distribution (which in our case is a uniform distribu-
tion) represented by input values. LHS performs better than random (Monte Carlo)
sampling when the output is dominated by a few components of the input factors.
The method ensures that each of these components is represented in a fully strati-
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fied manner, no matter which components might turn out to be important. LHS is
also designed to accurately recreate the input distribution through sampling in fewer
iterations when compared with the Monte Carlo method.
Once the sample m is created, propagation of the sample through the model
creates a mapping from analysis inputs to analysis results of the form
[yi,mi1,mi2, . . . ,mik] i = 1, . . . , n, (111)
where k is the number of input variables (rate parameters), n is the sample size, and
yi is the model output corresponding to sample mi. Once this mapping is generated
and stored, it can be explored in many ways to determine the sensitivity of model
predictions to individual input variables.
One of the most common and simplest of sensitivity analysis techniques is the
generation of scatter plots, where a plot is generated of the points (mij, yi), i =
1, . . . , n, for each independent input variableMj. Although this technique can provide
important information regarding the relationships between model input and model
predictions, one disadvantage is that it requires the generation and inspection of a
large number of plots. Indeed, one needs at least one plot per input variable, and in
our case this needs to be multiplied by the number of time points since our model
output is time-dependent. Furthermore, scatterplots offer only a qualitative measure
of the sensitivity, as the relative importance of each variable cannot be quantified.
In order to obtain a more quantitative global sensitivity analysis, we have chosen
the measure of standardized regression coefficients (SRCs) determined from multiple
regression analysis. Here the multivariate samplem of the input variables is generated
by the LHS sampling strategy (dimension n× k), and the corresponding sequence of
n output values is computed using our model equations, resulting in the mapping
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discussed above (111). We then seek a linear regression model of the form
yi = b0 +
∑
j
bjmij + εi
where yi, i = 1, . . . , n, are the output values of the model, bj, j = 1, . . . , k, are
coefficients to be determined and εi is the error, or residual, due to the approximation.
A common way of determining the coefficients bj is to use the method of least squares,
where the coefficients bj are determined so as to minimize the function
F (b) =
∑
i
ε2i .
After the bj, j = 1, . . . , k, are computed, they can be used to indicate the importance
of individual input variablesMj with respect to the uncertainty in the output y. Since
the bj are dimensionalized coefficients, it is common practice to rewrite the regression
model in its nondimensionalized form:
(yˆ − y¯)
sˆ
=
∑
j
(
bj sˆj
sˆ
)(
mj − m¯j
sˆj
)
,
where
y¯ =
∑
i
yi
n
, m¯j =
∑
i
mij
n
sˆ =
[∑
i
(yi − y¯)2
n− 1
]1/2
sˆj =
[∑
i
(mij − m¯j)2
n− 1
]1/2
,
and where yˆ is the vector of regression model predictions, and mj is the j
th column
vector in the LHS sample matrix. The coefficients bj sˆj/sˆ are the SRCs that we will
use for sensitivity analysis. The SRCs enable us to quantify the effect of varying each
input variable away from its mean by a fixed fraction of its variance while maintaining
all other variables at their expected values.
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We make note here that in order to use the SRCs as a measure of sensitivity, it is
also important to consider the model coefficient of determination, R2y, given by
R2y =
∑n
i=1(yˆi − y¯)2∑n
i=1(yi − y¯)2
where yˆi is the estimate of yi obtained from the regression model. R
2
y gives a way
of determining how close the linear regression model based on the SRCs comes to
reproducing the actual model output y. It represents the fraction of the variance
of the output explained by the regression, and the closer it is to one, the better
is the regression model’s performance and the more valid SRCs are in determining
sensitivity of input variables. Therefore, in order to be able to use SRCs as a measure
of sensitivity, one must first determine the R2y values, for if any of the R
2
y (one is
computed for each time point in time-dependent models) are less than some threshold
value, typically 0.7, the SRCs are not accurate indicators of sensitivity. In this case,
model-free methods can be used. Examples of such methods include but are not
limited to the following methods described in detail in [65, 67]: the method of Morris,
the FAST method, the importance measure, and the method of Sobol’.
IV.3.2 Implementation of the Sensitivity Methods
An LHS sample matrix was found using the coding environment SIMLAB 3.0.x, which
consists of a MATLAB m-file that, when called, will create a sample matrix based on
a user-specified sampling method. We therefore created an m-file which loaded pa-
rameters and their probability distributions (uniform distribution with 10% variation
from nominal value) and subsequently called the Latin Hypercube sampling code,
thus generating the LHS sample matrix. The m-file for this sample creation can be
found in Appendix B.
Another m-file was created to take as input each row, mi, i = 1, . . . , n of the
sample matrix and output the corresponding outputs, y
(l)
i , l = 1, . . . , 10, for each
of the original ten variables in the dimensionalized form of the model equations. R2y
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values and SRCs were then computed using the MATLAB regress function. R2y values for
all model outputs and all time points from 0 to 30 minutes were greater than 0.8 and in
most cases were very close to one (see, for example, the insets in Figures 8 and 7, which
show graphs of the time-dependent R2y values for DAG and IP3, respectively), ensuring
that the SRCs are good measures of sensitivity. The most sensitive parameters are
therefore those whose SRCs, in absolute value, are the largest. As different input
variables affect the model output differently at different times, certain parameters
are seen to be more senstive at early time points, while others are more sensitive
at later time points. The time-dependent SRCs corresponding to the most sensitive
parameters for IP3 and DAG = DAGp1 + DAGp2 are shown in Figures 7 and 8,
respectively.
Figure 7: Standardized Regression Coefficients (SRCs) corresponding to most sensi-
tive parameters for IP3. Most sensitive parameters are as follows: receptor rate of
phosphorylation, kp ( ), receptor recycling rate, kr ( ), PIP2 replenishment rate,
krep ( ), and IP3 degradation rate, kd3 ( ). Inset: R
2
y values for all time points are
≥ 0.8, enusuring that the SRCs for IP3 are good measures of sensitivity.
Figure 7 reveals that early IP3 output is most sensitive to changes in the rate
of degradation of IP3, kd3, which has a negative effect, and the PIP2 replenishment
75
Figure 8: Standardized Regression Coefficients (SRCs) corresponding to most sensi-
tive parameters for DAG. Most sensitive parameters are as follows: degradation rate
of DAGp1, kdp1 ( ), production rate of DAGp2, kap2 ( ), degradation rate of DAGp2,
kdp2 ( ), receptor rate of phosphorylation, kp ( ), and receptor recycling rate, kr
( ). Inset: Since R2y values for all time points are ≥ 0.95, the SRCs for DAG are
good measures of sensitivity.
rate, krep, which has a positive effect. At early time points (0 to 650 seconds) the
receptor recycling rate, kr, shows a slight negative effect; however, from 850 to 1800
seconds, kr becomes the parameter with the strongest positive influence on IP3. The
parameter most negatively affecting IP3 production at later time points is the rate of
receptor phosphorylation, kp.
As shown in Figure 8, the dynamics of DAG are mostly driven by the DAG kinetic
paramters of activation and degradation. For the first∼ 400 seconds after stimulation,
output of DAG is most sensitive to the rate of degradation of DAGp2, kdp2, with this
parameter having a negative influence on DAG production. Although the receptor
phosphorylation rate, kp, shows a small yet significant negative effect at later time
points, the most sensitive parameter with negative effects from 400 to 1800 seconds
is the DAGp1 degradation rate, kdp1. Those parameters with the strongest positive
influence are the DAGp2 production rate, kap2, and to a lesser extent the receptor
recycling rate, kr.
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Since from the sensitivity analysis kdp2, kap2, and kdp1 were determined to be the
most sensitive parameters for DAG output, Figures 9, 10, and 11 were generated
to better visualize the effects of varying each of these parameters about its nominal
value given in Table 4. Each figure displays the change in 34:1 DAG response to a
50% fluctuation in one of these three parameters. From Figure 9, we see that the
rate of phosphorylation in the second pool of DAG, kdp2, greatly affects the level of
early decrease in DAG levels over baseline. Further, while the effects of the rates
of pool 2 DAG replenishment and pool 1 DAG degradation resemble one another,
their effects are negatives of one another, as reflected by the SRC graph from Figure
8. Indeed, a rise in the activation rate kap2 causes an overall increase in DAG and
a slower recovery to baseline at later time points, where a similar DAG increase is
found by a decrease in the degradation parameter kdp1.
Figure 9: Changes in 34:1 DAG response to 50% variations in kdp2, the rate of degra-
dation of pool 2 DAG, from its nominal value of 1.71× 10−3.
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Figure 10: Changes in 34:1 DAG response to 50% variations in kap2, the rate of
degradation of pool 2 DAG, from its nominal value of 1.96×10−3. Note here that the
axis for kap2 is in reverse order from the axes for kdp2 and kdp1 as shown in Figures 9
and 11, respectively.
Figure 11: Changes in 34:1 DAG response to 50% variations in kdp1, the rate of
degradation of pool 2 DAG, from its nominal value of 1.2× 10−3.
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chapter v
diacylglycerol pathway analysis
V.1 Introduction
In this chapter we present experimental evidence that supports the two-pool DAG
model shown in Figure 2 and described in Section II.3. The data were obtained
from experiments performed on RAW 264.7 macrophages in collaboration with Paul
Sternweis and Dianne DeCamp at the University of Texas Southwestern. The data
discussed in Section V.2 include a comparison of the DAG response from two doses
of UDP (250 nM and 25 µM). The second data set, covered in Section V.3, includes
results from our investigation of the role of DAG kinase (DAGk) in DAG produc-
tion over the timecourse of 30 minutes, through inhibition of this enzyme with the
DAGk inhibitor II, also called R59949. In Section V.4 we discuss the third data
set containing results from a multiple inhibitors study, where we have tested several
different inhibitors of DAG metabolism, including U73122 (inhibits phosphoinositol
(PI)-specific PLC activity), U73433 (inactive analog of U73122), Propranolol (most
widely known as a beta-adrenergic receptor antagonist, but also inhibits conversion
of PA to DAG via lipid phosphate phosphatase (LPP)), R59949 (DAGk inhibitor II),
and Thimerosal (inhibits conversion of monoacylglycerol (MAG) to DAG via monoa-
clyglycerol acyltransferase (MGAT) as well as CoA-independent and CoA-dependent
acyl transferases [64]). The results of the experiments from Section V.4 suggested
further studies on the effects of Propranolol, which are discussed in Section V.5. For
these experiments we ran the same time course as for R59949 in Section V.3, with
and without 25 µM UDP, with and without 150 µM Propranolol.
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V.2 Two-Dose UDP Experiments
The graphs of several DAG species in response to UDP stimulation are shown in
Figure 12. Each graph shows the total change in DAG (in ng) over baseline levels, for
two concentrations of UDP: 250 nM (in green squares) and 25 µM (in red triangles).
The cells were stimulated for 30s, 2min, 3min, 15min, and 30min. This timecourse
was chosen after preliminary experiments revealed these times to display the most
significant aspects of the cellular DAG response (e.g., the DAG response from 3 to 15
minutes was essentially linear). Each data point is the average of nine experimental
repeats performed on three different experimental days. Error bars represent 1 SEM.
For all 29 DAG species measured, the fold changes and p-values for all time points
and for both doses of UDP are given in Figures 13 and 14.
In this data set, no species was found to be significantly decreasing over baseline
levels at any point in the tested timecourse. The most notable difference in the two
doses is at the 15 minute time point, where the higher dose produces a larger increase
in most of the responding DAG species. Furthermore, for the higher dose of UDP,
the response peaks at 15 minutes and begins to recover by 30 minutes. For the lower
dose, however, many species are either still increasing or not decreasing as rapidly
by 30 minutes. This suggests that with the lower dose the cells are responding more
slowly than with the higher dose.
V.3 DAG Kinase Inhibitor II (R59949) Experiments
In order to further investigate the origin of DAG responses to UDP, we collected data
on the DAG response to UDP with and without pretreatment of the DAG kinase
inhibitor II (R59949). Purkiss and Boarder [58] suggest the existence of two pathways
by which purinergic-receptor-mediated stimulation (in endothelial cells) may give rise
to PA: sequential activation of PLC and DAGk, or directly via PLD. They then have
evidence showing that PA derived from both routes is readily metabolized to DAG.
This could explain why we are seeing DAG levels rising at later time points than the
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Figure 12: Total change in DAG (in ng) over baseline levels, for two concentrations
of UDP: 250 nM (in green squares) and 25 µM (in red triangles). The cells were
stimulated for 30s, 2min, 3min, 15min, and 30min. Each data point is the average
of nine experimental repeats performed on three different experimental days. Error
bars represent 1 SEM.
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Figure 13: Fold changes and p-values for the response of 29 different DAG species to
250 nM UDP vs basal. Cells highlighted in pink show a fold increase with p-value <
0.01, and cells highlighted in red show a fold increase with p-value < 0.001.
Figure 14: Fold changes and p-values for the response of 29 different DAG species to
250 µM UDP vs basal. Cells highlighted in pink show a fold increase with p-value <
0.01, and cells highlighted in red show a fold increase with p-value < 0.001.
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timeframe for PIP2 hydrolysis. If these are the only two (or the major two) pathways
for PA production upon stimulation with UDP in the RAW 264.7 cells, since we do
not see PLD activity in the RAW 264.7 cells upon stimulation by UDP, inhibition of
DAGk would presumably decrease the DAG response of all DAGs coming from PA
production.
For these experiments, cells were pretreated with either 0.05% DMSO or 10 µM
R59949 (in DMSO) for 1 hour, and were stimulated with 25 µM UDP for 30s, 3min,
15min, and 30min, each in triplicate. The graphs of some of the DAG species showing
responses representative of a certain population of DAGs are shown in Figure 15. The
graphs on the left show total ng DAG produced for the following: UDP over basal (in
green squares), UDP + R59949 over basal (in red triangles), and R59949 over basal
(in cyan x’s). Each graph on the right represents the total change in DAG levels over
baseline for one of two conditions: UDP stimulation without inhibitor compared to
basal without inhibitor (shown in green) and UDP stimulation with R59949 compared
to basal with R59949 (shown in red).
For many of the DAG species, the DAGk inhibitor R59949, lowered the basal levels
of DAG at all time points. The differences between basal levels and R59949 levels
of DAG are shown in Figure 16. Due to the decrease in basal DAGs with R59949,
DAGk appears to play an important role in the level of resting DAGs in the RAW
264.7 cell.
Figure 17 includes the differences between DAG produced from UDP alone (over
basal) and DAG produced from UDP with R59949 (over DAG levels with R59949
alone). The cells in Figure 17 are highlighted according to the following conditions:
pink shows an increase over baseline with p-value less than 0.05; red shows an increase
over baseline with p-value less than 0.01; light blue shows a decrease over baseline
with pvalue less than 0.05; and dark blue shows a decrease over baseline with p-value
less than 0.01.
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Figure 15: Results from stimulation of RAW 264.7 cells +/- 25 µM UDP and +/- 10
µM R59949. Graphs on the left show total ng DAG produced for the following: UDP
over basal (green squares), UDP + R59949 over basal (red triangles), and R59949
over basal (cyan squares). Graphs on the right represent the total change in DAG
levels over baseline for one of two conditions: UDP stimulation without inhibitor
compared to basal without inhibitor (green squares) and UDP stimulation with 10
µM R59949 compared to basal with 10 µM R59949 (red triangles).
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Figure 16: DAG levels (in ng) and corresponding p-values for differences between cells
pretreated with and without 10 µM R59949 throughout the tested timecourse. Cells
highlighted in light blue show a decrease with p-value < 0.05, and cells highlighted
in dark blue show a decrease with p-value < 0.01. Cells highlighted in pink show an
increase with p-value < 0.05.
This figure includes two panels. The left panel shows the fold changes and p-
values for UDP stimulation versus basal levels. Species are grouped according to
their response to 25 µMUDP. There were three basic trends observed from these data:
1) species did not produce a significant change from baseline levels throughout the
tested timecourse, 2) species remained near baseline initially and then by 3 minutes
were increasing over baseline levels and continued to increase until 15 minutes, where
the response peaked and therefore levels dropped slightly by 30 minutes but were
still significantly above baseline, and 3) species responded similarly as in case two,
except the initial response was a significant decrease over baseline levels. Most of the
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higher-carbon PUFA-containing DAGs fell into the second category, while most of
the mono- and di-unsaturated DAGs fell into the third category. The saturated DAG
species either gave no significant change or produced small changes at one or two of
the four time points.
The right panel shows the total difference, in ng, between the amount of DAG
produced with UDP + R59949 (over amount from cells pretreated with R59949) and
the amount produced from UDP alone (over the amount from basal cells). The species
are listed in the same order as the panel on the left in order to compare the effects
of R59949 on the UDP response with the type of response each species exhibited
from UDP alone. For the species in category 1, the inhibitor produced slightly higher
levels of DAG, predominantly at the 15 minute time point. However, for the species
in categories 2 and 3, the cells pretreated with R59949 produced a much higher level
of DAG at 30 seconds than the cells with UDP alone (where for these species of DAG,
levels either remained near baseline or dropped below baseline, which is a behavior
we have seen previously but has not been very reproducible). This suggests a heavy
dependence on DAGk activity in the UDP pathway for high-carbon PUFAs and mono-
and di-unsaturated DAGs, especially at the early time points. If PIP2 hydrolysis is
the only other means of DAG production at early time points, the immediate increase
in DAG levels from categories 2 and 3 observed in the presence of R59949 is a result
of PIP2 hydrolysis, and the reason we are not seeing this rise in DAGs without the
inhibitor is a result of rapid phosphorylation of resting DAGs (in categories 2 and 3)
via DAGk activity. For most of the species which gave robust increases at later time
points, the overall shape of the curve with UDP + R59949 was also subdued slightly,
where we did not observe as robust an increase from the 3 minute to 15 minute time
point as we see with UDP alone, suggesting a combined role for DAGk and LPP at
the later time points.
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V.4 Multiple DAG Inhibitors Experiments
In order to further investigate the origin of both resting DAG and DAG produced post
UDP stimulation in the RAW 264.7 cells, we tested several different pharmacological
inhibitors and their affect on the UDP response at 15 minutes, the time point where
we see most DAG production in most DAG species. The inhibitors included in this
study and the concentrations used are as follows: 10 µM U73122 (inhibits PI-PLC
activity), 10 µM U73433 (inactive analog of U73122), 150 µM Propranolol (inhibits
conversion of PA to DAG via LPP), 10 µM R59949 (DAGk inhibitor II), and 50 µM
Thimerosal (inhibits conversion of MAG to DAG via MGAT). Figures 18 - 22 show
the results from three experimental repeats, each with three replicates.
Figure 18: Fold changes of DAG in response to a 15 minute stimulation of 25 uµM
UDP +/- 30min pretreatment with 150 µM Propranolol.
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Figure 19: Fold changes of DAG in response to a 15 minute stimulation of 25 uµM
UDP +/- 10min pretreatment with 50 µM Thimerosal.
Figure 20: Fold changes of DAG in response to a 15 minute stimulation of 25 uµM
UDP +/- 10min pretreatment with 10 µM U73122.
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Figure 21: Fold changes of DAG in response to a 15 minute stimulation of 25 uµM
UDP +/- 10min pretreatment with 10 µM U73433.
Figure 22: Fold changes of DAG in response to a 15 minute stimulation of 25 uµM
UDP +/- 60min pretreatment with 50 µM R59949.
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Propranolol is perhaps the most interesting as far as differential effects are con-
cerned, as it is enhancing UDPs ability to produce 38:3, 38:4, and 38:5 DAGs, slightly
inhibiting the UDP response for the 36 carbon-containing DAG series, and is almost
eliminating the UDP response in the lower carbon chain DAGs. Thimerosal and
U73122 appear to have a similar effect as they are significantly inhibiting the UDP
response across the board. Aside from a few obscure DAGs, U73433 does not have
a significant effect on the UDP response, which is what one would hope to see, as
U73433 is the inactive analog of U73122. Finally, R59949 gives the same effect as we
had seen before with the timecourse experiments, where the response at 15 minutes
is slightly inhibited for most DAGs. Although the results of these multiple inhibitor
experiments do not seem to point to one source of DAG production, this does reem-
phasize the complexity of this signaling pathway and the need for further study.
V.5 Propranolol Experiments
Next we tested a timecourse of the DAG response to 25 µM UDP with and without
pretreatment of 150 µM Propranolol, since out of all the tested inhibitors it was
providing us with the most interesting differential responses. These data include
four experiments performed in triplicate. Cells were pretreated with either 0.05%
DMSO or 150 µM Propranolol (in DMSO) for 1 hour, and were stimulated with 25
µM UDP for 30s, 3min, 15min, and 30min, each in triplicate. The graphs of four of
the DAG species showing responses representative of a certain population of DAGs
are shown in Figure 23. As in the R59949 experiments, the graphs on the left show
total ng DAG produced for the following: UDP over basal (in green squares), UDP
+ Propranolol over basal (in red triangles), and Propranolol over basal (in cyan x’s).
Each graph on the right represents the total change in DAG levels over baseline for
one of two conditions: UDP stimulation without inhibitor compared to basal without
inhibitor (shown in green) and UDP stimulation with Propranolol compared to basal
with Propranolol (shown in red).
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Figure 23: Results from stimulation of RAW 264.7 cells +/- 25 µM UDP and +/- 150
µM Propranolol. Graphs on the left show total ng DAG produced for the following:
UDP over basal (in green squares), UDP + Propranolol over basal (in red triangles),
and Propranolol over basal (in cyan x’s). Graphs on the right represent the total
change in DAG levels over baseline for one of two conditions: UDP stimulation with-
out inhibitor compared to basal without inhibitor (shown in green squares) and UDP
stimulation with 150 µM Propranolol compared to basal with 150 µM Propranolol
(shown in red triangles).
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Propranolol had little or no effect on the PUFA-containing DAG response to
UDP throughout the tested timecourse, with the least effect on 38:4 DAG. We make
note that this result is slightly different than what we saw in the multiple inhibitor
experiment, where 38:4 DAG levels with Propranolol + UDP were significantly higher
than with UDP alone. In most other species, Propranolol greatly reduced or even
completely eliminated the DAG response to UDP throughout the tested timecourse.
One trend that appeared in a few species was a decrease in DAG levels over baseline
with Propranolol at the 30 minute time point. For these species, we also observed an
increase in the Propranolol only (no UDP) samples (see the left graphs, cyan data
points for 34:1 DAG, 36:0 DAG and 32:1 DAG). This data suggests that 38:4 DAG
and, to a lesser extent, most PUFA-containing DAGs are not coming from PA via
LPP. For most other DAGs, however, under the assumption that Propranolol is only
inhibiting LPP and not activation other enzymes, one could propose that these DAGs
are directly or indirectly coming from LPP activity.
To compliment our studies of the Propranolol effect on the DAG response, we
also completed a set of three experiments testing the effects of Propranolol on the
UDP response of PA over the same timecourse as above. Each experimental condition
was performed in triplicate. The ratiomic analysis of these experiments is shown in
Figure 24. Each cell in this figure displays the number of times a certain condition
was seen to be significantly above or below the basal condition (or, in some cases, a
specific condition noted in the figure). For example, in the 0.5 minute time block, a
number of 3 for 34:1 DAG in the first column reveals that in all three experimental
repeats, the triplicate average of DAG levels in the cells pretreated with propranolol
was shown to be significantly increasing over the triplicate average for basal cells (no
propranolol).
The results were in direct agreement with the two-pool DAG model. Propranolol
had little effect on the PUFA-containing PAs, but had a profound effect on the mono-
and di-unsaturated and saturated PAs. For this latter group of PAs, Propranolol
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Figure 24: Lipid array for PA response to 25 µM UDP +/− 150µM Propranolol at
30s, 3min, 15min, and 30min. Cells highlighted in red (blue) show a significant in-
crease (decrease) in that PA species for a particular condition in all three data sets.
The first column lists the PA species along with any other species sharing the same
m/z (mass to charge) ratio. The second column lists the m/z values. The first three
columns of each time point block represent Propranolol, UDP, and UDP + Propra-
nolol, respectively, each vs control. The forth column in the block represents UDP +
Propranolol vs UDP, and the fifth and final column represents UDP + Propranolol
vs Propranolol.
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caused a large increase in unstimulated cells, suggesting that these PAs were com-
ing from mono- and di-unsaturated and saturated DAGs via a constitutively active
DAGk. Since the DAG assays with Propranolol revealed that Propranolol completely
eliminated the UDP response (for mono- and di-unsaturated and saturated DAGs),
this suggests that Propranolol may be affecting part of the pathway of the two-pool
DAG model, where PA generated from an intracellular pool of DAG is not allowed
to participate in the resynthesis of PIP2.
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chapter vi
quantification of molecular species of
diacylglycerol
VI.1 Introduction
In this chapter we discuss the method of DAG quantification used to collect all data
on species-specific DAG changes in response to UDP. As stated in Chapter I, dia-
cylglycerols are important cellular second messengers which play a significant role in
initiating changes in cell behavior. DAGs differ from other well characterized second
messengers (such as IP3) as they are a heterologous population, with over 50 different
species of DAG identified based on their varying acyl chain lengths and degrees of
unsaturation. With evidence of differential roles for these species in cellular processes
[14, 55], the need arises for a sensitive method for quantification of individual species
of DAG in order to elucidate both the function and source of these second messengers
in the complex background of several thousand cellular lipids.
Traditional methods for quantitative analysis of DAGs include radiolabeling as-
says where E. coli DAG kinase is used to convert DAG in neutral lipid fractions of
various cell types to [32P]-labeled phosphatidic acid [56, 57, 78]. Disadvantages of
this method include the low resolution analytical techniques such as thin layer chro-
matography [14, 17] and the inability to identify acyl chain composition of DAGs.
The identification of the molecular species of agonist-stimulated DAG production has
also been studied using component fatty acid analysis [9, 22], as well as argentation
(silver ion) chromatography [61]. Although both of these approaches provide interest-
ing information, neither determines the exact molecular species that are present. To
address the issue of detecting individual molecular species, capillary gas chromatog-
raphy has also been used [54]. Unfortunately, all these strategies are time-consuming
due to the process of derivatization via chemical reactions and involve larger amounts
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of sample which makes them unsuitable for high throughput analyses. DAG is a key
component of glycerophospholipid intermediate metabolism and serves as a cellular
second messenger, hence a new analytical method was needed to achieve comprehen-
sive molecular species analysis.
Mass spectrometry is the most sensitive and specific method for lipid analysis to
date [48]. The combination of gas chromatographynegative ion chemical ionization
mass spectrometry has been applied to a single species of DAG analysis from biological
samples, but this method has a limitation in the number of detected molecular species
and requires a multi-step derivatization prior to analysis [27]. As little as 30 fmol of
1-stearoyl-2-arachidonoyl-sn-3-glycerol can be analyzed in a sample.
New ionization techniques such as electrospray ionization mass spectrometry (ESI-
MS) or matrix-assisted laser desorption/ionization (MALDI) enable the detection and
identification of lipids with minimal fragmentation and direct data collection. With
MALDI, which has been previously applied to the analysis of DAGs [3], the sample
preparation is easy and fast and no derivatization is required. Despite its advantages,
however, MALDI is more suitable for high molecular weight biomolecules (peptides
and proteins). Due to their low molecular weight, lipids require special matrices and
considerations such as compatibility between matrix and analyte to achieve high
homogeneity between sample and matrix crystals; matrix ions are also detected and
might interfere with the interpretation of the spectra.
Here we describe a method that overcomes some of these challenges and is based on
soft ESI-MS. Introducing Na+ to the sample results in the formation of charged Na+-
DAG adducts rendering detection by ESI-MS possible. Separation of DAG species
from the more polar phospholipids results in higher sensitivity which makes this
method suitable for analysis of complex lipid mixtures and adaptable to medium- to
high-throughput assays. A multiple linear regression model for the construction of
calibration curves for specific DAG species based on their molecular characteristics is
also shown. As a result, we offer the first method for the simultaneous detection and
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quantification of up to 28 individual molecular species of DAG from the extract of a
macrophage-derived cell.
VI.2 Experimental Materials and Methods
VI.2.1 Materials
The materials used in this method of DAG quantification are listed in Table VI.2.1
below. RAW 264.7 cells, which are a macrophage-like, Abelson leukemia virus-
Table 5: Materials used in the method of quantification of multiple species of DAG.
Material Source
1,2-dilauroyl-sn-glycerol (24:0 DAG) Avanti Polar Lipids (Alabaster, AL)
1,2-dimyristoyl-sn-glycerol (28:0 DAG) Avanti Polar Lipids (Alabaster, AL)
1,2-dipalmitoyl-sn-glycerol (32:0 DAG) Avanti Polar Lipids (Alabaster, AL)
1-octadecanoyl-2-hexadecanoyl-rac-glycerol (34:0 DAG) Avanti Polar Lipids (Alabaster, AL)
1-palmitoyl-2-oleoyl-sn-glycerol (34:1 DAG) Avanti Polar Lipids (Alabaster, AL)
1,2-dioctadecanoyl-rac-glycerol (36:0 DAG) Avanti Polar Lipids (Alabaster, AL)
1,2-dioleoyl-sn-glycerol (36:2 DAG) Avanti Polar Lipids (Alabaster, AL)
1-eicosanoyl-2-octadecanoyl-rac-glycerol (38:0 DAG) Avanti Polar Lipids (Alabaster, AL)
1-stearoyl-2-arachidonoyl-sn-glycerol (38:4 DAG) Avanti Polar Lipids (Alabaster, AL)
1-O-hexadecyl-2-acetoyl-sn-glycero-3-phosphocholine (C16 PAF) Avanti Polar Lipids (Alabaster, AL)
Silica gel 60 (230-400 mesh) EMD Chemicals Inc. (Gibbstown,NJ)
methanol (MeOH) EMD Chemicals Inc. (Gibbstown,NJ)
chloroform (CHCl3) EMD Chemicals Inc. (Gibbstown,NJ)
Sodium acetate Sigma-Aldrich (St. Louis, MO)
transformed cell line derived from BALB/c mice, were obtained from the American
Type Culture Collection (ATCC catalog number TIB-71, lot number 2263775), ex-
panded, and stored in aliquots for use by the Alliance for Cellular Signaling (AfCS)
laboratories (http://www.signaling-gateway.org). Stock vials of frozen AfCS cells
were thawed and maintained in DMEM supplemented with 10% heat-inactivated fe-
tal bovine serum, 20 mM HEPES, and 2 mM L-glutamine at 37 ◦C in a humidified
atmosphere with 5% CO2. For routine maintenance in culture (passage), cells were
seeded at a confluence of approximately 10% (1 × 106 and 36 cells on 100 and 150
mm plates, respectively) and grown to a confluence of approximately 50%.
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VI.2.2 Extraction of glycerophospholipids from stimulated cells
Cells were seeded at 4×106 cells on 60 mm-diameter dishes and incubated for 24 hours
in 10% serum. Before stimulation the medium was changed to DMEM supplemented
with 20 mM HEPES, 2 mM L-glutamine, and 0.1 mg/mL BSA. Platelet-activating
factor (PAF, dissolved in ethanol) was added to the medium at a final concentration
of 100 nM, and cells were incubated at 37 ◦C for the indicated times. After treatment
plates were placed on ice, medium was aspirated and cells were washed with 2 mL
of ice-cold PBS, pelleted, and PBS aspirated. Phospholipids were extracted by a
modified Bligh/Dyer procedure [5]. Ice-cold 1:1 0.1N HCl:CH3OH (800 µL) was
added to each cell pellet, and the suspensions were transferred to individual cold 12
× 75 mm borosilicate glass test tubes. 24:0 DAG (10 µL, 10 µg/mL) was added to
all samples as an internal standard. After addition of 400 µL ice-cold CHCl3 and
thorough mixing, phospholipids were collected from the lower (organic) phase after
layer separation by centrifugation.
VI.2.3 Diacylglycerol isolation and recovery
Diacylglycerol isolation from total phospholipids extracts was achieved by separation
using silica gel column chromatography by means of an isocratic elution with 65:35:0.7
CHCl3:CH3OH:H2O. Each sample was applied to a glass Pasteur pipette column
plugged with glass wool and packed with a 6 cm bed of silica gel 60A˚ equilibrated with
10 mL of eluent. DAG molecular species were recovered in the first 3 mL of eluent, and
solvents were evaporated in a vacuum centrifuge (Labconco Centrivap Concentrator,
Kansas City, MO). Samples were dissolved in 105 µL of 9:1 CH3OH:CHCl3 containing
5 µL of 100 mM CH3COONa and analyzed by mass spectrometry.
To evaluate the accuracy of the method and the recovery of DAG during extraction
and separation procedures, cell extracts were spiked with known amount of 2 DAGs
(200ng each of 36:0 and 36:2) and 100ng of the internal standard 24:0 DAG. For
RAW 264.7 cell extracts the recovery was 98-103%. The basal level of total DAG (all
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detected species) in RAW 264.7 cells was 1.69±0.08 nmol/mg protein, calculated by
using a conversion factor of 1.27 mg protein / 107cells [62]. The reported abundance
of DAG in other cell types was of similar value (1.47±0.33 nmol/mg protein in SK-
N-SH neuroblastoma cells [37] and about 1.5 nmol/mg protein in pheochromocytoma
PC12 cells [2]).
VI.2.4 Mass spectrometric analysis of DAG extracts
Mass spectral analysis was performed on a Finnigan TSQ Quantum triple quadrupole
mass spectrometer (ThermoFinnigan, San Jose, CA) equipped with a Harvard Ap-
paratus syringe pump and an Ion Max electrospray ionization source. Samples were
analyzed at an infusion rate of 10 µL/min in positive ionization mode over the range
of m/z 400 to 900. Since DAGs ionize poorly under normal electrospray conditions,
Na+ adducts were utilized to better detect the individual DAG species. Peaks cor-
responding to known DAG species were fragmented to confirm the identity of the
species (Fig.25, A and B). Data were collected with the Xcalibur software package
(ThermoFinnigan).
VI.3 Results and Discussion
VI.3.1 Isotopic correction
Figure 26 shows a typical spectrum of the DAG species isolated from a RAW 264.7
cell extract. The ESI-MS analysis provides peaks corresponding to the molecular
ion of the sodiated adduct of each DAG. We recall here that the various species are
distinguished by the total number of carbons in the acyl chains and their degree
of unsaturation. Consequently, the DAGs are conveniently assigned a two-number
system xx:y (i.e., 38:4 DAG) in which xx designates the total number of carbons in
the acyl chains and y specifies the total number of double bonds.
The signals occur in clusters of peaks representing multiple species of DAGs having
the same total number of carbons and different degrees of saturation separated by two
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Figure 25: Identification of DAG sodium adducts. Identification of DAG lipid species
was accomplished by MS/MS analysis of biological samples and synthetic standards
when possible. As an example, the MS/MS fragmentation pattern for synthetic 36:2
DAG (A) compares favorably to that of naturally occurring 36:2 DAG (B).
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Figure 26: Positive ESI mass spectrum from a RAW 264.7 cell extract after chro-
matographic separation on a silica gel column to remove the polar phospholipids.
The peaks for various DAG series appear in the center of the spectrum and the in-
ternal standard (24:0 DAG) is shown (m/z 479). The series numbers indicate the
total number of carbons in the acyl chains on the DAG molecule. The PE and PC
peaks, which usually dominate the spectrum in positive mode, have been functionally
decreased as a result of chromatographic separation.
mass units. Spectra are complicated by the naturally occurring molecules containing
known fractions of heavy isotopes, e.g. 1.10% 13C and 0.2% 18O (Fig. 27). Thus,
each individual DAG produces two or more peaks for each of the molecular ions. One
peak is at the exact molecular mass and the others are one or more mass units higher
reflecting the natural abundance of 13C, 18O etc. In the case of DAG, contributions
to the mass distribution are made from carbon, hydrogen and oxygen atoms. These
multiple peaks lead to errors particularly for the peak that is two mass units higher,
due to interference with the species that has one less double bond. To correct for
this isotopic signal on neighboring peaks, the relative distribution of mass for each
DAG molecule is computed. For example, 38:4 DAG has the formula C41H72O5 which
produces the distribution of mass for 38:4 DAG displayed in Table 6. Data in Table
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Figure 27: Example of isotopic correction for the m/z range of 611 to 620. This
region contains several species of DAG containing 34 carbons in their acyl chains.
Solid lines represent the uncorrected signals while the dashed lines are the corrected
signals. Isotopic corrections are made from left-to-right, beginning with the species
having the second lowest m/z value within the particular group (here, the group of
DAGs containing 34 carbons), by subtracting the appropriate proportion of the signal
occurring two mass units to the left as explained in Section VI.3.1. Once this signal
has been adjusted, it is then used in the same manner to correct the signal for the
DAG species having m/z value two units higher. This iterative process continues
until the remaining members within the group are corrected.
Table 6: % Total abundance of masses of naturally occurring 38:4 DAG derived from
the distributions of isotopes of the constituting elements (carbon, hydrogen, and
oxygen).
% total abundance MW m/z [M+Na+]+
0.6211 644.536 667.524
0.2900 645.539 668.527
0.0735 646.542 669.530
0.0132 647.545 670.533
0.0018 648.548 671.536
0.0002 649.551 672.539
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6 shows that 62.11% of the total signal generated by sodium adducts of this molecule
is observed at m/z 667.52, while 7.35% of the signal appears at m/z 669.53. This
is the same m/z value where the primary signal (62.09%) for the 38:3 DAG sodium
adduct appears, thus complicating the quantification of these peaks.
Isotopic corrections are made from left-to-right (lower to higher m/z) to the signals
within a group of DAG molecules containing the same number of carbons. Begin-
ning with the signal for the DAG species having the second lowest m/z value within
a group, the intensity is corrected by subtracting a correction factor based on the
signal for the DAG species having m/z value two units less than this species. Figure
27 displays the centroid output for the m/z range 611 to 621; this region contains
five species of DAG: 34:4, 34:3, 34:2, 34:1, and 34:0. In the case of 34:3 DAG, the
correction factor is calculated by multiplying the intensity at m/z 611.47 (34:4 DAG)
by the fraction .0639/.6500 representing the ratio of the [M+Na++2]+ to [M+Na+]+
portion of the 34:4 DAG signal. This factor is subtracted from the intensity at m/z
613.48 (34:3 DAG). This process is then repeated from left-to-right on the remaining
members of the 34:X DAG species. The results of these corrections are displayed as
dashed lines to the left of each signal line in Figure 27.
VI.3.2 Chromatographic separation and DAG detection
The importance of DAG species in the signaling pathways of cellular networks re-
quires a sensitive method for their efficient detection and quantification. Lipids that
do not possess a head group and therefore no electric charge (such as DAGs and tria-
cylglycerols) cannot be detected under normal ESI-MS conditions [25, 29] unless there
is a presence of a cation to provide sufficient dipole potential for ionization through
complexation. The addition of CH3COONa (5 mM final concentration) ensures the
formation of predominantly Na+ adducts.
In order to improve detection of DAGs, normal phase chromatography was utilized
to separate the DAGs from polar phospholipids (such as phosphatidylcholine (PC)
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and phosphatidylethanolamine (PE)), which would otherwise dominate the spectra.
Another possible obstacle in DAG quantification is the fact that other products of
ligand stimulation could produce peaks at the same m/z as some of the DAG species,
thereby obscuring the quantitative results. For that reason the separation technique
was also designed to reduce the presence of such products, leaving mainly cellular
DAG in the sample. The effectiveness of this technique is illustrated in Figure 26.
The m/z range where most PC and PE peaks appear is essentially void of detectable
peaks. Because of the high level of sensitivity of the methods for analysis (ESI-MS)
and the low levels of DAGs present in the samples, many contaminant peaks were
detected at the same or close m/z values as the peaks of interest. With the use of
glassware throughout the process of isolation and separation of DAGs and the addition
of CH3COONa, impurity peaks are eliminated, and predominantly [M+Na]
+ adduct
peaks are observed.
VI.3.3 Mathematical analysis of data and development of standard curves
From the analysis of a mixture of DAG standards in the cellular (RAW 264.7) extract
background (Fig. 28) in positive ionization ESI-MS, the sensitivity for each DAG
species varies greatly between the tested species. This indicates a variable ionization
efficiency of individual DAG species. Therefore, the need for normalization of each
individual species toward an internal standard was evident since it is well known
that peak intensities are dependent on acyl chain and degree of unsaturation [34].
Thus, all samples included 100 ng of 24:0 DAG as an internal standard. This lipid
is present in negligible amounts in resting RAW 264.7 cells and was not detected in
response to several ligands tested including PAF (data not shown). The intensities
for all observed species of DAG in the cellular extracts are expressed in terms of this
fixed internal standard. Consequently, the intensity of each species is replaced with
the ratio (intensity/24:0 DAG intensity) for modeling purposes.
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Figure 28: Positive ESI mass spectrum after adding a mixture of 9 diacylglycerol
standards to a RAW 264.7 cell background, extracting the phospholipids and then
performing a chromatographic separation on a silica gel column to remove the polar
phospholipids. 100 ng of each of the following standards was added: 24:0 DAG (M +
Na+ = 479), 28:0 DAG (M + Na+ = 535), 32:0 DAG (M + Na+ = 591), 34:1 DAG
(M + Na+ = 617)*, 34:0 DAG (M + Na+ = 619), 36:2 DAG (M + Na+ = 643),
36:0 DAG (M + Na+ = 647), 38:4 DAG (M + Na+ = 667), and 38:0 DAG (M +
Na+ = 675). *For example, for 34:1 DAG, this corresponds to a concentration of 1.6
pmol/µL.
For the development of standard curves, 8 synthetic DAG standards with chem-
ically defined acyl chains were used. The standards included 38:4, 38:0, 36:2, 36:0,
34:1, 34:0, 32:0, and 28:0 DAG, representing a broad range of acyl chain length and
degree of unsaturation. To determine the working curves for the 8 DAG species in the
presence of a RAW 264.7 cell background, titrations of these compounds were added
to cellular preparations. Three separate experiments each with twelve samples con-
taining approximately 3×106 RAW 264.7 cells were generated, and these samples were
spiked with varying amounts of the 8 DAG standards at 4 different levels in triplicate.
Standard additions included 0, 25, 50, and 100 ng in the first two experiments and
0, 10, 75 and 150 ng in the third experiment. In addition, all samples had 100 ng of
24:0 DAG as an internal standard. Samples were extracted and chromatographically
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separated as described above, redissolved in 9:1 chloroform:methanol and analyzed
by mass spectrometry. After data collection and isotopic correction, the intensities
were scaled using the intensity of the 24:0 DAG internal standard and plotted. For
each of the 8 standards, the following linear model was utilized to analyze the data:
Yi= β0 + β1X1i + β2jX2ji + β3jX1iX2ji + εi, (112)
where
Yi = normalized intensity of sample i;
X1i = amount of standard added to sample i in ng;
X2ji = factor for experiment containing sample i;
εi = error term for sample i.
In equation (112), the index j runs from 1 to 3 representing the three different ex-
periments, while the index i runs from 1 to 36 for the individual samples in these
experiments (i.e., the i indexes 1-12 describe the first experiment, 13-24 the second,
and 25-36 the third.). The variable X2ji is an indicator variable (either a 0 or a 1)
that takes the value 1 if the index i is an element of experiment j and 0 otherwise.
For example, X2,1,11 = 1 since the 11
th sample is part of the first experiment while
X2,3,21 = 0 since the 21
st sample is not part of the 3rd experiment. This initial model
of the normalized signal intensity fits a total of 8 parameters: β0, which represents a
global constant term, β1 which represents a global slope term, β21, β22, and β23 which
represent corrections to the y-intercept for the individual experiments, and β31, β32,
and β33 which represent corrections to the slope for the individual experiments. The
interaction term X1iX2ji was included to find possible interactions between the ex-
perimental preparation and the slope of the working curve for the internal standard,
therefore allowing an examination of the effects of cell culture conditions and instru-
ment variability on this slope.
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For all examined standards, when this more comprehensive model was compared
to the model where β31 = β32 = β33 = 0 (no interaction between experiment and slope)
using the appropriate F-statistic, there was found to be no significant improvement
in the sum of squared deviations. That is, over the tested ranges, the slope for the
addition of standard over the background level in the RAW 264.7 cells was not affected
by the initial signal level for the tested species, and the simpler linear model with no
interaction term was found to be appropriate for modeling purposes. Thus, the lines
for the standard additions are statistically parallel, regardless of fluctuations in the
initial signal strength. An example of this result is seen in Figure 29.
Figure 29: Effects on normalized signal strength of additions of 34:1 DAG to lipid
extracts from RAW 264.7 cells. Three separate experiments, each with 12 samples,
were performed where RAW 264.7 cells were seeded at 1.5x106 cells per well and
grown to 80% confluence (∼ 3.0 × 106 cells). Prior to addition of chloroform for
extraction, 100 ng (0.2 nmol) of 24:0 DAG and varying amounts (10, 25, 50, 75, 100,
and 150 ng) of 8 other DAG standards (28:0, 32:0, 34:0, 34:1, 36:0, 36:1, 38:0, and
38:4) were added to samples. Results for the normalized signal strength for 34:1 from
experiment 1 (N) and experiment 3 () are presented with individual best fit lines.
The lines are essentially parallel but have different intercepts.
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In contrast, the coefficients for the experimental factor representing a correction to the
intercept values, β21, β22, and β23, were significant for several of the standards, and
may represent variation in cell-culture or the initial signaling state of the preparations.
Using the multiple parameter linear model, the slopes for the 8 DAG species
titrated into the RAW 264.7 cell background were computed. These slopes and their
associated standard errors are given in Table 7. Multiple parameter linear modeling
[70] was accomplished using the S-Plus R© Version 3.3 for Windows software suite
(StatSci division of Mathsoft Inc. Seattle, Washington).
Table 7: Slopes (in normalized signal/ng DAG) for the eight DAG standards deter-
mined for the addition to background in a cellular system.
DAG MW m/z [M+Na+]+ Multiple R2 a Slope Std. Errorb
38:0 652.59 675.59 0.9804 0.00464 0.00012
38:4 644.54 667.53 0.9940 0.01168 0.00017
36:0 624.57 647.56 0.9810 0.00594 0.00015
36:2 620.54 643.53 0.9919 0.01044 0.00025
34:0 596.54 619.53 0.9851 0.00592 0.00015
34:1 594.52 617.51 0.9869 0.00657 0.00038
32:0 568.51 591.50 0.9879 0.00610 0.00016
28:0 512.44 535.43 0.9933 0.01016 0.00015
aMultiple R2 for the overall model fit. bStandard error for the slope coefficient.
A single sample of the 36 analyzed was removed from each of these regressions
because it displayed a large Cooks distance for seven of the 8 standard curves. Cooks
distance [12] provides a method for the identification of points with abnormally high
influence in a regression setting. The differences in the slopes for the various DAG
species are likely due to solubility/ionization differences in the delivery and ionization
of the compounds into the mass spectrometer.
To expand this analysis to encompass all the detectable DAG species, we employed
a multiple linear regression model to predict the slope of the working curve for a
specific DAG species based on its molecular characteristics. That is, we used the
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information obtained with the 8 synthetic standards to predict the behavior of the
other DAG species. Specifically, the total number of carbons in the acyl chains and
their degree of unsaturation were utilized as independent variables and the slope of
the working curve was the dependent variable. This model has functional form:
Si=α0 + α1C1i + α2C2i + εi, (113)
where
Si = slope for the ith DAG species observed intensity;
C1i = total number of carbons present in the acyl chains minus 24;
C2i = degree of unsaturation in the acyl chains
(total number of double bonds present);
εi = error term.
Our analysis included DAG species containing at least 24 total carbons in their acyl
chains, since shorter acyl chains are uncommon in mammalian cells, and the variable
C1i is adjusted to reflect this value as 0 (e.g. for a 38 carbon-containing DAG species,
the value of C1i is 38 - 24 = 14). This multiple parameter linear model was based on
the results from the 8 standards, and had a multiple R2-value of .851, indicating that
over 85% of the variation in the slopes for the various DAG species can be accounted
for with these two variables. The coefficients of this model for the assay system are
presented in Table 8.
The predicted slopes for the 8 synthetic standards were calculated for comparison
with those observed empirically (Table 9). Using the model, the predicted slopes
for the other 20 DAG species in our assay panel were computed. For example, the
predicted slope for 34:2 DAG would be calculated as: 0.01103 − 0.00048(34 − 24) +
.00190(2) = .01003. A range of total carbons from 28 to 38 and 0 to 6 double bonds
were considered.
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Table 8: Coefficients for the multiple parameter linear model in equation (113) used
to estimate the slopes of the calibration curves for species of DAG not included in
the titration analysis.
Coefficient Value Std. Error
α0
a 0.01103 0.00157
α1
b -0.00048 0.00016
α2
c .00190 0.00036
aGlobal intercept. bSlope coefficient for the acyl chain length.
cSlope coefficient for degree of unsaturation.
Slopes shown in Table 9 were incorporated into a program written in S-Plus R© for
the rapid quantitative analysis of a total of 28 DAG species. For the 8 species for
which the slopes were directly measured, this value was utilized in the software. The
other 20 species were measured using the estimated slope value from the linear model.
To estimate the level of detection for the method, we employed the Residual Standard
Error (RSE) of the model used in the determination of the slope of the calibration
curve, which estimates the variance around the calibration curve, and the slope of the
curve, from which the detectable amount of each lipid species can be computed. That
is, the detectable limit for a two sample t-test was calculated with equal variances set
to the RSE, and this number was divided by the slope of the calibration curve. This
produces an approximation to the minimum amount of lipid which can be detected
with the method. The results for the 8 internal standards are presented in Table 10.
Approximate limit of detection (LOD) values for the other 20 DAG species were
computed in a similar manner, using the predicted slope from Table 9 and the baseline
variability of each DAG species in place of the RSE. The differences in the detection
limit are likely caused by a variance in the sample preparation, and the larger limits of
detection correlate with the species (e.g. 34:1) present in larger quantities in resting
RAW 264.7 cells.
The method is applicable to other cellular extracts with different lipid composi-
tions and backgrounds (e.g., presence of other neutral lipids in the analyzed fractions)
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Table 9: Predicted slopes for the 28 species of DAG determined from the linear model
whose coefficients are displayed in Table 8.
DAG Species MW m/z [M+Na+]+ Observed Slopea Predicted slopeb
38:0 652.60 675.59 0.00464 0.00431
38:1 650.58 673.57 N/A 0.00621
38:2 648.57 671.56 N/A 0.00811
38:3 646.55 669.54 N/A 0.01001
38:4 644.54 667.53 0.01168 0.01191
38:5 642.52 665.51 N/A 0.01381
38:6 640.51 663.50 N/A 0.01571
36:0 624.57 647.56 0.00594 0.00527
36:1 622.55 645.54 N/A 0.00717
36:2 620.54 643.53 0.01044 0.00907
36:3 618.52 641.51 N/A 0.01097
36:4 616.51 639.50 N/A 0.01287
36:5 614.49 637.48 N/A 0.01477
34:0 596.54 619.53 0.00592 0.00623
34:1 594.52 617.51 0.00657 0.00813
34:2 592.51 615.50 N/A 0.01003
34:3 590.49 613.48 N/A 0.01193
34:4 588.48 611.47 N/A 0.01383
32:0 568.51 591.50 0.00610 0.00719
32:1 566.49 589.48 N/A 0.00909
32:2 564.48 587.47 N/A 0.01099
32:3 562.46 585.45 N/A 0.01289
30:0 540.48 563.47 N/A 0.00815
30:1 538.46 561.45 N/A 0.01005
30:2 536.44 559.43 N/A 0.01195
30:3 534.43 557.42 N/A 0.01385
28:0 512.44 535.43 0.01016 0.00911
28:1 510.43 533.42 N/A 0.01101
aEmpirically observed slope calculated for the assay conditions.
bSlope estimate calculated from the linear model.
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Table 10: Approximation for the limit of detection (ng) for the 8 internal standards
used in the titration experimentsa.
DAG RSEb slopec LODa
power of test 1-β = .50 1-β = .75
number of replicates 3 6 9 3 6 9
38:0 0.03052 0.00464 11.44d 6.88 5.41 15.43 9.55 7.56
38:4 0.04271 0.01168 6.36 3.66 3.01 8.58 5.3 4.2
36:0 0.03866 0.00594 11.32 6.8 5.35 15.27 9.44 7.47
36:2 0.06476 0.01044 10.79 6.49 5.11 14.55 8.99 7.13
34:0 0.03911 0.00592 11.5 6.91 5.44 15.49 9.58 7.58
34:1 0.09741 0.00657 25.81 15.51 12.21 34.78 21.77 17.03
32:0 0.0403 0.0061 11.49 6.92 5.44 15.49 9.59 7.59
28:0 0.03886 0.01016 6.65 4.01 3.15 8.97 5.55 4.39
aLimit of detection for the method was based on a two-sample t-test for a test with power (1 - probability of a Type II error) of
0.50 and 0.75, with three, six, and nine replicates respectively. The alpha level for all results was 0.05. bResidual Standard Error
for the linear model. cSlope of the calibration curve. dA limit of detection of 11.44 ng for 38:0 DAG corresponds to a concentra-
tion of 167 fmol/µl (or 17.5 pmol/sample).
after recalculating the slopes for the standard curves as described above and then per-
forming the linear regression technique using the newly defined slopes. Figure 30A
illustrates the linear relationship between the spiked and detected amounts of DAGs
in different cell extracts despite differences in the DAG peaks environment in the
mass spectra (Fig. 30B). By contrast a plasma preparation was analyzed by the same
approach. Short carbon chain DAG internal standards demonstrate good linearity,
while significant problems were encountered in accurate quantification of long-chain
polyunsaturated DAG species. Whether this was the result of selective enzymatic
processes that survived typical heat inactivation protocols (data not shown) or more
complex contaminants present in plasma (relative to cell extracts) that contribute to
ion suppression is unknown. This is the focus of ongoing investigation.
VI.3.4 Quantification of DAG species in RAW 264.7 cells after PAF stim-
ulation
To illustrate the method, RAW 264.7 cells were stimulated with 100 nM PAF, for
30 s, 1 min, 2 min, 3 min, and 5 min. PAF is a proinflammatory phospholipid
affecting various processes, including increasing cell permeability of blood vessels
and contracting assorted involuntary muscles. PAF stimulates G-protein coupled
receptors which activate phospholipase C and phospholipase A2 enzymes inducing
the formation of DAG and arachidonic acid, respectively.
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Figure 30: Illustration of differences in standard curves among different cellular ex-
tracts. Three different cellular extracts (RAW 264.7 macrophages, 1321N1 astrocy-
toma cells, and CHO-K ovarian cells) were tested using the method, by adding the
indicated amounts of DAG standards (see panel A) to the extracts. Though the slopes
for the standard curves may be different for each cellular extract, as is the case for
34:1 DAG (A), the relationships remain linear and the method of multiple linear re-
gression may still be applied to determine slopes of the remaining DAG species. The
spectra of the three cellular extracts with addition of 24:0 DAG internal standards
are shown in panel B.
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The graphical results for 4 of the 28 DAG species measured are shown in Figure 31.
Panels 31A and 31B show the kinetic behavior of 32:0 and 34:1 DAG. Both species
depict a slight initial decrease from baseline, followed by an increase at 1 minute,
and a subsequent and sustained decrease to levels below baseline. This response was
observed in most of the saturated and mono- and di-unsaturated fatty acid containing
DAG species.
In contrast, the PUFA-containing 38:4 and 38:5 DAG species in panels 31C and
31D display a drastically different trend, which was representative of all of the PUFA-
containing DAGs. They remain near baseline levels at 30 seconds and then exhibit
a sustained increase over baseline throughout the time course. These results demon-
strate species-dependent differential metabolism of DAGs suggesting specificity in
DAG metabolic pathways determined by acyl chain composition. Clearly, a full un-
derstanding of DAG metabolism requires an analytical method that provides the
detection and quantification of the individual species.
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Figure 31: Time-based behavior of four DAG species, with varying numbers of car-
bons and double bonds, after addition of 100 nM PAF. The cellular DAG levels were
measured as described in Section VI.3.3, using ESI-MS after chromatographic sepa-
ration. Time points contain a minimum of 9 replicates performed on three different
experimental days. Error bars represent 2 SEM. In panels A and B PAF addition
results in an initial decrease in total cellular DAG content that is followed by a brief
increase and subsequent decrease over baseline levels. In panels C and D, however,
PAF addition results in an immediate increase in total cellular DAG that is main-
tained throughout the tested time course.
116
chapter vii
conclusions and future directions
VII.1 Modeling Results
A mathematical model of the UDP signaling pathway in RAW 264.7 macrophages has
been developed to better understand the underlying mechanisms of species-specific
DAG production and degradation. In order to capture the necessary elements and
behaviors of this complex signaling pathway while also maintaining a certain degree
of simplicity, a minimalistic yet realistic approach has been taken, and a successful
quantitative representation of the events downstream activation of the P2Y6 receptor
has been achieved.
The mechanisms of receptor activation and desensitization were modified for the
P2Y6 receptor from a detailed description given by Lemon in P2Y2 receptors [39]
in order to accurately represent the slow receptor internalization of surface P2Y6
receptors seen by Brinson and Harden [6].
There are multiple pathways which could be involved in the production of IP3 and
DAG, as multiple G-protein subunits and isoforms can activate multiple isoforms of
PLC. This often depends on the cell type under consideration as well as the receptor
or receptors undergoing stimulation. Since P2Y6 receptors have been shown to couple
to the Gαq isoform [86], and PLCβ-3 isoforms have been shown to exhibit strongest
sensitivity to Gαq [72], we have assumed a single mechanism for PIP2 hydrolysis:
activation of Gαq and PLCβ-3.
As modeling Ca2+ dynamics was not been a focus of this work, Ca2+ contribution
in the signaling pathway was formed after a model previously developed by Li and
Rinzel [40] and was handled in such a way as to treat Ca2+ more as an input into
the model. Therefore, parameter values for the Ca2+ module were chosen so as to
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most accurately mimic the experimental Ca2+ data in the RAW 264.7 population
data from the Alliance for Cellular Signaling (http://www.signaling-gateway.org).
Initial efforts using the canonical pathway for DAG production and degradation
(via PIP2 hydrolysis only) were unsuccessful, as we were unable to reproduce the be-
havior seen experimentally from different species of DAG. In particular, the biphasic
dynamics of mono- and di-unsaturated DAGs could not be reproduced for any choice
of parameter values. Furthermore, the general theory that later DAG production
originates from PLD activity does not hold true in RAW 264.7 macrophages stimu-
lated with UDP, as we found there to be no PLD activity in these cells post agonist
stimulation with UDP. Instead, upon incorporating into this canonical pathway a
known pathway in DAG metabolism involving a second pool of DAG present in high
concentrations in resting cells, we were able to obtain in silico results comparable
to those seen empirically. Under this two-pool model structure for DAG kinetics
shown in Figure 2, we could reproduce differential kinetics among multiple species
of DAG, holding all parameters fixed except those directly related to the production
and degradation associated with different DAG species. For the same choice of all
remaining rate parameters, we obtained a good fit for the experimental results of IP3
and Ca2+.
Sensitivity analysis of model output to variations in model parameters was per-
formed using a multiple linear regression model. The vast majority of model coeffi-
cients of determination, R2y, were all sufficiently close to one for all time points and
for all model outputs, with the smallest values being greater than 0.8. Thus, the stan-
dardized regression coefficients were proven to be appropriate measures of parameter
sensitivity. Both IP3 and DAG were shown to be sensitive to the rate of receptor
phosphorylation, kp, and the rate of PIP2 replenishment, krep, suggesting that the
uncertainty in the output of these two variables could be significantly reduced by
obtaining a better estimate of these two rate parameters. DAG was seen to be most
sensitive to the activation and degradation parameters of DAGp2 and the degradation
118
rate of DAGp1, which were all directly estimated from the experimental data.
Rigorous analysis of the model behavior proved the local existence and uniqueness
of the full system of nonlinear ODEs, while global existence as well as positivity and
boundedness of solutions was established for the simplified model. Steady states for
the simplified model were also shown to be globally asymptotically stable within the
region of biological interest.
Ongoing work involves investigation of stability behavior for the full model, in-
volving the three-equation system for Ca2+ dynamics. We would also like to relax the
assumption of a well-mixed cell to include the spacial aspects of the UDP signaling
pathway through incorporation of partial differential equations as well as inclusion
of delay terms to better represent what is seen experimentally and known to be true
biologically.
VII.2 Pathway Analysis Results
As the mathematical modeling suggested the addition of another branch in the sig-
naling pathway, we conducted a set of experiments to test this hypothesis. First, the
two-dose UDP data showed that both levels of UDP produce a similar DAG response
out to 15 minutes. For the higher UDP dose, the level of DAGs produced at 15
minutes was slightly higher than in the lower dose. Furthermore, the response from
the higher dose peaked at 15 minutes and was recovering by 30 minutes, whereas the
levels for the lower dose at 30 minutes were either similar to those at 15 minutes or
slightly higher. This suggests that for the higher dose, the cells are responding more
rapidly.
Next, there were two major results from the R59949 study: 1) the inhibitor caused
a decrease in DAG levels over baseline, though not all of these decreases were seen to
be significant, and 2) for most of the PUFA-containing and mono- and di-unsaturated
DAGs, the inhibitor had the greatest effect at the 30 second time point, where levels
were significantly higher with cells pretreated with 10 µM R59949 and stimulated
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with 25 µM UDP compared to non-pretreated cells stimulated with 25 µM UDP.
This data suggests a role for DAG kinase in these DAG species immediately after
UDP stimulation.
Although Propranolol had no effect on the UDP response for 38:4 DAG, it ap-
peared to eliminate the UDP response in many of the mono- and di-unsaturated
DAGs. This together with the R59949 data suggests an interplay between DAG ki-
nase and LPP. We also conducted a global lipid analysis of the effects of Propranolol.
In unstimulated cells pretreated with Propranolol, we observed an increase in levels of
mono- and di-unsaturated and saturated PAs throughout the tested timecourse, sug-
gesting that there exists a constitutively active DAG kinase and lipid phosphate phos-
phatase which are phosphorylating mono- and di-unsaturated and saturated DAGs
and dephosphorylating mono- and di-unsaturated and saturated PAs, respectively,
in resting cells. In stimulated cells pretreated with Propranolol, however, there was
no significant increase in the mono- and di-unsaturated and saturated PAs over the
amount of PA produced from Propranolol alone. For the PUFA-containing DAGs,
especially 38:4 DAG, Propranolol had essentially no effect on the UDP response. For
most of the PUFA containing PAs, Propranolol did not significantly increase levels
in resting cells and had no significant effect on the UDP response. This also agrees
with our two-pool model (Fig. 2), if we assume that Propranolol is affecting the
transfer of PI to the plasma membrane: If there exist resting levels of mono- and
di-unsaturated and saturated DAGs, inhibition of constitutively active LPP would
lead to a depletion of the DAG pool and an increase in PA. If the remaining parts
of the pathway were left intact, upon stimulation we should still see an increase in
these DAG species through PA conversion to CDP-DG to PI, which is shuttled to the
plasma membrane, phosphorylated to phosphatidylinositol monophosphate and again
to PIP2, which is hydrolyzed to form DAG. Since we did not see an increase in mono-
and di-unsaturated and saturated DAGs with Propranolol and UDP, we must assume
Propranolol is somehow affecting this part of the pathway. We still have an increase
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in PUFA-containing DAGs when cells have been pretreated with Propranolol since
the majority of these DAGs were coming from hydrolysis of existing PIP2. There was
also no increase in PUFA-containing PAs after pretreatment with Propranolol since
there were low basal levels of PUFA-containing DAGs.
The remaining inhibitors tested at the 15 minute time point gave responses in
agreement with the two-pool model for DAG production. Of special mention is the
effect of U73122, which essentially eliminated the UDP response for most of the
DAG species. This behavior would be expected within the two-pool model pathway
structure, as the majority of DAG production from UDP stimulation comes through
hydrolysis of PIP2.
VII.3 DAG Quantification Results
Finally, we demonstrate here that DAG molecular species can be reliably quantified
from a cellular extract by ESI-MS. The newly developed multiple linear regression
model for raw mass spectral data analysis allows adjustment for the differences in
ionization due to the differences in acyl chain composition as well as compensation
for the nature of the lipid extracts (cell type and/or instrumental variability). The
methodology described here also calculates the contributions of individual isotopic
molecular species to each parent ion peak, making it more accurate and useful in the
quantitative determination of a low abundant class of lipids such as diacylglycerols.
The optimized ionization and detection conditions together with the inclusion of an
internal standard permit the quantitative determination of 28 DAG species present
in a RAW 264.7 cell extract after ligand stimulation. The differential kinetic be-
havior of DAG species with different acyl chain composition after PAF stimulation
suggests a differential metabolism. With respect to the individual species detection
and quantification, the proposed analytical method offers a valuable tool for compre-
hensive understanding of DAG metabolism. This work also provides an example of
metabolomic profiling of mammalian cells. Differences between any two states can
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be compared (e.g., with or without a receptor ligand) in a discovery phase approach
[20, 63] which allows identification of changes in the relative abundance of different
lipid classes and even individual lipid species. Subsequent absolute quantification of
these changes require optimized separation approaches with tailored internal stan-
dards, such as those described here. The comprehensive analysis of species level
changes in the cellular lipome is an essential goal in understanding cellular networks
and identification of novel biomarkers.
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appendix
A. Additional SIMULINK Figures
Here we include all SIMULINK subsystems contained in the full SIMULINK model
in Figure 4 as well as a list of all blocks used and their corresponding function.
Figure 32: SIMULINK activated receptor subsystem.
Figure 33: SIMULINK inactivated receptor subsystem.
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Figure 34: SIMULINK activated G-protein subsystem.
Figure 35: SIMULINK PIP2 subsystem.
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Figure 36: SIMULINK IP3 subsystem.
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Figure 37: SIMULINK DAGp1 subsystem.
Figure 38: SIMULINK DAGp2 subsystem.
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Figure 40: SIMULINK h subsystem (from Ca2+ module).
Figure 41: SIMULINK c0 subsystem (from Ca
2+ module).
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Figure 42: SIMULINK blocks used in the model from Figure 4.
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B. MATLAB Code for Numerical Simulations
Here we include the MATLAB code used to generate all numerical simulations from
Section IV.2 and to perform sensitivity analysis discussed in Section IV.3.
B.1 M-file to create sample matrix
%---------------------------------------------------------------------
% create_sample_matrix.m
% THIS FILE IS USED TO CREATE A RANDOM SAMPLE MATRIX USING SIMLAB
% AND IS MADE TO RUN ON "hannah_odes.m" and "run_hannah_odes.m"
% THIS FILE IS A DERIVATIVE OF SIMLAB’S "sampleRepLatin.m" FILE
% WHICH CAN BE FOUND ON THE SIMLAB WEBSITE:
% http://simlab.jrc.cec.eu.int/
%---------------------------------------------------------------------
global final_time runstot sample
runstot = 5000; % total number of samples created
% equals total number of rows in sample matrix
gsaBegin %opens SIMLAB
% Below we add each input factor (parameter) using a uniform
% distribution where the left and right endpoints are 10% variations
% from the nominal value
addFacUnif(’p1’,1,[432,528,1],’initial_384_DAG’)
addFacUnif(’p2’,1,[450,550,1],’initial_341_DAG’)
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addFacUnif(’p3’,1,[18000,22000,1],’RT’)
addFacUnif(’p4’,1,[0.0001575,0.0001925,1],’kr_Lemon’)
addFacUnif(’p5’,1,[0.001575,0.001925,1],’kp_Lemon’)
addFacUnif(’p6’,1,[0.0054,0.0066,1],’ke_Lemon’)
addFacUnif(’p7’,1,[4.5,5.5,1],’K1_Lemon’)
addFacUnif(’p8’,1,[90,110,1],’K2_Lemon’)
addFacUnif(’p9’,1,[270000,330000,1],’GT’)
addFacUnif(’p10’,1,[22.5,27.5,1],’L’)
addFacUnif(’p11’,1,[0.1233,0.1507,1],’ka_tilde’)
addFacUnif(’p12’,1,[0.018,0.022,1],’kd’)
addFacUnif(’p13’,1,[0.000009,0.000011,1],’khyd_tilde’)
addFacUnif(’p14’,1,[0.0126,0.0154,1],’krep’)
addFacUnif(’p15’,1,[0.0054,0.0066,1],’kd3’)
addFacUnif(’p16’,1,[8100000,9900000,1],’PIP2T’)
addFacUnif(’p17’,1,[0.001539,0.001881,1],’k_dp2’)
addFacUnif(’p18’,1,[0.001764,0.002156,1],’k_ap2’)
addFacUnif(’p19’,1,[0.00108,0.00132,1],’k_dp1’)
addFacUnif(’p20’,1,[0.36,0.44,1],’Kc’)
addFacUnif(’p21’,1,[0.405,0.495,1],’x7fac’)
setMethodLatin(14237,runstot) % the first number is the seed, and the
% second number is the number of samples I want to generate using the
% Latin Hypercube sampling method
sample = createSample
% generate random sample and store under "sample"
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%sample_42 = [480 500 20000 0.000175 0.00175 0.006 5 100 300000 25
%0.137 0.02 1.00E-05 0.014 0.006 9000000 0.00171 0.00196 0.0012 0.4
%0.45]; %This sets the sample to all of the nominal values
%---------------------------------------------------------------------
B.2 M-file defining system of ODEs
function xdot = hannah_odes(t,x)
%HANNAH_ODES
%xdot = hannah_odes(t,x)
%---------------------------------------------------------------------
% Declaring global variables to be seen by "hannah_odes.m" as well as
% "create_sample_matrix.m" and the m-file to run the numerical
% simulations called "run_hannah_odes"
global Nav v m2uM kr_Lemon kp_Lemon ke_Lemon RT K1_Lemon K2_Lemon GT
global ka_tilde kd lambda khyd_tilde krep kd3 PIP2T PIP2T_conc k_dp2
global k_ap2 k_dp1 Kc CaT Kctilde L
global v1 d_ip3 d_act v2 c1 v3 k_er epsilon j_in v4 k_pl a d_inh
global zeta_341 zeta_384
global initial_384_DAG initial_341_DAG
global P i final_time runstot % global variables for random parameter
% matrix "P"
%---------------------------------------------------------------------
% Temp equations for Calcium module
temp1 = x(5)/(x(5) + d_ip3);
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temp2 = x(8)/(x(8) + d_act);
temp3 = (x(8)*x(8))/(k_er*k_er + x(8)*x(8));
temp4 = (x(8)*x(8))/(k_pl*k_pl + x(8)*x(8));
temp5 = d_inh / (x(8) + d_inh);
%---------------------------------------------------------------------
% XDOT: xdot with the random sample parameter matrix P (built in the
% file "create_sample_matrix.m")
xdot = [P(i,4) * P(i,3) - (P(i,4) + (P(i,5) * P(i,10) / (P(i,7) +
P(i,10))))*x(1) - P(i,4) * x(2); % x(1) = activated receptors
P(i,10)*((P(i,5)*x(1) / (P(i,7) + P(i,10))) - ((P(i,6)*x(2))/
(P(i,8) + P(i,10)))); % x(2) = phosphorylated receptors
P(i,11)*m2uM*x(1)*(P(i,9)-x(3)) - P(i,12)*x(3); % x(3) = GaGTP
-P(i,13) * x(8) / (P(i,20) + x(8)) * x(3) * x(4) + P(i,14) *
(P(i,16) - x(4)); % x(4) = PIP2
P(i,13)* x(8) / (P(i,20) + x(8)) * x(3) * x(4)* m2uM -
P(i,15) * x(5); % x(5) = IP3
P(i,13) * x(8) / (P(i,20) + x(8)) * x(3) * x(4)* m2uM -
P(i,19) * x(6) + P(i,17)*P(i,21)*x(7); % x(6) = DAGp1
-P(i,17) * x(7) + P(i,18) * (P(i,2) - x(7)); %x(7) = DAGp2
(v1*(temp1*temp1*temp1)*(temp2*temp2*temp2)*((x(9))^3) +
v2) * (x(10) - (1 + c1) * x(8)) - v3 * temp3 + epsilon *
(j_in - v4 * temp4); %x(8) = Ca2+
a * (x(8) + d_inh) * (temp5 - x(9)); %x(9) = h
epsilon * (j_in - v4 * temp4)]; %x(10) = c0
%---------------------------------------------------------------------
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B.3 M-file to run simulations and sensitivity analysis
%RUN_Hannah_Odes
%Script file to run hannah_odes and output plot
%---------------------------------------------------------------------
%Clearing statistical variables
clear res1 resint1 src1 srcint1 R2Fpe1
clear res2 resint2 src2 srcint2 R2Fpe2
clear res3 resint3 src3 srcint3 R2Fpe3
clear res4 resint4 src4 srcint4 R2Fpe4
clear res5 resint5 src5 srcint5 R2Fpe5
clear res6 resint6 src6 srcint6 R2Fpe6
clear res_DAG resint_DAG src_DAG srcint_DAG R2Fpe_DAG
clear res7 resint7 src7 srcint7 R2Fpe7
clear res8 resint8 src8 srcint8 R2Fpe8
clear res9 resint9 src9 srcint9 R2Fpe9
clear res10 resint10 src10 srcint10 R2Fpe10
clear b1 bint1 r1 rint1 stats1
clear b2 bint2 r2 rint2 stats2
clear b3 bint3 r3 rint3 stats3
clear b4 bint4 r4 rint4 stats4
clear b5 bint5 r5 rint5 stats5
clear b6 bint6 r6 rint6 stats6
clear b341 bint341 r341 rint341 stats341
clear b7 bint7 r7 rint7 stats7
clear b8 bint8 r8 rint8 stats8
clear b9 bint9 r9 rint9 stats9
clear b10 bint10 r10 rint10 stats10
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clear i j k m q tspan final_time P
%---------------------------------------------------------------------
% Declaring global variables to be seen by "hannah_odes.m" as well as
% "create_sample_matrix.m" and the m-file to run the numerical
% simulations called "run_hannah_odes"
global Nav v m2uM kr_Lemon kp_Lemon ke_Lemon RT K1_Lemon K2_Lemon GT
global ka_tilde kd lambda khyd_tilde krep kd3 PIP2T PIP2T_conc k_dp2
global k_ap2 k_dp1 Kc CaT L
global v1 d_ip3 d_act v2 c1 v3 k_er epsilon j_in v4 k_pl a d_inh
global zeta_341 zeta_384
global initial_384_DAG initial_341_DAG
global P i final_time runstot sample
% global variables for random parameter matrix
%---------------------------------------------------------------------
P = sample; % random sample matrix of model parameters for
% "hannah_odes.m"
final_time = 450; % number of points to plot for each graph
tspan(1) = 0;
for j = 2:final_time + 1
tspan(j) = tspan(j-1)+4;
end
% tspan = [0 1800]; % set time span to integrate over 1800 seconds
% x0 = [1,0,0,1,0,0,1,0.00058,0.8,2]; % sets initial conditions
%---------------------------------------------------------------------
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% Conversion constants
Nav = 6.02252e23; % Avogadro’s constant
v = 5e-13; % Cell volume in L; taken from Sasada 1983, who used
% 395-589 um^3 which is approximately 5e-13L since 1 m^3=1000 L
% (also, 1e15 um^3 = 1 L) (1 um = 1 micron)
m2uM = 1 / (Nav * v * 1e-6); % multiply this by # of molecules to get
% concentration in uM
uM2pmoles = 1e6 * 5e-013; % multiply this by quantity in uM to get
% # of pmoles
uM2ng384 = 1e3 * v * 644; % multiply this by quantity in uM to get
% # ng of 38:4 DAG (since mass of 38:4 is 644)
uM2ng341 = 1e3 * v * 594; % multiply this by quantity in uM to get
% # ng of 34:1 DAG (since mass of 34:1 is 594)
initial_384_DAG = 480; % calculated value
% P(i,1)
initial_341_DAG = 500; % calculated value
% P(i,2)
%---------------------------------------------------------------------
% Parameters for Lemon’s receptor equations
% NOTE: These parameters fit Harden 2001 P2Y6 data as well
RT = 20000; % total number of P2Y2 receptors in 1321N1 cells
136
% taken from Garrad et al. (1998)
% P(i,3)
kr_Lemon = 0.000175; % (in /s)
% taken from Lemon
% receptor recycling rate
% P(i,4)
kp_Lemon = 0.00175; % (in /s) receptor phosphorylation rate
% best fit for SIMULINK estimation 070404d
% P(i,5)
ke_Lemon = 0.006; %(in /s) receptor endocytosis rate
% taken from Lemon
%P(i,6)
K1_Lemon = 5; % (in uM)
% unphosphorylated receptor dissociation constant
% taken from Lukas 2004a and Flaherty 2007
% P(i,7)
K2_Lemon = 100; % (in uM)
% phosphorylated receptor dissociation constant
% taken from Lemon
% P(i,8)
%---------------------------------------------------------------------
%% Parameters G-protein cascade and DAG dynamics
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GT = 3e5; % total number of G-protein molecules in the cell
% taken from Flaherty 2007 (measured in RAW)
% P(i,9)
L = 25; % (in uM) % ligand concentration
% P(i,10)
ka_tilde = 0.137 * m2uM * RT; % nondim. G-protein activation rate
% 0.137 /uM /s taken from Flaherty 2007
% P(i,11)
kd = 0.02; % (in /s) % GTP-ase parameter
% Mahama & Lindermann 1994
% P(i,12)
khyd = 1e-005; % (in /#mol /s) % effective hydrolysis rate
% SIMULINK 070404d
khyd_tilde = 1e-005 * GT; % khyd for nondim. system
% P(i,13)
krep = 0.014; % (in /s) % recycling of PIP2 to PM
% SIMULINK 070404d
% P(i,14)
kd3 = 0.006; % (in /s) % IP3 removal rate to IP4 or IP2
% SIMULINK 070404d
% P(i,15)
138
PIP2T = 9e6; % initial number of PIP2 molecules
% estimated from mass spec measurements in RAW cells
% P(i,16)
% PIP2T_conc = P(:,16)*m2uM;
% converts number of PIP2T to concentration (uM)
k_dp2 = 0.00171; % (in /s)
% effective phosphorylatoin rate of DAG from pool2
% better fit for SIMULINK 070404d (for 34:1 DAG)
% P(i,17)
% k_dp2 = 0.0050712; value for 38:4 DAG from SIMULINK 070404m
k_ap2 = 0.00196; % (in /s)
% effective production rate of pool 2 DAG
% SIMULINK 070404d (for 34:1 DAG)
% P(i,18)
k_dp1 = 0.0012; % (in /s)
% effective degradation rate of pool 1 DAG (PM)
% SIMULINK 070404d
% P(i,19)
Kc = 0.4; % (in uM)
% Ca2+ dissociation constant from PLC
% taken from Flaherty 2007
% P(i,20)
x7fac = 0.45; % controls the percentage of pool 2 DAG immediately used
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% for pool 1 DAG production (to in effect simulate the delayed response
% SIMULINK 070404d
% P(i,21)
zeta_341 = initial_341_DAG/(m2uM*PIP2T);
zeta_384 = initial_384_DAG/(m2uM*PIP2T);
N = 8e6; % number of cells we are simulating for DAG
%---------------------------------------------------------------------
%Paramters for Ca2+ contribution
v1 = 40; % (in /s)
% taken from Li
d_ip3 = 0.2; %(in uM)
% taken from Li
d_act = 0.4; %(in uM)
% taken from Li
v2 = 0.00508; % (in /s)
% SIMULINK est. on 3/30/07
c1 = 0.185;
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% taken from De Young 1992
v3 = 0.24; % (in uM /s)
% taken from Li
k_er = 0.4; % (in uM)
% taken from Lemon
epsilon = 0.01;
% taken from Li 1994 and De Young 1992
j_in = 0.44715; % (in uM /s)
% SIMULINK est. on 3/30/07
v4 = 1.3958; % (in uM /s)
% SIMULINK est. on 3/30/07
k_pl = 0.015555; % (in uM)
% SIMULINK est. on 3/30/07
a = 3.1; % (in /s)
% SIMULINK est. on 3/30/07
d_inh = 0.02; % (in uM)
% taken from Lemon
%---------------------------------------------------------------------
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% ODE solver that calls "hannah_odes" and integrates the system of
% odes
clear y y1 y2 y3 y4 y5 y6 y7 y8 y9 y10
for i = 1:runstot % "i" goes from 1 to the number of rows in P
% zeta_341 = .1*initial_341_DAG/(m2uM*P(i,16));
x0 = [P(i,3),0,0,P(i,16),0,0,P(i,2),0.0009,0.8,2];
[t,x] = ode15s(@hannah_odes, tspan, x0);
% evaluate ODEs using ode15s solver
y(:,:,i) = x;
% hold on
plot(t,(x(:,6)*uM2ng341*N + (x(:,7)-P(i,2))*uM2ng341*N))
% plot(t,(x(:,6)*PIP2T_conc*uM2ng384*N + (x(:,7)-1)
% *initial_384_DAG*uM2ng384*N))
% plot(t,(x(:,5)*P(i,16)*m2uM*uM2pmoles*3.5e5),’k’)
% plot pmoles of IP3 per 3.5E5 cells
% Note: I can include the plot functions in this loop to see
% what’s happening to the shape of each graph for each of the
% sample matrices.
end
% hold off
% Here I’m getting the y’s in the form that’s easier to input into
% SimLab
for k = 1:final_time+1 % the k’s are time points
for m = 1:runstot % the m’s are sample numbers
y1(m,k) = y(k,1,m);
% e.g. y1(5,10) = the value of y1 at the 10th
% time interval, for the 5 sample in the parameter matrix P
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y2(m,k) = y(k,2,m);
y3(m,k) = y(k,3,m);
y4(m,k) = y(k,4,m);
y5(m,k) = y(k,5,m);
y6(m,k) = y(k,6,m);
y7(m,k) = y(k,7,m);
y8(m,k) = y(k,8,m);
y9(m,k) = y(k,9,m);
y10(m,k) = y(k,10,m);
end
end
%---------------------------------------------------------------------
%%%%%%%%%%%%%%%%%%%%%% PLOT IP3 %%%%%%%%%%%%%%%%%%%%%%%%%
% plot(t,(x(:,5)*uM2pmoles*3.5e5),’k’)
% plots pmoles of IP3 per 3.5E5 cells
% ylabel(’{\bf \Delta IP_3 (in pmoles per 3.5E5 cells)}’)
ip3t = [0 180 240 300 600 900 1200 1800];
ip3_data = [0.00 8.78 8.94 7.46 6.74 5.95 5.15 1.25];
ip3_error = [0.55 1.64 2.83 1.59 0.83 1.08 1.20 2.09];
%used to plot IP3 data points
% hold on
% errorbar(ip3t,ip3_data,ip3_error,’k.’)
% hold off
% axis([-200 2000 -2 18]);
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%%%%%%%%%%%%%%%%%%%%%% PLOT 34:1 DAG %%%%%%%%%%%%%%%%%%%%%%%%%
% plot(t,(y6(1,:)*uM2ng341*N)+ (y7(1,:)-P(2))*uM2ng341*N,’k’)
% plot(t,(x(:,6)*PIP2T_conc*uM2ng341*N)+ (x(:,7)-1)
% *initial_341_DAG*uM2ng341*N,’k’)
% plot ng amount of total 34:1 DAG
% ylabel(’{\bf \Delta 34:1 DAG (in ng per 8E6 cells)}’)
% xlabel(’{\bf time (seconds)}’)
dag341t = [0 30 120 180 900 1800];
dag341_data = [0 11.01 43.20 10.86 103.61 75.01];
dag341_error = [0 18.88 28.57 9.59 13.34 22.90];
% used to plot 34:1 DAG data points
% hold on
% errorbar(dag341t,dag341_data,dag341_error,’k.’)
% hold off
% axis([-200 2000 -10 120]);
%%%%%%%%%%%%%%%%%%%%%% PLOT 38:4 DAG %%%%%%%%%%%%%%%%%%%%%%%%%
% plot(t,(y6(1,:)*PIP2T_conc*uM2ng384*N)+ (y7(1,:)-1)
% *initial_384_DAG*uM2ng384*N,’k’)
% plot(t,(x(:,6)*PIP2T_conc*uM2ng384*N)+ (x(:,7)-1)
% *initial_384_DAG*uM2ng384*N,’k’)
% plot ng amount of total 38:4 DAG
% ylabel(’{\bf \Delta 38:4 DAG (in ng per 4E6 cells)}’)
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% xlabel(’{\bf time (seconds)}’)
dag384t = [0 30 120 180 900 1800];
dag384_data = [0 2.50 14.54 26.20 45.48 25.98];
dag384_error = [0 2.83 3.97 3.58 5.43 4.78];
% used to plot 38:4 DAG data points
% hold on
% errorbar(dag384t,dag384_data,dag384_error,’k.’)
% hold off
% axis([-200 2000 -10 60]);
% plot(t,y8(1,:)) % Ca2+ trace
%%%%%%%%%%%%%%%% STATS FOR Y1 = activated receptors %%%%%%%%%%%%%%%%%%
for q=1:final_time+1
[b1,bint1,r1,rint1,stats1] = regress(y1(:,q),[ones(runstot,1) P]);
src1(:,q) = b1;
% SRC for coefficients at t(q)
srcint1(:,:,q) = bint1;
% SRC interval for coefficients at t(q)
res1(:,q) = r1;
% residuals for coefficients at t(q)
resint1(:,:,q) = rint1;
% residual intervals for coefficients at t(q)
R2Fpe1(q,:) = stats1;
% R^2 value, Fstatistic, p-value for F statistic,
% and error for coefficients at t(q)
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end
% rcoplot(res1(:,43),resint1(:,:,43)) % plots the residuals and their
% error bars for y1 at the 15th time point
%%%%%%%%%%%%%%%% STATS FOR Y2 = phos. receptors %%%%%%%%%%%%%%%%%%%%%
for q=1:final_time+1
[b2,bint2,r2,rint2,stats2] = regress(y2(:,q),[ones(runstot,1) P]);
src2(:,q) = b2;
% SRC for coefficients at t(q)
srcint2(:,:,q) = bint2;
% SRC interval for coefficients at t(q)
res2(:,q) = r2;
% residuals for coefficients at t(q)
resint2(:,:,q) = rint2;
% residual intervals for coefficients at t(q)
R2Fpe2(q,:) = stats2;
% R^2 value, Fstatistic, p-value for F statistic,
% and error for coefficients at t(q)
end
% rcoplot(res2(:,15),resint2(:,:,15)) % plots the residuals and their
% error bars for y2 at the 15th time point
%%%%%%%%%%%%%%%% STATS FOR Y3 = G-proteins %%%%%%%%%%%%%%%%%%%%%%%%%%
for q=1:final_time+1
[b3,bint3,r3,rint3,stats3] = regress(y3(:,q),[ones(runstot,1) P]);
src3(:,q) = b3;
% SRC for coefficients at t(q)
srcint3(:,:,q) = bint3;
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% SRC interval for coefficients at t(q)
res3(:,q) = r3;
% residuals for coefficients at t(q)
resint3(:,:,q) = rint3;
% residual intervals for coefficients at t(q)
R2Fpe3(q,:) = stats3;
% R^2 value, Fstatistic, p-value for F statistic,
% and error for coefficients at t(q)
end
% rcoplot(res3(:,15),resint3(:,:,15)) % plots the residuals and their
% error bars for y3 at the 15th time point
%%%%%%%%%%%%%%%% STATS FOR Y4 = PIP2 molecules %%%%%%%%%%%%%%%%%%%%%%
for q=1:final_time+1
[b4,bint4,r4,rint4,stats4] = regress(y4(:,q),[ones(runstot,1) P]);
src4(:,q) = b4;
% SRC for coefficients at t(q)
srcint4(:,:,q) = bint4;
% SRC interval for coefficients at t(q)
res4(:,q) = r4;
% residuals for coefficients at t(q)
resint4(:,:,q) = rint4;
% residual intervals for coefficients at t(q)
R2Fpe4(q,:) = stats4;
% R^2 value, Fstatistic, p-value for F statistic,
% and error for coefficients at t(q)
end
% rcoplot(res4(:,15),resint4(:,:,15)) % plots the residuals and their
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% error bars for y4 at the 15th time point
%%%%%%%%%%%%%%%% STATS FOR Y5 = IP3 concentration %%%%%%%%%%%%%%%%%%%
for q=1:final_time+1
[b5,bint5,r5,rint5,stats5] = regress(y5(:,q),[ones(runstot,1) P]);
src5(:,q) = b5;
% SRC for coefficients at t(q)
srcint5(:,:,q) = bint5;
% SRC interval for coefficients at t(q)
res5(:,q) = r5;
% residuals for coefficients at t(q)
resint5(:,:,q) = rint5;
% residual intervals for coefficients at t(q)
R2Fpe5(q,:) = stats5;
% R^2 value, Fstatistic, p-value for F statistic,
% and error for coefficients at t(q)
end
% rcoplot(res5(:,15),resint5(:,:,15)) % plots the residuals and their
% error bars for y5 at the 15th time point
%%%%%%%%%%%%%%%% STATS FOR Y6 = DAG p1 %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
for q=1:final_time+1
[b6,bint6,r6,rint6,stats6] = regress(y6(:,q),[ones(runstot,1) P]);
src6(:,q) = b6;
% SRC for coefficients at t(q)
srcint6(:,:,q) = bint6;
% SRC interval for coefficients at t(q)
res6(:,q) = r6;
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% residuals for coefficients at t(q)
resint6(:,:,q) = rint6;
% residual intervals for coefficients at t(q)
R2Fpe6(q,:) = stats6;
% R^2 value, Fstatistic, p-value for F statistic,
% and error for coefficients at t(q)
end
% rcoplot(res6(:,15),resint6(:,:,15)) % plots the residuals and their
% error bars for y6 at the 15th time point
%%%%%%%%%%%%%%%% STATS FOR Y6 + Y7 = DAG p1 + DAG p2%%%%%%%%%%%%%%%%%
for q=1:final_time+1
[b341,bint341,r341,rint341,stats341] =
regress((y6(:,q)+ (y7(:,q))),[ones(runstot,1) P]);
src_DAG(:,q) = b341;
% SRC for coefficients at t(q)
srcint_DAG(:,:,q) = bint341;
% SRC interval for coefficients at t(q)
res_DAG(:,q) = r341;
% residuals for coefficients at t(q)
resint_DAG(:,:,q) = rint341;
% residual intervals for coefficients at t(q)
R2Fpe_DAG(q,:) = stats341;
% R^2 value, Fstatistic, p-value for F statistic,
% and error for coefficients at t(q)
end
% rcoplot(res_DAG(:,15),resint_DAG(:,:,15)) % plots the residuals and
% their error bars for y6+y7 at the 15th time point
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%%%%%%%%%%%%%%%% STATS FOR Y7 = DAG p2 %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
for q=1:final_time+1
[b7,bint7,r7,rint7,stats7] = regress(y7(:,q),[ones(runstot,1) P]);
src7(:,q) = b7;
% SRC for coefficients at t(q)
srcint7(:,:,q) = bint7;
% SRC interval for coefficients at t(q)
res7(:,q) = r7;
% residuals for coefficients at t(q)
resint7(:,:,q) = rint7;
% residual intervals for coefficients at t(q)
R2Fpe7(q,:) = stats7;
% R^2 value, Fstatistic, p-value for F statistic,
% and error for coefficients at t(q)
end
% rcoplot(res7(:,15),resint7(:,:,15)) % plots the residuals and their
% error bars for y7 at the 15th time point
%%%%%%%%%%%%%%%% STATS FOR Y8 = Ca2+ %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
for q=1:final_time+1
[b8,bint8,r8,rint8,stats8] = regress(y8(:,q),[ones(runstot,1) P]);
src8(:,q) = b8;
% SRC for coefficients at t(q)
srcint8(:,:,q) = bint8;
% SRC interval for coefficients at t(q)
res8(:,q) = r8;
% residuals for coefficients at t(q)
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resint8(:,:,q) = rint8;
% residual intervals for coefficients at t(q)
R2Fpe8(q,:) = stats8;
% R^2 value, Fstatistic, p-value for F statistic,
% and error for coefficients at t(q)
end
% rcoplot(res8(:,15),resint8(:,:,15)) %plots the residuals and their
% error bars for y8 at the 15th time point
%%%%%%%%%%%%%%%% STATS FOR Y9 = h %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
for q=1:final_time+1
[b9,bint9,r9,rint9,stats9] = regress(y9(:,q),[ones(runstot,1) P]);
src9(:,q) = b9;
% SRC for coefficients at t(q)
srcint9(:,:,q) = bint9;
% SRC interval for coefficients at t(q)
res9(:,q) = r9;
% residuals for coefficients at t(q)
resint9(:,:,q) = rint9;
% residual intervals for coefficients at t(q)
R2Fpe9(q,:) = stats9;
% R^2 value, Fstatistic, p-value for F statistic,
% and error for coefficients at t(q)
end
% rcoplot(res9(:,15),resint9(:,:,15)) % plots the residuals and their
% error bars for y9 at the 15th time point
%%%%%%%%%%%%%%%% STATS FOR Y10 = c0 %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
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for q=1:final_time+1
[b10,bint10,r10,rint10,stats10] =
regress(y10(:,q),[ones(runstot,1) P]);
src10(:,q) = b10;
% SRC for coefficients at t(q)
srcint10(:,:,q) = bint10;
% SRC interval for coefficients at t(q)
res10(:,q) = r10;
% residuals for coefficients at t(q)
resint10(:,:,q) = rint10;
% residual intervals for coefficients at t(q)
R2Fpe10(q,:) = stats10;
% R^2 value, Fstatistic, p-value for F statistic,
% and error for coefficients at t(q)
end
% rcoplot(res10(:,15),resint10(:,:,15)) % plots the residuals and their
% error bars for y10 at the 15th time point
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